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ABSTRACT
Fluorescent sensing systems offer the potential for minimally invasive monitoring 
with implantable devices, but they require carrier technologies that provide suitable 
immobilization, accessibility, and biocompatibility while maintaining adequate response 
characteristics. Towards the development of this goal, a general design of a biosensor 
with the capability of detecting different metabolites was investigated. The approach is 
based on the encapsulation of a competitive binding assay in microcapsules and 
monitoring the changes in fluorescence resonance energy transfer (FRET) in the presence 
of analyte. To experimentally demonstrate this type of sensing system, glucose was 
chosen as the model target analyte. The design, fabrication, and characterization of 
several embodiments of a non-consuming fluorescence affinity glucose sensor are 
described in this dissertation. The novel feature of this system used through out the work 
is the employment of microcapsules for entrapping the sensing assay, which allows for 
the free movement of sensing elements while maintaining their constant concentrations 
with continuously-varying analyte concentration.
Initially, a FRET based glucose sensor was demonstrated by encapsulating multi­
layers of Concanavalin A (Con A)/dextran in microcapsules. Even though microcapsules 
comprised of Con A/dextran complexes showed reasonable glucose sensitivity, there are 
some significant obstacles to practical use of this system due to toxicity, aggregation, and 
irreversible binding. Therefore, to overcome the limitations of Con A, an improved FRET
iii
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assay was developed by replacing Con A with apo-glucose oxidase (apo-GOx). Apo-GOx 
is highly specific toward P-D-glucose, reduces the concern over aggregation as it can 
only bind to one glucose molecule (whereas, Con A binds to four glucose molecules), and 
also could be more biocompatible than Con A by recombinant production.
The first attempt at the apo-GOx/dextran assay encapsulated in microcapsules 
used a blue-light-excited FRET pair (FITC/TRITC). The assay elements were 
encapsulated in microcapsules using photosensitive polymers (poly(styrene sulfonate) 
and diazoresin) in the shell structure. The results of glucose sensitivity experiments 
showed a controllable and reversible sensor response with sensitivity in the range of 2 -  6 
% /mM over the range of 0 -  40 mM glucose. In spite of the advantages of this system, it 
is not ideal for in vivo studies, as the short-wavelength dyes will be difficult to interrogate 
transdermally due to high tissue scattering. Additionally, diazoresin contains 
formaldehyde groups that could prove to be toxic.
To reduce the interference of tissue scattering, the sensor operating region was 
extended into the longer and near infrared (NIR) wavelength regions by choosing 
appropriate donor (Alexa Fluor™ 647)-acceptor (QSY21) pair and reference dye (Alexa 
Fluor™ 750). The competitive binding assay operating in red/near infrared region was 
loaded into organo/inorgano microcapsules using glycidyl-silane as the crosslinking 
element. These microcapsules exhibited glucose sensitivity of ~2-5%/mM over the range 
of 0-30mM, which is comparable to the assay operating in the visible region. Thus, this 
assay is superior to the apo-GOx/dextran based assays operating in visible region, 
because it has the advantages of excellent sensitivity, and a significant increase in the 
detected signal levels due to the use of NIR dyes (during in vivo measurements), and the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
use of silane simplifies the encapsulation procedure and also makes this system more 
biocompatible. Based on the sensitivity, specificity, and reversible response in the region 
of interest (0-30mM), this sensing system can potentially be used for glucose monitoring 
in diabetic patients.
These findings demonstrate the feasibility of designing different biosensors using 
apo-enzymes as specific molecular recognition elements in competitive binding assays. 
The concept of the encapsulation of a competitive binding assay in microcapsules is 
advantageous, as it allows for the stable entrapment of the sensing assay elements and 
free movement of the analyte molecules. Thus, the concept of sensing that is 
demonstrated in this dissertation can potentially be used to develop a wide variety of 
biosensors by choosing corresponding apo-enzyme and ligand molecules.
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CHAPTER 1
INTRODUCTION
In recent years, interest towards developing biosensors for continuous monitoring 
with high specificity has increased, mainly because of the potential of avoiding the long­
term side affects of many diseases, by taking appropriate measures when the disease is in 
its early stage. Several variations of biosensors were previously reported for various 
applications.1"4 Some of the molecular recognition techniques used in developing 
biosensors are based on antigen/antibody, enzyme/substrate, and affinity (competitive 
binding) interactions. One of the sensing mechanisms that has been extensively explored 
in the past, is the competitive binding process, which is based on the variations in the 
binding affinities of two molecules towards the substrate. The main goal of this 
dissertation is to develop a generic design for biosensors, based on the combination of 
competitive binding and fluorescence spectroscopic techniques. This design must also be 
applicable to the detection of a wide variety of analytes.
In order to demonstrate the working principle of this sensing system, glucose is 
chosen as the model analyte molecule, because of its importance and need in the 
biosensor industry. Biosensors for monitoring blood glucose are of special interest, 
because the incidence of diabetes mellitus is increasing uncontrollably worldwide, and is
1
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2one of the leading causes of death by disease, with over 170 million diabetics 
worldwide.5'7 Diabetes is a disease affecting the body’s ability to produce or use insulin 
and thus resulting in large fluctuations in blood glucose levels, unless proper treatment is
O 1A
provided in time. ’ When left untreated or improperly managed, diabetes can increase 
the risk of heart disease, adult blindness, kidney disease, and erectile dysfunction.11
Therefore, most diabetics are required to measure the blood glucose concentrations
8 12several times a day. ' In spite of the enormous advantages in monitoring glucose level 
several times a day, and the availability of about 40 types of glucose meters in the market 
place (which are based on the fmger-prick method), frequent monitoring is not widely 
practiced due to a number of reasons such as, painful testing procedures or ignorance of 
the advantages, difficulty in understanding the readings, tediousness, etc.10,13,14 Therefore, 
there is an urgent need for the development of a simple and painless monitoring system to 
help improve the lives and longevity of diabetic patients.
In an attempt to advance glucose sensing technology, a variety of minimally 
invasive continuous glucose monitoring systems (e.g. implantable needle-type 
amperometric electrode), have been introduced into the market.8’10’15,16 However, these 
instruments are not yet completely reliable, as they have problems associated with 
unpredictable drift, stability, lifetime, repeated calibration (~4 times a day), a long warm 
up time, etc.17,18 In spite of enormous efforts to develop implantable glucose monitoring 
systems, there are many parameters that need to be improved. In order to be frequently 
used by the diabetic patients, sensors should be less cumbersome, require fewer 
calibrations, have a biocompatible surface, offer long sensor lifetime, and understandable 
read-out technology.6 Other parameters that are necessary include repeatable sensor
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3fabrication, specificity, linear response in the region of interest, accuracy, and rapid 
response time. In order to meet all the requirements for the production of glucose sensors, 
different sensing approaches are being continuously explored. Among these, fluorescence 
spectroscopy is receiving significant attention because of its high sensitivity and 
suitability for fast and non- or minimally-invasive measurements.
Currently, fluorescence techniques are widely used as a read-out technology for 
various biosensors based on different working principles. Several variations of enzymatic 
activity and affinity based glucose sensors based on using fluorescence intensity and 
lifetime measurements have been previously reported in the literature19-23 and are 
proposed for in vivo use. However, a practical design for their use under in vivo 
conditions was not reported. Thus, there remains a need to develop an implantable 
glucose monitoring system permitting frequent monitoring of glucose level.
1.1 Implantable Glucose Sensors 
-  Under Research
In order to develop a subcutaneously implantable glucose sensor, the sensing 
assay chemistry must be encapsulated into a microcontainer, which can allow the analyte 
molecules to diffuse in, while holding the assay elements without leaching. The assay 
loaded microcontainers can then be implanted subcutaneously and interrogated remotely 
by exciting the fluorescent molecules in the microcontainers and collecting the emitted 
light coming out of the skin, the so called “smart tattoo” approach,24-27 as shown in 
Figure 1.1. This technology has significant advantages over other mechanisms, because 
there is no need for inserting any kind of probes, and it can also prevent some of the 
cytotoxicity problems without allowing the leaching of free assay elements.
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4The first sensor designed to function similar to the above-mentioned “smart 
tattoo” technology, was based on the encapsulation of lectin/dextran in poly(ethylene 
glycol) hydrogel spheres.26 However, the prototype of the fabricated sensors showed 
substantial leaching of assay components from the hydrogel spheres. The millimeter size 
of the spheres is also not appropriate for implantation, as the body mounts a substantial 
host response. There were also difficulties in the production of monodispersed and 
uniformly loaded spheres. These sensors showed sensitivity in the range of 0-600mg/dL. 
Although it was mentioned that the sensor response was 90% reversible, results were not 
shown.
Figure 1.1. (a) Skin cross-section showing the implanted sensors between dermis and epidermis, (b) 
Subcutaneous implantation of micropsheres loaded with sensing assay elements and interrogation of 
sensors by (c) exciting the fluorescent assay elements and (d) collecting the emitted light28
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51.2 Objectives and Novel Aspects
Due to the severe limitations of existing smart tattoo systems, this dissertation 
work is focused on developing smart tattoo based non-consuming glucose sensors by 
overcoming the problems associated with previously reported sensing systems. The 
sensing mechanism in this new system is based on the competitive displacement of ligand 
by target-analyte, in order to occupy a binding site on the receptor molecule. These 
changes in the distance between ligand and receptor are monitored using fluorescence 
spectroscopic techniques. The significant advancement in this design is the packaging of 
competitive binding assay in microscale containers. In fact, as the microcapsules are 
about 5 pm in diameter they can also be used as implantable sensors for frequent or 
continuous monitoring.
The novelty of this work is the demonstration of a general design of a new 
approach to the fluorescent affinity glucose sensing system based on a competitive 
binding assay. It is believed that this system can be extended to the detection of a wide 
variety of analytes other than glucose. The uniqueness in the competitive binding assay is 
the use of apo-enzyme (deactivated enzyme) as the receptor molecule whereby the apo- 
enzyme results in high specificity and does not exhibit the problems of aggregation and 
toxicity, which were seen with lectins. This design can potentially be used as a platform 
technology for detecting different analytes simply by selecting the appropriate enzyme 
and competitive ligand molecules.
In comparison to previously reported sensors, a significant achievement in this 
study is the efficient and stable encapsulation of sensing assay elements in microcapsules, 
without any loss in sensitivity which makes them more appropriate for use in the smart-
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6tattoo system. Also, this work demonstrates step-by-step development of the fluorescent 
affinity sensors operating in visible (green/orange, orange/red), and near-infrared (NIR) 
regions. Another notable feature is that even after extending the operating region from 
visible to NIR, there is no loss in sensitivity, which makes it more suitable for in vivo use, 
because there will be a significant increase in signal to noise ratio in NIR regions 
compared to shorter wavelengths. The important features of this sensing system are (1) 
non-toxic, which was the major disadvantage of all the lectin-based sensors, (2) efficient 
encapsulation of sensing assay elements in microcapsules, and (3) excellent sensor 
response of microcapsules comprised of sensing elements. The major objectives of this 
work are to design, fabricate glucose sensors and characterize its functional properties 
and response. Chapter Four to Chapter Seven will demonstrate various designs for 
developing glucose sensors, which have the potential to be used in minimally invasive 
systems based on the smart tattoo approach.
1.3 Organization of Chapters
The chapters in this dissertation are organized as follows. Chapter Two reviews 
various non-consuming fluorescence glucose monitoring techniques reported by different 
researchers and addresses the disadvantages in these systems and the need for 
improvements. Chapter Three explains the theory involved for the sensing mechanisms 
employed in this work. Chapter Four demonstrates for the first time a fluorescence 
glucose sensor based on the encapsulation of a Con A/dextran competitive binding assay 
into microcapsules. This work has been published in a peer reviewed journal, in a special 
issue on glucose sensing (Journal o f Fluorescence, 14 (5), 585-595, 2004). Chapter Five 
demonstrates the apo-glucose oxidase (apo-GOx)/dextran based glucose assay,
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7encapsulated in microcapsules. This is believed to be superior to the Con A/dextran 
approach, due to the reduced toxicity and higher specificity to P-D-glucose. This work 
was divided into two parts and was published in two peer reviewed journals, (apo- 
enzyme competitive binding assay in Biomacromolecules, 5(5), 1657-1661, 2004; 
microcapsule system for glucose sensing in Analytical Chemistry, 77(17), 5501-5511, 
2005). Chapter Six demonstrates the extension of apo-GOx/dextran based glucose sensor 
into the long wavelength (orange/red) visible light region. This work on the extension of 
the operating region of apo-GOx/dextran assay into longer wavelength regions was also 
submitted to a peer reviewed journal, Diabetes Technology and Therapeutics. Chapter 
Seven demonstrates a novel glucose sensor based on the quenching mechanism using the 
apo-GOx/dextran assay, operating in the NIR region. Also, this assay is encapsulated into 
organo/inorgano microcapsules using glycidyl-silane as the crosslinking element to 
entrap the loading assay elements. As this assay operates in the NIR region, it is superior 
to all the sensors demonstrated in the previous chapters. The successful demonstration of 
the competitive binding assay into NIR region indicates that the assay can be modified to 
meet the requirements of the application. Finally, Chapter Eight summarizes the major 
findings of this work and discusses possibilities of further experiments.
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CHAPTER 2
LITERATURE REVIEW
The main goal of this research is to develop a minimally invasive approach for 
glucose monitoring by designing subcutaneously implantable microcarriers comprising 
glucose sensitive materials. These microcarriers can be excited from outside the body 
using harmless visible or near infrared (NIR) light and the fluorescence light coming out 
of the skin can be collected using suitable detectors — the so-called “smart tattoo” 
concept. This chapter reports on the previous work on non-consuming fluorescent 
glucose sensors for the application as implantable systems. This discussion starts with a 
brief description of the types of glucose sensors (enzymatic and affinity), and then 
focuses more on the different types of affinity (non-consuming) based glucose sensors.
2.1 Types of Glucose Sensors
Frequently used transduction mechanisms in glucose sensors reported to-date, can 
be classified into two groups, electrochemical and optical techniques.1"4’6 Electrochemical 
sensors are the glucose sensors which include one of the following devices: 
amperometric, potentiometric, and conductometric devices, which are based on 
monitoring the electric current associated with the electrons involved in the redox 
processes, concentration of selective ions using ion selective electrodes, and conductance
8
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9changes due to changes in the overall ionic environment, respectively.6,29 In spite of good 
in vitro results, long term in vivo glucose monitoring with amperometric sensors has not 
been completely successful due to a gradual loss of sensor function, which indicates that 
the surrounding environment plays an important role in the sensor’s behavior. These 
sensors faced challenges in preventing the biofouling of enzyme-containing membranes, 
frequent replacement of the sensor, insufficient selectivity, and only allowing for 
retrospective data analysis.30 The influences of wound healing, host response to the 
implant, and blood supply in the surrounding tissue on sensor performance need to be 
addressed. Also, more insight is needed in the physiological processes at the sensor- 
tissue interface.31 The sensors based on reverse-iontophoresis have most of the defects 
found in amperometric sensors such as, the need of calibration on a daily-basis. Sensors 
based on optical measurements are an attractive alternative, as they may transduce 
chemical concentration information into an optical signal which may be analyzed
T9 •spectroscopically. Among all the available techniques, fluorescence measurements are 
considered to be superior; the reasons for which, are described below.
Need for fluorescence measurements
Fluorescence spectroscopy is one of the widely used techniques in biomedical 
research. Its sensitivity, which is a thousand times greater than absorption spectroscopy, 
is a major asset of this technique. The high sensitivity is due to the emission intensities 
measured with a lower background level. This technique allows the research at very low 
concentrations, which is very economical when working with expensive reagents.33'35 
Fluorescence measurements cause no damage to the body, as long as sub UV frequencies 
are not used in excitation. As NIR light can pass through several centimeters in tissue, by
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selecting suitable NIR dyes, the sensors can be efficiently interrogated from outside the 
body by sending light in and then collecting the light coming out of the skin. Thus, this 
technique opens the door for minimally-invasive monitoring.
By using different fluorescent dyes, analyte-sensitive structural and micro­
environment changes in a molecule can be monitored in real-time. For example, 
fluorescence intensity of anilino-naphthalenesulfonic acid (ANS) conjugated to glucose 
binding protein decreases with the addition of glucose, as it is exposed to a high polarity 
environment. Also, fluorescence resonance energy transfer (FRET), which is described 
in detail in Chapter Three, is widely used for monitoring the glucose-sensitive distance 
changes (~ few angstroms) between two molecules.22
In the enzymatic sensors (e.g. glucose oxidase, GOx), GOx catalyzes the 
conversion of P-D-glucose and oxygen to D-glucono-1,5-lactone and hydrogen
7/r ->7
peroxide. ’ In these sensors, fluorescent dyes are incorporated in the sensing assay in 
order to indicate the changes in the concentration of the resultant by-products, such as 
change in pH due to the production of acid, and change in oxygen levels during the 
reaction between glucose and GOx. Thus, the fluorescence techniques are widely used all 
over the world for developing glucose sensors and various biomedical applications. The 
fluorescence glucose sensors can be broadly divided into two categories (a) Enzymatic 
sensors, and (b) Affinity sensors. The following section provides a brief description of 
enzymatic sensors, with detailed discussion on affinity sensors, which is the research 
topic of this dissertation.
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2.1.1 Enzymatic Sensors
Most of the currently available glucose sensors are based on a flavo-enzyme, 
GOx. GOx is a homo-dimer, which catalyses the oxidation of p-D-glucose, in a two step
-JO
process. In the first step, two protons and electrons are transferred from glucose to 
GOx, resulting in the oxidation of P-D-glucose to 8-gluconolactone, and reduction of 
GOx to GOxH2 . In the second step GOXH2 is oxidized to GOx by molecular oxygen, 
releasing hydrogen peroxide (H2O2); and 5-gluconolactone is hydrolyzed non- 
enzymatically into gluconic acid.39 The overall reaction is written as,
Glucose + 02 —GluC0seOxldase >H202 + 6 - gluconolactone
All together, there are three ingredients (O2 consumption, H2O2 , and acid 
production) of the glucose oxidation catalyzed by GOx, which can be monitored to 
estimate the changes in glucose concentration. Thus, different fluorescent glucose sensors 
can be designed by incorporating an oxygen-sensitive or pH sensitive fluorophore to 
indicate the changes in glucose, and a reference fluorophore, which is insensitive to 
glucose concentrations, in a sensing chamber. Different variations of GOx based 
fluorescent glucose sensors will be discussed below.
Kopelman et al., proposed ratiometric sensors for real-time biochemical 
monitoring, which are also known as polyacrylamide PEBBLEs (Probes Encapsulated By 
Biologically Localized Embedding). 40 ' 42 They proposed a glucose sensor, by 
incorporating all the sensing elements: the enzyme, GOx, oxygen sensitive fluorescent 
indicator, ruthenium (Ru), and an oxygen insensitive fluorescent dye, Oregon Green 488- 
dextran or Texas Red-dextran, as a reference dye for conducting ratiometric 
measurements, in nanospheres prepared using microemulsion polymerization process.40
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The enzymatic oxidation of glucose to gluconic acid results in the decrease in oxygen 
levels, which is measured by the oxygen sensitive dye, Ru.40 The nanosensors showed a 
linear range of 0.3-5 mM glucose with a response time of 150 seconds. PEBBLEs were 
also used in developing intracellular sensors for pH and calcium,43 oxygen,44 ’45 
potassium,46 magnesium,47 zinc,48 chloride,49 glucose,40 and iron.50 However there are 
some significant disadvantages, such as, the uniformity cannot be maintained from sensor 
to sensor within the same batch and from batch to batch, due to the nature of the emulsion 
process, and the leaching of encapsulated chemistry over time. Since PEBBLEs are 
typically less than 200 nm in diameter, they are not suitable for dermal implantation since 
they are likely to be phagocytosed by macrophages.
Brown et al., proposed a glucose sensor based on the incorporation of enzyme, 
analyte indicator and reference dyes in a microcontainer, which has the potential for 
application as an implantable glucose sensor -  so called “smart tattoo” concept.51,52 In 
this work, calcium alginate microspheres coated with polyelectrolyte multilayers (PEM’s) 
were used as microcarriers for holding GOx, and entrapping an oxygen-quenched Ru- 
compound. A reference dye, Alexa Flour 488 (AF488), was incorporated in the 
multilayer nanofilms on the surface of the microspheres, which can also stabilize enzyme 
entrapment and control glucose diffusion. The confocal microscope image shown in 
Figure 2.1(a) for the completed sensor, shows the indicator dye (red) in the sphere 
interior and reference dye (green) on the sphere walls. The changes in fluorescence 
spectra with varying glucose concentrations are represented in Figure 2.1(b) as a change 
in peak ratio. Rsat is the intensity ratio of Ru to AF488 in (Vsaturated buffer, and Rg is 
the intensity ratio at each glucose concentration. These sensors have a more suitable size
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range (20-3 Opm) as compared to above-mentioned PEBBLE sensors. Also, these sensors 
were made much more sensitive and stable through several advances in modeling and 
fabrication approaches.51,53' 56 However, major limitations in these enzymatic based 
sensors are glucose consumption and high dependence of the measurements on local 
oxgen levels.
i n
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Figure 2.1. (a) Confocal microscopy image of spheres used for glucose sensitivity experiments; (b) 
Plot of experimentally and theoretically obtained fractional fluorescence peak ratio values at 
different glucose concentrations.51
In recent years, there have been several variations of biosensors based on 
nanotubes and their surface modification.57'61 Strano and co-workers reported a single 
walled nanotube (SWNT) based near infrared glucose sensor.61 They showed that the 
surfactant used to suspend the nanotubes can be exchanged with GOx to obtain a single 
layer of GOx on the surface of SWNTs. Ferricyanide, which reduces the inherent 
fluorescence (in NIR region) of nanotubes was irreversibly absorbed onto the nanotube 
sidewall. In the presence of P-D-glucose, hydrogen peroxide is produced due to the 
reaction between glucose and GOx, which then reduces ferricyanide. This reduction 
transfers electrons back into the nanotube, thereby increasing the fluorescence. Therefore,
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by monitoring the changes in fluorescence, glucose concentration can be estimated. In 
order to use biosensors based on SWNTs, the surface of the nanotube must functionalized 
with ligand specificity. This step of surface modification is very complex and hard to 
achieve as the covalent sidewall functionalization of SWNTs diminishes their optical 
properties owing to the disruption of the one-dimensional electronic structure. Therefore, 
non-covalent binding is required for optical SWNT biosensors. In addition, the SWNTs 
must be maintained as individual molecules, otherwise the aggregation may result in loss 
of fluorescence.61,62
Hexokinases, in comparison to GOx, have been less explored as glucose receptors 
for fluorescence-based sensing. These enzymes catalyze the transfer of the y-phosphoryl 
group of ATP to the hydroxyl group at position C6 of glucose:
ATP + D -  glucose ADP + D -  glucose -  6 -  phosphate
Pickup et al., proposed a glucose sensor based on the glucose sensitive changes of the 
intrinsic fluorescence from hexokinase.63 In solution, there was about a 23% (Figure 
2.2(a)) change in fluorescence of hexokinase (at 320nm) with the addition of 1 mM 
glucose solution. However, it was observed that the glucose sensitive changes in 
hexokinase were abolished in the presence of serum, as shown in Figure 2.2(a). To 
overcome this problem, hexokinase was immobilized in tetramethylorthosilicate-derived 
sol-gel. With the entrapment in sol-gel, hexokinase showed 25% change in intrinsic 
fluorescence and the signal saturation was extended to 50 mM glucose (Figure 2.2(b)). 
The linear range was further increased to 110 mM by covering the sol-gel with a 
polymethacyrlate membrane. The effect of serum on the sensitivity was very minimal 
when hexokinase was entrapped in sol-gel, with or without covering membrane, opening
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
15
the doors for in vivo monitoring. However, a major disadvantage of this system is the use 
of UV light for excitation, which requires complex or bulky light sources, and also there 
will be interference from various proteins in the biological samples.
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Figure 2.2. (a) Intrinsic fluorescence of hexokinase in solution with increasing glucose concentration, 
in (•) PBS; (□) serum; (A)low-molecular weight fraction of serum; (b) Change in intrinsic
. 63fluorescence of sol-gel immobilized hexokinase in (■) PBS or (•) serum.
2.1.2 Affinity Sensors
Affinity biosensors are analytical devices comprising a recognition element such 
as an antibody, receptor protein, biomimetic material, or DNA interfaced with a signal 
transduction mechanism to convert the analyte concentration to a measurable signal. 
Several variations of affinity glucose sensors are discussed in the following section.20'23 
Unlike enzymatic sensors, for the case of affinity based glucose sensors, glucose is not 
consumed during the receptor and glucose binding and, therefore, no by-products are 
produced; thus the name “non-consuming” glucose sensors. Also, the measurements are 
more direct, as they are not affected by oxygen and pH variations.
There are different types of glucose sensors that fall into this category, as depicted 
in Figure 2.3. Among all these sensors, competitive-binding based glucose sensing has 
been extensively explored for the last two decades. This concept is discussed in more 
detail in the following sections of this chapter.
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Figure 23. Different types of non-consuming glucose sensors.
2.2 Competitive Binding (CB) -Based 
Glucose Sensors
A competitive binding (CB) based glucose sensing scheme, as depicted in Figure 
2.4, involves three components, (i) receptor/substrate (e.g. Con A), (ii) ligand/analyte- 
analog (e.g. dextran), and (iii) analyte (e.g. glucose). The CB mechanism for glucose is 
based on the fact that the receptor has different binding affinities for various sugars 
(Figure 2.5). When receptor is exposed to ligand and analyte they will compete to occupy 
the binding sites on receptor. As receptor has greater affinity toward analyte over ligand, 
analyte displaces ligand from receptor. This process generates more free-ligand and 
receptor/glucose complexes (Figure 2.4(c)). Generally, free-ligand concentration or the 
distance between receptor/ligand is monitored to estimate glucose concentrations. This 
process is called CB technique, which is generally used in conjunction with several other 
techniques, such as FRET, QCM, SPR, and viscosity to estimate glucose concentration. 
Concanavalin A (Con A) and dextran are widely used as the model receptor and ligand 
molecules during the demonstration of CB process. The structure of Con A and its 
interaction with dextran, will play a significant role in the sensing process.
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Figure 2.4. Illustration of Competitive binding technique: (a) donor molecules, (b) Mixture of donor 
and acceptor molecules, and (c) glucose competes with dextran to occupy binding sites on Con A, and 
displaces dextran from Con A.
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Figure 2.5. Binding affinity of various sugars to Concanavalin A.86
Con A belongs to a group of proteins called lectins, which are known for binding 
to specific sugar molecules. Con A has specific binding sites for a-D-glucose. Native 
Con A is comprised of four subunits each having a molecular weight of 26kDa and one 
sugar binding site. Also, Con A contains bound calcium and manganese ions per subunit, 
which are essential for the occurrence of sugar binding. Depending on the solution 
characteristics and properties, Con A can exist in dimeric, tetrameric, and higher order 
forms.64 It has been observed that Con A recognizes terminal as well as internal
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saccharide residues.64 Because of the sugar specificity of Con A, it has been successfully 
employed in glucose sensors.65 Previously reported Con A based affinity sensors in 
conjunction with different transduction mechanisms are discussed in detail below.
2.2.1 Viscosity Measurements -  CB Assay
Viscosity is the measure of a fluid's resistance to flow. A fluid with large viscosity 
moves slowly, because it experiences a large amount of internal friction, and a fluid with 
low viscosity flows easily because it experiences very little friction when it is in motion. 
Ehwald et al., showed that there are significant changes in the viscosity values of the 
dextran/Con A complexes with the addition of glucose due to the competitive 
displacement of dextran from Con A, as shown in Figure 2.6.66,67
2500
2000
S. 1500
1000
500
40
Figure 2.6. Changes in Viscosity (r)) of dextran and Con A (10 gm/L) dispersions. Dextran 
concentrations were, (o) 190 gm/L, (T) 120 gm/L, (▲) 80 gm/L, (•) 40 gm/L.6
It can be observed from Figure 2.6 that with the increase in glucose concentration, 
there is a decrease in viscosity value, because of the decrease in large complexes of Con 
A/dextran. Also, viscosity values were observed to vary with the change in dextran 
concentration and molecular weight.
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2.2.2 Mass/Thickness Measurements -
CB Assay
Sugar specificity of Con A based on mass/thickness measurements was 
demonstrated in 1991, using layer-by-layer (LbL) assembly process.69 LbL self assembly 
is well known for its simplicity in constructing multilayer thin films of various 
macromolecules. In most cases, this process involves the construction of thin films of
70oppositely charged molecules on a substrate based on electrostatic forces of attraction. 
However, in the present case, multilayers of Con A/glycogen thin films were coated on a 
flat substrate based on the binding affinity between the two molecules. The Con 
A/glycogen assembly process was monitored by measuring frequency changes in a quartz 
crystal microbalance (QCM) resonator. It was observed that the binding constants can be 
varied by controlling the glycolipid concentrations.71 Lvov et al., further demonstrated 
the multilayer assembly of Con A in two modes of interactions, as a polyion and a 
biospecific agent, as shown in Figure 2.7(a).72 This was demonstrated by constructing 
the thin films of Con A (anionic)/poly(ethyleneimine) (PEI, polycation), and Con 
A/glycogen on a QCM resonator in the neutral pH region (Figure 2.7(a)). It was observed 
that there are linear frequency shifts in two modes of assembly. The multireceptor sites of 
Con A are very important in building multilayers of Con A and glycogen.72 The sugar 
specific nature of Con A was further utilized to build a multilayer of Con 
A/glycoproteins73 (GOx, HRP) and Con A/avidin.74 UV-Vis absorption spectroscopy74 
and QCM73,74 measurements were used to monitor the LbL assembly process. This 
research was further developed by Anzai’s group to demonstrate the glucose sensitivity 
of the Con A/glycogen multilayers. It was shown that the Con A/glycogen multilayers 
can be completely disintegrated (Figure 2.7(b)) upon exposure to sugars (D-glucose, D-
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mannose) in the aqueous solution at neutral pH.75 This behavior is observed because of 
the competition between the sugar and glycogen to occupy the binding sites on Con A, 
and since the sugar has greater affinity toward Con A compared to glycogen, glycogen is 
displaced from Con A, thus disintegrating the con A/glycogen multilayers.75 Also, the 
variation in the sensor response with different sugars is shown in Figure 2.7(b).
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Figure 2.7. (a) Layer-by-Layer assembly of Con A/glycogen multilayers using two modes of 
interactions; (b) Disintegration of the Con A-glycogen multilayer film (10 bilayers) in the presence of 
10 mM (a) D-galactose, (b) D-glucose, (c) D-mannose, (d) Methyl-a-D-glucopyranoside, and (e) 
Methyl-a-D-mannopyranoside at pH 7.4.75
2.2.3 Surface Plasmon Resonance
Based Glucose Sensors
Surface plasmon resonance (SPR) is a relatively new technique. It is a powerful 
tool for studying the interactions between high molecular weight molecules, e.g. 
antibody-antigen and nucleic acid interactions. The detection capability of SPR is 
extended to low molecular weight compounds, such as pesticides,76 saccharides,77 etc., 
using indirect or CB approaches. The SPR detection principle relies on the change in 
refractive index and the corresponding shift in the SPR angle that occurs on binding of
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the target-analytes to the immobilized receptor/recognition molecules. Thus, the glucose- 
sensitive dissociation of Con A and dextran was demonstrated using SPR techniques.
Ballerstadt et al., were the first to demonstrate a glucose sensor based on SPR and 
CB techniques. A glucose sensing SPR-probe was constructed by placing a thin layer of
7RCon A/dextran (high viscosity) dispersion on the gold surface of an SPR-probe. The 
changes in viscosity were monitored when the Con A/dextran SPR-probe came in contact 
with different glucose concentrations. By monitoring the shift in SPR angle, as shown in 
Figure 2.8, it can be observed that with the increase in glucose concentration there is a 
decrease in resonance angle due to the separation of dextran and Con A.
A novel technique for glucose monitoring was developed by Geddes et al., based 
on the changes in SPR peak due to the aggregation of dextran coated-gold nanoparticles 
in the presence of Con A and disassociation in the presence of glucose.81'83 Due to the 
binding affinity between Con A and dextran, dextran coated-gold particles form large 
aggregates in the presence of Con A (Figure 2.9), resulting in a significant shift and 
broadening of gold plasmon absorption. As Con A has greater affinity towards glucose 
over dextran in the presence of glucose, dextran coated-gold particles are displaced from 
Con A, which results in the segregation of gold particles (Figure 2.9). This reduction in 
gold particle aggregation will be indicated as a shift in SPR angle. These sensors were 
also optimized in regard to stability, pH effects and dynamic range of glucose
oi 09
sensing. ’ A similar sensor was developed using silver nanoparticles.
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Figure 2.9. Competitive binding and SPR based glucose sensing mechanism: the dissociation of Con 
A-aggregated dextran-coated gold nanoparticles.81
All of the above mentioned Con A-based glucose sensors using viscosity, 
frequency, and SPR techniques were successfully demonstrated. There are some 
disadvantages, such as low sensitivity and need to realize the final goal, which is an
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implantable continuous glucose monitoring system. For reaching the final goal 
fluorescence sensors are more practical, because of the high sensitivity and the possibility 
of remote interrogation of the implanted sensors.
2.2.4 CB Based Fluorescence Affinity Glucose Sensors
The combination of CB and fluorescence techniques for glucose sensing is very 
popular because of its simplicity and reliability. This sensing mechanism attracted many 
researchers, because of the non-consumption property and the employment of highly 
sensitive fluorescence measurement techniques. The advantages of fluorescence 
techniques, specifically FRET are discussed in detail in the sections that follow.
Schultz et al., developed the first affinity glucose sensor in 1979, based on the 
binding specificity between Con A and saccharides.84,85 This transduction mechanism 
employs the CB based Con A/dextran system.85 Dextran was conjugated to fluorescein- 
isothiocyanate (FITC) in order to use fluorescence techniques to measure ffee-dextran. 
The sensing system was fabricated by immobilizing Con A on the inner surface of the 
dialysis fiber and filling the interior with freely floating FITC-dextran (FD). Finally, one 
end of the fiber was sealed and an optical fiber was inserted into the other end (Figure 
2.10).85 The molecular weight of the dextran and porosity of the membrane were selected 
such that the fiber can retain dextran in the interior while glucose can move freely. In the 
absence of glucose, certain fraction of FD was bound to the Con A immobilized on the 
fiber. Exposure of the fiber to glucose results in the displacement of FD from Con A. 
This competitive displacement of FD in the presence of glucose will result in the increase 
in number of free-FD molecules. Thus, glucose concentration was estimated by 
measuring free-FD concentration using fluorescence measurements.
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Figure 2.10. Heterogeneous fluorescence affinity sensor.86
In spite of the novelty of this technique there were some disadvantages such as, 
the repeatability of the Con A immobilization on the fiber and the alignment of the 
optical and mechanical fibers.22 Sensor properties were affected by the quenching affects 
on FITC or alterations in the Con A binding activity. The change in fluorescence signal 
due to concentration and instrumental drift, cannot be corrected because of the absence of 
a reference fluorophore. In order to overcome these limitations, the above mentioned 
design was improved using FRET techniques.
2.2.5 CB and FRET Based Glucose Sensors
FRET is a phenomenon between two fluorescent molecules, which involves non- 
radiative energy transfer from one fluorophore (donor) to another (acceptor) when the 
two fluorophores are in close proximity. As the distance between the two fluorophores 
increases, there is a decrease in energy transfer. Thus, the glucose concentrations can be 
by monitored by observing the changes in energy transfer. The FRET phenomenon is 
discussed in detail in Chapter Three.
Glucose Sensors Based on Intensity Measurements. The Schultz group 
demonstrated a FRET based homogeneous glucose sensor as shown in Figure 2.11, by 
eliminating the Con A immobilization step from the above-demonstrated heterogeneous
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system. FITC and Rhodamine (Rh) were used as the donor and acceptor fluorophores, 
conjugated to ligand (dextran) and receptor (Con A), respectively.86
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Figure 2.11. (a) Schematic of homogeneous FRET based glucose sensor; Changes in FITC fluoresnce 
with the addition of (b) Rh-Con A to FD, and (c) glucose to FD/Rh-COn A complexes.86
When FD/Rh-Con A complex was excited at the FITC-excitation wavelength 
(488 nm), energy is transferred non-radiatively from FITC to Rh, which results in the Rh 
emission. It was observed that with the addition of glucose, FD and Rh-Con A were 
dissociated, increasing the distance between them, which in turn resulted in the decrease 
in energy transfer from FITC to Rh, and was indicated as an increase in FITC emission
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peak relative to Rh (Figure 2.11). Thus, the level of FITC fluorescence was used to
or
determine the glucose concentrations.
It is well known that aggregation is one of the main problems associated with Con 
A, mostly when it is bound to dextran. While it is also known that the aggregation can be 
prevented by maintaining optimal pH (6 to 7) and temperature (< 40°C), this is not 
always possible, especially for in vivo measurements. To overcome this problem, the 
Schultz group proposed the idea of replacing Con A with succinyl (succ)-Con A, which 
will not aggregate at high temperatures and pH.87,88
Succ-Con A is prepared by reacting lysine residues on Con A with succinic 
anhydride, which results in the conversion of the positively charged lysine side chains 
into negative charges. These changes in the charge distribution of the Con A and the 
sterical interactions will result in two identical dimers from one tetramer that do not re­
aggregate into the tetramers even at high temperatures.88 Dextran and succ-Con A were 
labeled with FITC and TRITC respectively. This assay is similar to the above-mentioned 
system,86 with the variation in the type of Con A and acceptor fluorophore. Glucose 
concentrations of up to 1600mg/dL could be detected with a time response of 
-lOmin.87’88
In all of the above described sensing mechanisms, Con A must be either 
chemically modified or otherwise labeled with a fluorophore, which is time consuming. 
In addition, these procedures on Con A could affect the binding activity between 
ligand/analyte. In order to overcome these concerns, Schultz lab proposed the idea of
OQ
fluorescence quenching of ligands held in close proximity by a multivalent receptor. In 
order to reduce this idea into practice, some fraction of the ligand (dextran) molecules
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was labeled with FITC (donor) and the rest was labeled with RITC (acceptor). In the 
absence of any Con A-specific sugars (e.g. a-D-glucose), Con A binds to FITC and RITC 
labeled dextrans bringing them into close proximity, which results in the energy transfer 
from FITC to RITC. With the addition of glucose, two dextran molecules are displaced 
resulting in the increase in FITC fluorescence due to the decrease in RET.89
In all the above demonstrated sensing systems, changes in fluorescence intensities 
were measured to estimate the changes in glucose concentration. Even though this 
method is highly sensitive, allowing one to work at very low concentrations, there are 
some disadvantages when the issue of non-invasive monitoring is considered. There will 
be significant loss in intensities when the measurements are performed in a scattering 
media (skin). To avoid these problems, lifetime measurements were proposed by 
Lakowicz et al., using the same transduction mechanism. Also, the lifetime 
measurements are not affected by the concentration and optical properties of the 
sample.90 Several variations of lifetime measurements based glucose sensors are 
discussed below.
Glucose Sensors Based on Lifetime Measurements. Based on the same CB and 
FRET transduction principle, several methods for glucose sensing were demonstrated 
using fluorescence lifetime measurements.90'95 In one of the sensor designs, Con A was 
labeled to Ru (donor), and malachite green (MG, acceptor) was labeled to insulin and 
maltose (MIMG) to provide binding affinity for Con A. With the addition of Ru-Con A to 
MEMG, there was a decrease in the fluorescence intensity and decay time of Ru, due to 
the energy transfer from Ru to MG. However, with the addition of glucose, MIMG was 
displaced from Ru-Con A, resulting in the increased intensity and decay time of Ru.90
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Another sensor design was reported on similar grounds by replacing Ru with Cy5, as 
shown in Figure 2.12.91 By comparing the results from Ru-Con A and Cy5-Con A, it was 
observed that the reversibility was significantly improved in the case of Cy5-Con A. It is 
noteworthy that Cy5 has a smaller stokes shift and lifetime, but relatively high quantum 
yield. Also, the use of Cy5 allows excitation with red laser diodes.
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Figure 2.12. Excited state decay of CyS-Con A with the addition of (a) MIMG, and (b) glucose.91
Another FRET based glucose sensor operating in the NIR region was developed 
using allophycocyanin (APC, donor) labeled Con A and MG (acceptor) labeled dextran.96 
As glucose competitively displaces MG-dextran, there was a reduction in FRET as shown 
in (Figure 2.13), which was assessed by fluorescence lifetime measurements. This assay 
showed significant changes in the range of 2.5-30 mM glucose levels. It was observed 
that albumin and serum inhibit FRET significantly (Figure 2.13(a)), but the interference 
was prevented by removing high molecular weight substances using filters, as shown in 
Figure 2.13(b). Thus, APC showed promise for use in a glucose sensor, which can be 
interrogated remotely.96
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Figure 2.13. Changes in FRET between APC-Con A and MG dextran in the presence of (a) PBS, 
Serum and BSA; (b) PBS, serum passed through lOkDa and 30kDa filters, and unfiltered serum.96
Most of the above-mentioned intensity and lifetime measurements based sensing 
systems were successfully demonstrated in solution. The potential disadvantage of these 
fiber-based approaches is the risk of infection at the site of optical fiber intrusion into the 
skin. However, in order to implement these sensors for non-invasive monitoring, the 
sensing elements must be encapsulated in a microcarrier, e.g. microcapsules, 
microspheres, etc., which have the ability to display changes in fluorescence for varying 
glucose concentrations. The following section will discuss all the previously reported 
fluorescence affinity sensing systems for transdermal monitoring.
2.2.6 Transdermal Glucose Sensing
PEG hydrogel based glucose sensor. To overcome the difficulties with currently 
available non-invasive monitoring systems, a novel system based on the “smart tattoo” 
concept was proposed, which could be implanted in the skin and interrogated remotely 
using harmless visible or NIR light excitation.26,27 The feasibility of this concept has 
been demonstrated for the short wavelengths of the FITC-TRITC RET pair, by modeling 
and experimental studies of tissue.24'27 Prototypes consisting of poly(ethylene glycol) 
(PEG) hydrogel microspheres with covalently-immobilized TRITC-Con A molecules and
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physically entrapped FD in the gel matrix were constructed, and the glucose response for 
the system was further controlled by varying the Con A:dextran ratio inside the hydrogel. 
In vitro experiments of hydrogel spheres showed an optimum fluorescent intensity
'inchange between 0-800mg/dL with a linear response up to 600mg/dL. Despite the 
encapsulation of Con A/dextran assay into microspheres, there still remain some critical 
problems in maintaining the stability of the response and the production of uniform and 
strongly responsive glucose-sensitive microspheres.
Sephadex bead based affinity glucose sensor. The Schultz group proposed a 
minimally-invasive approach for glucose monitoring based on the implantation of the 
semi-permeable membrane chamber containing glucose-sensitive assay elements.97 In 
this sensing system, AF 488-Con A molecules were bound to the glucose residues on the 
interior of the sephadex beads (Figure 2.14(a)), which were made up of dextran tagged to 
an absorption dye. The excitation light cannot excite AF 488-Con A molecules residing 
inside the beads as the absorption spectrum of the dye conjugated to dextran overlaps 
with the fluorescence excitation spectrum of the fluorophore labeled to Con A. But, with 
the addition of glucose, the AF 488-Con A is displaced from the dextran matrix, and 
diffuses out of the colored beads into the outside space (Figure 2.14(b)) where it is 
exposed to light, thus resulting in a fluorescence increase corresponding to AF 488 peak, 
as shown in Figure 2.14(c). This sensor featured a glucose detection range extending 
from 0.15 to 100 mM, exhibiting the strongest dynamic signal change from 0.2 to 30 
mM. It showed a reasonably fast response time of 4-5 min.97 In order to use the affinity 
sensor in vivo, it is desirable to replace the visible range fluorescent dyes with NIR 
fluorophores to compensate for the high tissue scattering losses.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
31
l=ffi7*!?5I.TrK'BSl
■m-mm
Oiicoso
Fluorcch rexn*.|e6*ted Dy«d ptircus b>#Ad 
Ccncan^am A Holfcw* ft bar mambran a
a 180 ‘
I 175 
I 170 
|  165 1 
160 ■
0 05 1.5 2 25
GIucom (mM)
Figure 2.14. Fluorescence affinity glucose sensor, (a) In the absence of glucose, AF 488 labeled Con A 
is bound to fixed glucose residues inside porous beads, (b) In the presence of glucose, Con A is 
displaced from the beads and diffuses out of them, and (c) Changes in Fluorescent intensity of AF 
488-Con A with the addition of glucose.97
The above mentioned sephadex bead based affinity sensor system was further 
extended into the NIR region by conjugating Con A with AF647 dye.98 From the long 
term performance studies conducted on this system, it was observed that the signal levels 
were dropping after 3-4 weeks, due to the leakage of Con A through the sealed 
membrane.98 Thus, there are some issues to be resolved in this design.
Glucose sensor based on quenching mechanism. Ballerstadt et al., proposed 
another design for a glucose sensor operating in the NIR region. In this system, Con A 
and dextran were linked to NIR dyes, such as QSY21™, Alexa Fluor® 647 (AF647), and
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LD800, which were used as acceptor/quencher, donor and reference dyes, respectively." 
QSY21 quenches AF647 when they are in close proximity, but it will not fluoresce, 
resulting in the non-ratiometric measurements. Therefore a glucose-insensitive dye 
(reference dye), LD800 was incorporated in the sensing system for correcting varying 
concentrations, instrumentation drifts, etc. The sensor system was fabricated by making a 
hollow fiber-based capsule using regenerated cellulose, which is comprised of three 
fibers filled with QSY21™ ConA-Sepharose and AF 647-dextran, and two fibers 
containing the reference dye LD800. The size of the completed sensor was estimated to 
be 2mm in diameter and 6mm in length. In the absence of glucose, AF-dextran and QSY- 
Con A are closely spaced, which results in low donor fluorescence due to acceptor 
quenching. However, the quenching is reversed by competitive displacement of dextran 
from Con A by glucose. It can be observed that the quenching is reduced with the 
addition of glucose, which is indicated as an increase in the AF647 peak normalized to 
the LD800 reference peak, as shown in Figure 2.15." Thus, a glucose sensor operating in 
the NIR region is successfully demonstrated.
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Figure 2.15. Fluorescence emission spectra from the fiber (comprised of QSY-Con A and AF 647 
dextran) during its exposure to different glucose concentrations."
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However, it is important to note that all of the above mentioned Con A/dextran 
based affinity sensing systems carry the disadvantages of Con A, such as toxicity, 
aggregation, and non-specific binding. Therefore, it is necessary to find a replacement for 
Con A. One such molecule, is apo-glucose oxidase (apo-GOx), which was previously 
used as a biosensor based on its ability to reconstitute into a holoenzyme with the 
addition of semi-artificial cofactors.20’21 In order to overcome the limitations of Con A, 
D’Auria et al., proposed the idea of using a deactivated enzyme, which retains the 
binding ability towards glucose without any catalytic activity and shows a decrease in 
intrinsic fluorescence upon binding to glucose, thus acting as a sensor by itself. The 
details of these sensors based on deactivated enzymes are given below.
2.3 Glucose sensors Based on 
Apo-Enzvmes
2.3.1 Apo-Glucose Oxidase
Glucose oxidase (GOx) is an oxidoreductase enzyme, highly specific for P-D- 
glucose. GOx catalyzes the conversion of P-D-glucose and oxygen to D-glucono-1,5- 
lactone and hydrogen peroxide. GOx is a flavoprotein which is widely used for the 
estimation of glucose concentration in blood or urine samples and is based on the 
production of hydrogen peroxide in the reaction.36 To overcome the problems associated 
with the consumption of glucose in GOx based sensors, such as production of by­
products, instability, and irreversibility, a glucose sensor was proposed based on the 
intrinsic fluorescence changes in apo-GOx with the addition of glucose. Apo-GOx is 
produced by completely deactivating the native enzyme, GOx, by removing the FAD 
cofactor. The intrinsic fluorescence peak of apo-GOx at 340 nm is the characteristic of
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partially shielded tryptophan residues. Although apo-GOx showed an 18% decrease in 
the fluorescence at 340 nm with the addition of 20 mM glucose, indicating retention of its 
ability to bind P-D-glucose, there is no indication of catalytic reaction.23,100,101
The intrinsic fluorescence from proteins cannot be used for realistic clinical 
applications because of the huge background signal from the biological samples and the 
need for complex or bulky light sources. To overcome this problem, a visible dye (ANS) 
is linked to apo-GOx. ANS is known as a polarity-sensitive fluorophore, and displays an 
increasing quantum yield in low polarity environments. It was observed that the addition 
of apo-GOx to an ANS solution resulted in an approximate 30-fold increase in the ANS 
intensity, suggesting that it is exposed to a lower polarity environment. However, this 
effect was reversed, as apo-GOx showed a decrease in intensity upon glucose addition, 
indicating that ANS is being exposed to an increasing polar environment with glucose
O'Xaddition, as shown in Figure 2.16(a).
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Figure 2.16. (a) Emission spectra, and (b) Average lifetime of apo-glucose oxidase-1,8-ANS in the 
presence of varying glucose concentrations.23
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Fluorescence lifetime studies of ANS-labeled apo-GOx showed that the addition 
of glucose shifts the frequency response to higher frequencies due to a decreased ANS 
lifetime. The shorter lifetime of ANS in the presence of glucose is consistent with the 
suggestion that glucose displaces the ANS in a more polar environment. There was over a 
40% decrease in mean lifetime upon glucose addition, as shown in Figure 2.16(b).23
The apo-GOx based glucose sensor described above showed positive results, but 
the binding ability of GOx can be easily hindered by its low stability to heat, pH changes, 
and organic solvents. To overcome these problems, enzymes isolated from thermophilic 
sources were used, which are very stable and active at higher temperatures. A sensor 
based on the enzyme from a thermophilic source is demonstrated below.
2.3.2 Apo-Glucose Dehvdrogense
(apo-GD)
Glucose dehydrogenase (GD) from the thermoacidophilic archaeon 
Thermoplasma acidophilum, is used as the glucose binding protein in this sensing system. 
GD is a tetramer (160 kDa) composed of four similar subunits of about 40 kDa each. GD 
shows full activity at 55°C after 9 hrs and at 75°C the half-life is approximately 3 hrs. 
Also, the incubation of enzyme with 50% (v/v) methanol, acetone or ethanol for up to 6 
hrs, at room temperature showed no appreciable loss of activity.102
The transduction mechanism in apo-GD is similar to the above-demonstrated apo- 
GOx sensor. 103 As the thermophilic proteins show increased activity at higher 
temperatures and in the presence of non-polar solvents, all the experiments were 
conducted in the presence of 3% acetone. A drastic increase in ANS intensity values was 
observed with the addition of apo-GD. Also, with the addition of glucose, ANS showed a 
25% decrease in the intensity values.103 The lifetime studies showed modest changes.
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Therefore, glucose induced changes were more carefully studied using polarization 
techniques, which indicated that the ANS-apo-GD system can sense glucose 
concentrations up to 20 mM with an accuracy of ±2.5 mM (Figure 2.17).103 The 
dissociation constant was observed to be 10 mM. In spite of its robustness, apo-GD based 
sensors respond better in the presence of acetone, which is not the ideal case for 
implantable glucose sensors.
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Figure 2.17. Polarization spectra of ANS-labeled GD in the presence of 3% acetone, and at different 
concentrations of glucose.1 3
2.3.3 Glucokinase Based Sensor
As a further development to the above described sensing mechanisms, D’ Auria 
et al., proposed a glucose sensor using glucokinase from the thermophilic microorganism 
Bacillus stearothermophilus. 104 This system has the advantages of CB and FRET 
mechanisms in addition to apo-enzyme based sensors (e.g. specificity, non-consuming). 
These enzymes catalyze the reaction shown below. However, in the absence of ATP, 
glucokinase will not consume any glucose, thus phosphorylation will not occur.
ATP + D -  glucose —G|y°kl.nase/M82— > ADP + D -  glucose -  6 -  phosphate
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Using the idea of carrying on the above reaction in the absence of ATP, a glucose 
sensor based on CB and RET was proposed. The intrinsic fluorescence from glucokinase 
and 0-Nitrophenyl-/?-D-glucopyranoside (ONPG) were used as donor-receptor and 
acceptor-ligand molecules. It was observed that ONPG quenched the intrinsic 
fluorescence from tryptophan residues on glucokinase. This effect was reversed with the 
addition of glucose (Figure 2.18), as glucose has higher affinity towards glucokinase over 
ONPG. The changes in polarization with the addition of glucose to the above described 
glucokinase based sensor system were also reported.104
The wide variety of biosensing schemes that are demonstrated in the previous 
sections are highly-specific towards the analyte, but they are not attractive for practical 
purposes, e.g. noninvasive detection due to the lack of an intrinsic sensing mechanism. 
For example, a variety of well characterized glucose binding proteins (GBPs), do not 
show any change in optical signal with glucose binding which renders them unattractive 
for noninvasive monitoring. Many researchers are working towards the development of a 
transduction mechanism to monitor the binding events in GBPs. The next section will 
focus on the mechanism developed to monitor glucose levels using GBPs.
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Figure 2.18. Effect of ONPG and glucose on the emission intensity of BSGK.104
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
38
2.4 Glucose Binding Proteins
Hellinga et al., were the first to propose protein engineering techniques to develop a 
transduction mechanism to detect glucose using GBPs.105,106 An optical transduction 
mechanism was designed by incorporating environmental sensitive fluorophores into 
GBPs (Figure 2.19(a)). This technique involved the prediction of potential fluorescent 
allosteric signal transduction (FAST) sites in the periplasmic GBP of Escherichia coli (E. 
coli), and creation of single cysteine mutations at these FAST sites.
To observe the responses of different sites, acrylodan, and (((2- 
(iodoacetoxy)ethyl)methyl)amino)-7-nitrobenz-2-oxa-l,3-diazole (LANBD) were selected, 
based on their environmental sensitive behavior, as the indicator dyes to be covalently 
coupled to the L255 and H I52 cysteine residues, respectively. The glucose sensitivity of 
GBPs coupled with acrylodan and LANBD, in Figure 2.19(b-c), shows that with the 
addition of glucose both samples are showing significant changes in fluorescence 
intensity.105 This technique of introducing FAST sites into analyte-indicator proteins was 
further used by several groups to develop biosensors using proteins from E. Coli.
Based on this approach of introducing sensing elements into GBPs, a simple 
design for glucose sensing was proposed by Tolosa et al., based on a mutant 
glucose/galactose binding protein (GGBP) from E. Coli and phase modulation 
fluoremetry.93 The glutamine 26 in GGBP (Figure 2.19(a)) was mutated to contain a 
single cysteine residue and was conjugated with a sulfhydry 1-reactive probe 2-(4- 
iodoacetamidoanilino)naphthalene-6-sulfonic acid (I-ANS). The labeled protein 
displayed a twofold decrease in intensity in response to glucose, with dissociation 
constant near lpM  glucose (Figure 2.20(a)), but displayed modest lifetime changes.
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Figure 2.19. (a) Tertiary structure of GBP 21’93; Change in fluorescence intensity due to the binding of 
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Figure 2.20. (a) Emission spectra of ANS-Q26 GGBP in the presence of glucose, (b) Modulation at 
2.1MHz with the addition of glucose to ANS-Q26 GGBP.93
In order to overcome this problem, a sensor was created by combining ANS- 
GGBP with Ru metal-ligand complex on the surface of the cuvette. With the addition of
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glucose, there were significant changes in the relative intensity of the ANS26-GGBP and 
Ru complex resulting in a dramatic change in modulation at a low frequency of 2.1 MHz, 
as shown in Figure 2.20(b). Modulation measurements at 2.1 MHz were shown to 
accurately determine the glucose concentration.93
Rao et al., further developed this sensor to overcome the problems associated with 
lifetime measurements. They used an E. coli GBP labeled with two fluorophores, 
acrylodan (environment-sensitive) and metal ligand complex of Ru at the cysteine 
(Leucine 255) mutation and N-terminal, respectively (Figure 2.19(a)). The acrylodan 
emission is quenched in the presence of glucose while the Ru emission remained constant, 
thereby serving as a reference, as shown in Figure 2.21(a). In addition to ratiometric 
measurements, the presence of the long-lived Ru metal-ligand complex allows for low- 
cost modulation-based sensing.21 It can be observed from Figure 2.21(b) that there is 
significant change in modulation with the addition of glucose.
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1.0 0.80
2 0.78
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Figure 2.21. (a) Emission spectra, and (b) Modulation at 1.58Hz with the addition of glucose to Ru- 
GBP-Acrylodan.21
Schultz et al., proposed another variation of a biosensor based on a glucose 
indicator protein (GIP), which was created by conjugating two fluorescent reporter
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proteins to each end of the E. coli GBP, as shown in Figure 2.22(a). In this method, the 
distance between the two fluorescent proteins changes with the addition of glucose 
(Figure 2.22(a)), which can be monitored by measuring the changes in FRET.107 The 
GBP adopts an “open” form in the presence of the glucose, which triggers a 
conformational change, causing GFP and YFP to move apart from the center line of GBP 
leading to the change in FRET, as shown in Figure 2.22(a).
Reduced FRET 4^Glucose^  niiuc c ^  n w
%
W  J -Glucose GFPuv
W  (a)
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Figure 2.22. Design of a (a) glucose indicator protein for glucose sensing based on FRET between two 
green fluorescent proteins, (b) glucose sensor by incorporating Figure 2-15(a) in a hollow-fiber.107
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Figure 2.23. Fluorescence intensity (average of 3 measurements) at 527 nm (YFP emission) with 
increasing glucose concentration.107
Green (GFPUV) and yellow (YFP) fluorescent proteins were used as donor and 
acceptor molecules, respectively, in the FRET phenomenon. GIP is created by 
conjugating GFPUV and YFP to C terminus and N terminus of GBP, respectively, as
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shown in Figure 2.19. A glucose microsensor was fabricated as shown in Figure 2.22(b), 
by entrapping GIP into the hollow fiber which is accomplished by placing one end of a 
hollow fiber in a GIP solution and sealing the other end. When glucose binds to a GBP, 
there is change in the protein conformation, resulting in the increase in separation 
between GFPUV and YFP and thus producing a reduction in FRET. This sensing system 
showed a response time within lOOsec and an optional range of 10pM of glucose (Figure 
2.23).107 The main disadvantage of the GBP based glucose sensors is the low dissociation 
constant, because of which it cannot be used for glucose monitoring in diabetics.
2.5 Boronic Acid Based Sensors
Boronic acids (BAs) are known to have high affinity for carbohydrates, based on 
which several variations of glucose sensors have been reported by Lakowicz,108-114 
Shinkai,19 and Wang.115 BAs are weak Lewis acids, consisting of one boron (electron- 
deficient) atom and two hydroxyl groups. These acids have the tendency to form anionic 
borate by reacting with strong bases (OH"), with a pKz of ~9. BAs coupled with esters to 
form BA diester groups show a pKa of ~ 6.109
In the last decade, BA containing fluorophores were used to monitor changes in 
sugar concentration by observing the changes in spectral properties of the fluorophores 
due to a charge transfer (CT) mechanism. CT occurs when there is high concentration of 
fluorophores containing BA and electron donor groups on the same fluorophore. For this 
mechanism, BA group (in the absence of sugar) acts as an electron withdrawing group, 
but, in the presence of sugar, BA takes on its anionic form as [-B(OH)(sugar)]- and is no 
longer an electron withdrawing group. Hence, many fluorescent dyes with BA group can 
be used for glucose sensing by monitoring spectral (intensity, peak wavelength) shifts.109
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Lakowicz et al., proposed the idea of non-invasive glucose monitoring by using a 
contact lens as the substrate to dope these glucose-sensitive fluorophores containing BA 
groups.109 4’-Dimethylaminostilbene-4-boronic acid (DSTBA), 4’-cyanostilbene-4- 
boronic acid (CSTBA), l-(p-boronophenyl)-4-(p-dimethyl-aminophenyl)buta-l,2-deine 
(DDPBBA), chalcl, and chalc 2 were used as the glucose sensitive BA containing 
fluorophores, among which the results corresponding to DSTBA and CSTBA are 
demonstrated below. Fluorescence spectra corresponding to DSTBA and CSTBA, with 
the addition of glucose, are shown in Figure 2.24(a-b). It can be observed in the case of 
DSTBA that there is a decrease in the intensity and a blue-shift in the peak wavelength 
with the increase in glucose concentration. Whereas in the case of CSTBA, there is also a 
decrease in intensity but with a red-shift in the peak wavelength.
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Figure 2.24. Change in fluorescence spectra of DSTBA and CSTBA in solution-phase (a,b) and when 
doped in contact lens (c,d).109
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The changes in fluorescence spectra of DSTBA and CSTBA doped contact lenses 
are monitored with the increase in glucose concentrations, as shown in Figure 2.24(c-d). 
By comparing solution phase and contact lens doped results, it can be observed that there 
is a significant decrease in the linear range and sensitivity. It is also noteworthy that these 
fluorophores showed more affinity towards fructose over glucose. Also, there is the 
significant effect of leaching, i.e. ~ 10 -  12 % of the fluorophore concentration is leached 
out in 45min.109 Using similar principles, BA-fluorophores were designed to measure the 
tear glucose levels in hyperglycaemia patients.108 A mono-BA based fluorescent sensor 
was designed using 3-nitronaphthalic anhydride and 3-aminophenylboronic acid. This 
novel saccharide probe exhibited dual emission, enabling ratiometric sensing, and 
displayed a remarkable sensitivity for glucose relative to fructose and galactose.111 In 
spite of the successful demonstration of BA-based glucose sensors, there are unsolved 
problems due to the specificity109,110,115 and leaching that occurs overtime.
In conclusion, this chapter has provided a broad background of previously 
reported literature on glucose sensors. It was noted from these previous studies that many 
researchers have proposed the idea of developing an implantable fluorescence affinity 
glucose sensor, but there have been limited research articles (~5) where the idea has been 
demonstrated. These sensors were based on Con A, glucose binding proteins, and boronic 
acids, which have major disadvantages such as toxicity, low dissociation constant, and 
very low specificity, respectively. Also, all these systems lack an efficient encapsulation 
technique.
This dissertation work is focused on developing biosensors by encapsulating 
competitive binding based fluorescence sensing assay in microcontainers. The work is
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novel based on the encapsulation of sensing assay into hollow containers where the assay 
molecules are free to move. This kind of free movement is restricted in previously 
demonstrated PEG hydrogel spheres. Due to the toxic nature of Con A, we proposed a 
novel idea of replacing Con A with apo-GOx, which has been previously used as a 
glucose sensor by itself. Using apo-GOx, the problems associated with Con A, such as 
toxicity, low specificity, and aggregation can be eliminated. Thus, this work on the 
incorporation of apo-GOx into a competitive binding assay and the encapsulation of 
sensing assay into hollow microcontainers is unique and is not being pursued anywhere 
else in the world. As described in the following chapters, it has been possible to 
demonstrate (a) the glucose sensitivity of apo-GOx/dextran complexes in solution phase, 
(b) the formation of several embodiments of hollow containers used for the encapsulation 
of sensing assay, and (c) the glucose sensitivity of microcontainers loaded with sensing 
assays from the visible to near-infrared operating region.
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CHAPTER 3
THEORY
One of the most important and extensively explored fluorescence sensing 
techniques is fluorescence resonance energy transfer (FRET). FRET has been employed 
in spectroscopy and microscopy techniques for detecting and imaging various 
biomolecular interactions. Glucose sensors based on FRET in conjunction with the 
competitive binding process, are being continuously explored and are highly promising, 
as detailed in Chapter Two. This chapter discusses the theory behind glucose sensing 
mechanisms, such as FRET, and competitive binding processes. Modeling of the affinity 
sensors, which illustrates the influence of various parameters, e.g. receptor and ligand 
concentrations, dissociation constants, etc., on sensor response, is discussed in detail. 
These modeling results assist in estimating assay concentrations to obtain certain sensor 
parameters. Also, the effect of changing various parameters can assist in speculating the 
sensor response characteristics, thus helping in designing a customized sensing system.
3.1 Fluorescence Resonance Energy 
Transfer (FRET) Phenomenon
FRET is the non-radiative energy transfer of excited state energy from the excited 
state fluorophore (donor, D) to another (acceptor, A). FRET occurs when, (i) the 
fluorophores are in close proximity, (ii) the emission spectrum of donor overlaps with the
46
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excitation spectrum of the acceptor (Figure 3.1), and (iii) the dipoles are properly 
oriented.116 This phenomenon is a non-radiative transition i.e., it does not occur via 
photon emission from excited-state-D and its re-absorption by A. When the donor 
fluorophore is excited at an appropriate wavelength, its electrons jump from the ground 
state (So) to higher vibrational level (Si, S2 , S3 ). Within picoseconds these electrons decay 
to the lowest of these vibrational levels (Si) and then decay more slowly (nsec) to one of 
the So states and a photon is emitted with wavelength longer than the exciting wavelength 
(Figure 3 .2). FRET can be regarded as the interaction of transition dipoles of donor and 
acceptor groups; thus, the name fluorescence resonance energy transfer (FRET).117,118
Wavelength
Figure 3.1. Fluorescence excitation and emission spectra of (a) donor and (b) acceptor molecules.
S5-
psec D*
S5-
31
nsec
A*
so-
D = g round  state donor; A = acceptor 
*■ -  excited state
  rad ia tive  transition
  radiationless transition
O -----o  -  coupled transitions
Figure 3.2. A simplified Jablonski diagram showing the coupled energy transfer transitions between 
the donor and acceptor molecules during the FRET process.117
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3.1.1 FRET Theory
1 1  77The FRET phenomenon is a very complex process. ' A simplified theory of
FRET that is sufficient to describe the affinity sensors of this work is described as 
follows. Assuming a single D-A pair is separated by a distance r, the rate of energy 
transfer, kr, from a donor to acceptor molecule is given by:
where, td is the fluorescence lifetime of the donor in the absence of the acceptor, and Ro 
is the Forster distance, i.e, the distance at which half the donor molecules are quenched 
by the acceptor molecules. Ro is proportional to several parameters, according to
In this Equation 3.2, A" is a numerical constant, which depends on the units used. 
The term k 2 refers to the relative spatial orientation of the dipoles of D and A. Based on 
the relative orientation of donor and acceptor, k 2 value can range from 0 to 4. For
sixth root of k 2 is considered in the Equation 3.2, the variation of k 2 from 1 to 4 results 
in 26% error in r (in Equation 3.1) value. For the random orientation case (as is usually 
assumed, especially for solution phase measurements), k 2 value is taken as 2/3. Though 
this value is debatable, it was previously reported that the uncertainty in intra-molecular 
distance as determined using FRET is only 10%'18. The remaining terms, n, <j)D, and J[RJ 
correspond to the solvent refractive index, quantum yield of D in the absence of A, and 
the overlap integral, which measures the degree of overlap between the emission 
spectrum of D and the absorption spectrum of A, respectively. A key point from this
T
T D \ r )
(3.1)
(3.2)
collinear and parallel transitional dipoles k 2 =  4, and for parallel dipoles k 2 -  1. As the
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discussion is that there must be significant spectral overlap for the dipoles to interact and 
for the proper excitation of A by D. Also, the energy transfer efficiency is directly 
proportional to the spectral overlap, and this also directly effects the Forster distance of a 
particular D-A pair. Figure 3.1 shows the D and A excitation and emission spectra in an 
ideal energy transfer system, wherein D and A have very distinct excitation spectra (so 
that A can only be excited by energy transfer, and not by direct photon absorption at the 
wavelengths used to excite D); the D emission and A excitation spectra overlap strongly; 
and the D and A emission maxima are well separated, so that the quenching of D 
fluorescence and the enhancement of A fluorescence can be individually measured.121,122
In Practice, Ro values vary significantly for different D-A FRET pairs, ranging 
from 40-80 A. This distance must be comparable to the size of the proteins or other 
biomacromolecules being used for efficient energy transfer from D to A. The energy 
transfer (E) is given as the fraction of photons absorbed by D that are transferred to A 
and, therefore, is given as the ratio of transfer rate to the total decay rate of the donor,
It should be clear from the above Equation 3.4 that when D and A are separated 
by Forster distance (Ro), the FRET is 50% efficient. However, another noticeable 
property is that the FRET efficiency is highly dependent on the distance between D and 
A molecules, which is shown graphically in Figure 3.3. The notable feature is that FRET
(3.3)
From Equations 3.1 and 3.3, we have, E = 6 0 6
R0 +r
(3.4)
efficiency decreases rapidly when the distance between D and A molecules is greater
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than the Forster distance, because FRET is inversely proportional to the sixth power of 
the distance between D and A molecules (Equation 3.4).
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Distance between donor and acceptor molecules (r/RO)
Figure 3.3. Effect of the distance between donor and acceptor molecules (r) on the energy transfer 
efficiency (£); where Ro is the Forster distance.
Energy transfer efficiency (E) is generally measured using relative fluorescence 
intensity of the donor in the absence (Fo) and in the presence of acceptor (Fda), as given 
in Equation 3.5. Fluorescence lifetimes are also used under similar conditions to estimate 
E  value. The relationships are given as,
E = and E = 1 - ^ -  (3.5)
F D  t  D
These mathematical representations highlight the main advantages of using FRET 
as a transduction mechanism; it is highly sensitive to the distance between two molecules, 
and the ratiometric nature allows variations in instrumental parameters, assay component 
concentrations, and measurement configuration to be internally compensated.123 In recent 
years, FRET has been applied in various fields of biochemistry, such as single molecule 
FRET for detecting conformational changes and molecular interactions,124 distance 
measurements in a-helical melittin,125 protein folding measurements,126 orientation of the
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197 • • • 99 19R 19Qprotein bound peptide, nanoscale biosensors using organic, and quantum dot ’ 
FRET donors, etc.
In this project, FRET is used as a transduction mechanism in a glucose sensing 
system, which is based on the competitive binding process. In particular, FRET is used as 
a readout technique for translating the changes in the distance between D and A 
molecules in the absence/presence of glucose. The following sections will demonstrate 
the theory behind a glucose sensing system, which is based on the combination of 
competitive binding and FRET techniques.
3.2 Competitive Binding Process
The competitive binding process, depicted in Figure 3.4, involves three 
components, (i) receptor/substrate (Con A), (ii) competing ligand/analyte-analog 
(dextran), and (iii) analyte (glucose). When a receptor is exposed to a ligand, they will be 
in close proximity because of the binding affinity (Figure 3(a)). However, in the presence 
of glucose the receptor/ligand complexes will be dissociated (Figure 3.4(b)), as the 
receptor has greater affinity toward the target-analyte over ligand. This process generates 
relatively more free ligand and receptor/glucose complexes. Generally, free ligand 
concentration (or the average distance between receptor/ligand) is monitored to estimate 
glucose concentrations.
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Figure 3.4. Schematic representation of the combination of FRET and competitive binding 
techniques: (a) FITC-dextran/TRITC-Con A complexes, and (b) displacement of dextran from Con 
A in the presence of glucose; (c) strong donor and acceptor peaks (d) strong donor peak relative to 
acceptor peak in the presence of glucose.
3.2.1 Competitive Binding Theory
Theoretical models for the above described sensing system were developed to 
hypothesize the effects of different parameters.130' 135 Different heterogeneous models 
were generated for two different cases, (a) immobilized receptor, ’ and (b) 
immobilized ligand.131 The theoretical modeling of the receptor-immobilized competitive 
binding system is given below. The only difference in this model compared to the above 
described competitive binding mechanism is that the receptor is immobilized on the solid 
gel. However, this is of little consequence when taking the assumptions of this model into 
consideration. The assumptions in this system are: (1) the single binding site on receptor 
molecules is available even after the immobilization process, (2) both the ligand and 
analyte are competing for the same binding site on a receptor molecule, (3) only 
monovalent interactions occur between receptor and ligand, and (4) equilibrium exists at 
all times. As mentioned above, with the addition of more analyte there is an increase in 
the free ligand concentration in the solution. Thus, the free ligand concentration can be 
measured independent of the analyte concentration. A calibration curve can be obtained
$Addition
of glucose
(d v
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for this sensor system by plotting bulk free ligand concentration with respect to the 
increasing analyte concentration.130,133
The competitive binding reactions between the analyte (A), immobilized receptor 
(/?), and ligand (L ), and the corresponding association constants (Kj  &  K 2) are given as,
L  + R  — >LR , AT, = ; where LR  is the ligand/receptor complex (3.6)
A  + R  ——— > A R , K 2 = 5 where AR  is the analyte/receptor complex (3.7)
In the current model design, all the sensing elements are conserved with in the 
transducer, as given below,
o s )
[ I ,  ] =  [ ! ] + [ M ]  (3 .9 )
k b M + M  <31°)
where R, L,  and A  represent the concentrations of free acceptor-labeled receptor, donor-
labeled ligand, and analyte, respectively, and subscript Y denotes total concentrations.
The free receptor concentration [/?], which is not bound to either ligand or 
analyte, can be written in terms of dissociation constant, and total and free (unbound) 
ligand concentrations as given below.
From Equations 3.6 and 3.9, we have, [/?] = \  (3.11)
The analyte/receptor complex concentration [/I/?] can be written in terms of 
dissociation constant and free analyte and receptor concentrations as given below,
From Equation 3.7, we have [/I/?] = (3.12)
From Equation 3.9 and 3.8, we have
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, W  . [ * , ] - [ * ] - 1 « ]
[i,]  [ i,l
Substituting Equation 3.12 into Equation 3.13, we have
i
(3.13)
This can be reduced as shown below,
(3.14)
1 (3.15)
Substituting Equation 3.11 into Equation 3.15 and reducing the equation, we obtain 
Equation 3.18,
[i,] h i  M k l V
1
[L] . . [ R , ]  [ l] ,- [ l]  _ 0
t , ]  Ia I ' M a K ' H a K , 1
1 + 1 _ M * 2 + M * 2 =0
f c]  H  W l  k \ l ,] \l ,]k x
(3.16)
(3.17)
(3.18)
Multiplying the above Equation 3.18 by [L\l[Lt], we obtain a dimensionless equation,
( M V  M + M w ]  _ ! _  M _ L _  U K l + M E K - o (319>
U i,]J  ' w w w ' h n  + [£ ,]* ,[ i ,] " [ £ ,k + [i , ] [ i ,K ,  ( *
By further simplification, we obtain the below equation, 
f  r , i \ 2Ml +M M i + U K -  r—T ~ ( t^ K . + 0  = 0 (3.20)
The above equation can be simplified further,
MY+M
[A]J [4]
R [a ^ 2 +1
e t t  f e f c
T - l 1
[4 K ,
= 0 (3.21)
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([L]/[X(]) and (([A]K2 +I)/([Lt\Ki)) give the ratio of free to total ligand and 
dimensionless analyte concentration, respectively. A plot of Equation 3.21, which gives 
the relationship between dimensionless analyte and fraction of free ligand, is shown in 
Figure 3.5. It can be observed that the fraction of free ligand is dependent on the analyte 
concentration, and also on the ratio of total ligand/receptor concentration. For example, if 
the required dimensionless analyte concentration range is from 0 to 40, then the total 
ligand/receptor ratio must be maintained in the range of 0.01-0.1 to obtain good 
sensitivity across the range of interest. This information, which is critical in tailoring the 
sensor parameters according to specified applications, is used in optimizing sensor 
response characteristics, such as sensitivity, detection range, etc.
0.8
o.i
jj 0.6
0.2
<l<
0.0 100
'Dimensionless analyte concentration'
Figure 3.5. Effect of dimensionless analyte concentration and the total ligand/receptor (L,/ R,) ratio 
on the response of competitive binding based assay.134
Effect of total assay concentration
From the above discussion, it is obvious that the ratio of ligand to receptor has a 
significant effect on the sensor response. Apart from this, the total assay concentration 
may also have a considerable effect on the sensitivity, though this point was not
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previously appreciated. In order to study this variation in total assay concentration, while 
maintaining the constant ligand to receptor ratio, we have simplified Equation 3.21 to
y 2+ y [ c - l  + Ad] - A d =0  (3.22)
where relative sensor response = y  = {L/Lt), constant = c = (R,/L,), and dimensionless 
analyte concentration = [Ad] -  ((Kai[A]+l)/(LtKa2)).
The effect of total assay concentration on sensor response was tested by plotting 
sensor response versus dimensionless analyte concentration at different total ligand and 
receptor concentrations. The results are given in Table 3.1. It is important to note that the 
ratio between ligand/receptor is maintained constant in all cases. It can be observed that, 
for each case, a quadratic equation is derived (Table 3.1) and the corresponding plots are 
shown in Figure 3.6. From these results, the concentrations of the assay elements needed 
for any application can be estimated based on the required detection range.
Table 3.1. Parameters used to study the effect of total assay concentration on sensor response.
Receptor,/?, Ligand, Lt Constants Equation
1 *R, \* L t c=10; A(f= 20 /+ y [ 2 9 ] - 2 0  = 0
2* R, 2* Lt c=10; Ad=20 y 2 +y[76]-40 = 0
10* Rt 10* Lt c=10; Ad=20 y 2 + y [ll0 0 ]-200 = 0
29* Rt 29* Lt c=10; Ad=20 y 2 +y[8149]-580 = 0
100* R, 100* Lt c=10; Aj= 20 y 2 + y [92000]- 2000 = 0
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Figure 3.6. Effect of the total assay concentration on sensor response.
Hsu et al., further extended this work on theoretical modeling of affinity sensors, 
to study the effect of various parameters on the sensor response, such as ligand and 
receptor concentrations, variation in the ratio between ligand/receptor, type of receptor, 
etc. In this system, the receptor is assumed to be immobilized in a resin with volume Vr. 
They derived a cubic equation (Equation 3.23) instead of quadratic, for analyzing the 
sensor response due to the variations in several parameters.
and r = -y- where V, is the total volume (resin + buffer).
The above Equation 3.23 is derived similar to the quadratic equation (Equation 
3.21), using Equations 3.6 to 3.13, and writing A in terms of A0, K2, and R, which can be
Y 3 + Y 2( \ /a  + \ / a b - l - ( l  + X ) / ( \ - c ) }  +
Y{(X + \ - \ / a - \ / a b ) / ( \ - c ) - \ / a b }  + \ / a b ( \ - c )  = 0
(3.23)
where, Y
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obtained from Equations 3.7 and 3.10. The variable signal that is being measured in this 
system is the concentration of ligand in the bulk solution ([Z,]). Using the above cubic 
Equation 3.23, the dimensionless signal, defined as Y (L/L,) can be obtained as a function 
of varying analyte concentration X  (A /L ,), for any given values of a, b, and c.
Equation 3.23 was used to build calibration curves (Figure 3.7) for the proposed 
affinity sensing system. The asymptotic minimum values of the signals represent the 
initial condition, where, in the absence of the analyte, the equilibrium concentration of 
the ligand produces the background. However, with the addition of analyte, ligand is 
displaced from the receptor and thus, the ligand concentration in the bulk increases with 
the increase in analyte concentration, which can be observed in Figure 3.7. Eventually, 
the dimensionless signal (or ligand in the bulk) reaches saturation indicating the 
displacement of all the ligand molecules with the addition of analyte. All the graphs 
shown in Figure 3.7 are produced using the cubic Equation 3.23, thus they are influenced 
by the three parameters, a, b, and c. The effect of these individual parameters on sensor 
response was studied by varying one parameter at a time and holding the other two 
parameters constant.
The effect of changing parameters a, b, and c (Equation 3.23) one at a time, while 
holding the other two parameters constant, is shown in Figure 3.7. In practice, parameters 
a, b, and c, can be tailored by changing the initial concentration of the loaded ligand (Lt), 
the amount of the immobilized receptor or by choosing the receptor with different 
binding affinity (Kd), and by choosing a receptor, which has different (more or less) 
affinity towards ligand compared to analyte, respectively. In this system, sensitivity is 
considered as the change in the dimensionless signal resulting from changes in analyte
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concentration. Detection range is the range of analyte concentration in which there will 
be a significant change in the dimensionless signal with an increase in analyte 
concentration.
It can be observed from Figure 3.7(a) that the background signal generated was 
observed to increase with a, but the sensitivity and detection range were correspondingly 
decreasing. Also, the calibration curve is shifting to the right (a<l .0), which indicates that 
the senor is suitable for detecting high analyte concentrations. Also, when a>10, there is a 
significant drop in sensitivity and detection range rendering the system unsuitable for 
practical cases. It is obvious from these results that a compromise must be made between 
the signal strength and the sensitivity of the sensor when choosing the initial 
concentration of the ligand.130 It is noteworthy that the results obtained in this section 
(Figure 3.7(a)), match with the results obtained by the Schultz group using a quadratic 
equation (Figure 3.5). In both the cases, it is shown that with the increase in ligand 
concentration (i.e., increase in ligand/receptor ratio), there is an increase in background 
signal and a drop in sensitivity and detection range values.
It can be observed from Figure 3.7(b) that the effect of parameter b on the sensor 
response is contrary to the effect of parameter a. The increase in b results in lower signal, 
but increased sensitivity and detection range.130 Again, the compromise must be made 
between the signal strength, detection range, and the sensitivity of the sensor when 
choosing the concentration of the receptor.130
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Figure 3.7. Effect of (a) parameter a, with constant b=100 and c=1.01; (b) parameter b, with constant 
a=l and c=1.01; (c) parameter c, with constant a=land b=100; on the calibration curves obtained 
from the theoretical model (Equation 3.19). Values of the variable parameters are given in the 
corresponding graph.130
Unlike the previous two cases, the asymptotic minimum signal value is 
independent of the parameter c, which can be observed in Figure 3.7(c). It can be 
observed that sensors designed with a lower c value will be useful for detecting lower 
analyte concentrations. In order to increase the range to a higher level, it is highly 
desirable to increase the value of c by choosing a different receptor. Also, the results 
obtained in this section (Figure 3.7(c)) appear to be similar to the results shown in Figure
3.6 (obtained using quadratic Equation 3.22), even though the variables in both cases are
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not identical. The response curves in Figure 3.7(c) were obtained by varying the 
parameter c (or choosing a different receptor), whereas the response curves in Figure 3.6 
were obtained by varying the total assay concentrations. Thus, the detection range of the 
sensor can be controlled by varying two different parameters, total assay concentrations 
and choosing different receptor protein.
Thus, these theoretical models for competitive binding based sensing systems are 
essential for choosing the initial assay element concentrations and are also very helpful 
during the optimization of the sensor response characteristics.
3.3 Combination of FRET and Competitive Binding
Techniques
In order to combine the FRET and competitive binding (CB) techniques, ligand 
and receptor were labeled with donor and acceptor fluorophores (FRET pair), 
respectively. This process is demonstrated in Figure 3.4. In the absence of analyte, ligand 
and receptor will be in close proximity (Figure 3.4(a)), which results in significant energy 
transfer from donor to acceptor, and is indicated by the strong emission peaks 
corresponding to donor and acceptor molecules (Figure 3.4(c)). With the addition of 
analyte, ligand is displaced from the receptor increasing the distance between two 
fluorophores (Figure 3.4(b)), and eventually reducing the energy transfer from donor to 
acceptor; this is indicated by a strong donor peak relative to acceptor (Figure 3.4(d)). The 
combination of competitive binding and FRET techniques is very attractive as it can 
retain the advantages of both techniques, such as the non-consumption of analyte, 
absence of reaction by-products, and the ratiometric nature of the FRET analysis.
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3.3.1 Theorv-Combination of FRET 
and CB Techniques
The information obtained in section 3.2 regarding the change in the fraction of 
free ligand concentration with the increase in analyte concentration can be converted into 
the relative amount of fluorescence that is being transferred from donor to acceptor 
molecules, by using FRET efficiency values.133 The relation between the relative 
fluorescence and the ratio of free to total ligand concentration is given as,
Relative Fluorescence = 1 1 -  x efficiency
. w
(3.24)
The combined results of competitive binding and FRET are shown in Figure 3.8. 
It can be observed that at constant ligand/receptor ratio, FRET efficiency has significant 
effect on the sensor response characteristics. In Figure 3.8, the sensitivity curves are 
shown for two different ligand/receptor ratios. It can be observed that with the increase in 
FRET efficiency, there is increase in linear response. The main parameters influencing 
FRET efficiency, other the necessary conditions (such as, overlap integral, distance 
between the fluororphores, etc.,), are the labeling ratios of acceptor and donor molecules. 
Thus, the fluorophore conjugation can have significant effect on the sensor response 
characteristics.
These modeling results emphasize the importance of each parameter in achieving 
the desired sensor parameters, mainly sensitivity and detection range. It helps in deciding 
the labeling ratio of the donor and acceptor molecules and sensing assay concentrations, 
in order to obtain the required sensor response characteristics. Thus, these theoretical 
models for competitive binding and FRET based sensing systems are very helpful in 
hypothesizing and optimizing the sensor response characteristics.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
63
o . a o
sc
8  0 .6 0  W
£o3H
a  0 .4 0  
>  Efficiency =0.2
 Efficiency -0.4
—““ Efficiency =0.6 
— Efficiency =0.8
£
0 . 20
20 40 60 80 1000
0 .6 0
— -  -Efficiency =0.2
 Efficiency =0.4
■— Efficiency -0 .6  
Efficiency =0.8
oc 0 . 2 0
o.o
o 20 4 0 6 0 00 too
Dimensionless Analyte Concentraiion
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fluorescence when the total ligand/receptor ratio is (a) 0.01, and (b) 0.1.133
In conclusion, this chapter discussed the theoretical modeling involved in energy 
transfer based competitive binding based sensing systems and has highlighted the 
significance of the individual and total assay concentrations and binding affinities in 
determining the sensitivity and detection range of the sensors. Chapters four to seven will 
discuss experimental work for several variations of the energy transfer based competitive 
binding sensors which involves the demonstration of the design, fabrication, and 
characterization of microcapsule based sensors.
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CHAPTER 4
LECTIN/SACCHARIDE BASED 
GLUCOSE SENSOR
Since 1988, several variations of Concanavalin A (Con A)-based fluorescence 
resonance energy transfer (FRET) glucose sensors have been reported in the literature. 
However, most of the reports demonstrated Con A-based glucose sensitivity in solution 
phase, which will not achieve the final goal of an implantable glucose sensor, because the 
sensing assay chemistry is not enclosed in any microcontainer. Schultz et al., proposed 
several variations of Con A/dextran based fiber-optic glucose sensors. However, the 
length and diameter of a completed sensor are ~ 6cm and ~0.4mm, respectively, making 
them inappropriate for transdermal monitoring. After a decade of investigation into this 
transduction mechanism, in 1999, Russell et al., proposed a sensing design close to the 
clinical application, which involves the encapsulation of sensing assay in hydrogel 
microspheres.27 There was also another report in 2003 by the Schultz group based on the 
changes in fluorescence intensity due to the exposure of Con A loaded sephadex beads to 
glucose.97 Nevertheless, even this system requires microdialysis tubing. Other than the 
above-mentioned sensing mechanisms with the potential for achieving transdermal 
sensing, there were no previous reports on Con A-based implantable sensors.
64
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This chapter demonstrates a Con A-based FRET glucose sensing assay 
encapsulated in true microscale capsules. This work expands on previous work by 
elaborating on the precise assembly of Con A/dextran multilayers on planar substrates to
• 72microcapsules, and packaging of these dynamic nanoassemblies within permeable 
polymeric capsules. This study was completed to characterize the self-assembly 
properties and, in particular, the glucose sensitivity of self-assembled Con A/dextran 
multilayer films. Furthermore, the glucose sensitivity of the tetramethylrhodamine 
isothiocyanate (TRITC)-Con A and fluorescein isothiocyanate (FITC)-dextran-coated 
particles and capsules was demonstrated by measuring changes in FRET between FITC 
and TRITC resulting from titration of glucose. Such micro/nano scale systems 
containing Con A/dextran multilayers may potentially be used for in vivo glucose 
sensing, if appropriately designed to eliminate concerns over Con A toxicity.
4.1 Sensor Design
A schematic of the glucose microsensor fabrication process is shown in Figure
4.1. To produce hollow capsules containing the assay components, soluble microparticles 
are coated with multilayers of FITC-dextran and TRITC-Con A thin films, followed by 
sequential deposition of oppositely charged polyelectrolytes. In the final step of 
fabrication, the particle core is dissolved, resulting in hollow capsules with immobilized 
Con A and dextran as the interior wall. The advantage of hollow capsules is the decreased 
diffusion barrier provided by the interior, which should give rise to rapid equilibrium and 
more uniform distribution of glucose in the films. As shown in Figure 4.1, strong 
fluorescence peaks due to both FITC and TRITC are present after assembly of the films, 
indicating there is considerable energy transfer. With the addition of glucose, dextran is
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displaced from Con A, resulting in a decrease in energy transfer efficiency as indicated 
(Figure 4.1) by a stronger FITC peak relative to TRITC. The details of experiments 
investigating these properties are given in the following sections.
Figure 4.1. Fabrication process flow diagram (LbL assembly) of the biosensor (a) Microparticle as 
positively-charged substrate (b) Deposition of dextran (anionic) and Con A layers alternatively (c) 
Adsorption of the polymer multilayers (d) Dissolution of core to yield capsules (e) Titration of glucose 
to displace dextran from Con A.
Materials. Poly(allylamine hydrochloride) (PAH, 15kDa), poly(dimethyldiallyl 
ammonium chloride) (PDDA, MW 200kDa), and poly(styrene sulfonate) (PSS, MW 
70kDa) from Aldrich were used as polyelectrolytes. Solutions of 2 mg/mL in DI water 
were prepared for each polymer, and these were used at neutral pH. An aqueous 
dispersion, 10 wt% of 5 (im diameter melamine formaldehyde (MF) dissolvable resin 
particles, was obtained from Microparticles Gmbh (Germany). FITC Dextran (MW 
9kDa, 150kDa and 2MDa) and Succinyl-Con A (MW 54kDa) were purchased from 
Aldrich and EY Labs, respectively. Aqueous stock solutions of 0.5 mg/mL and 1 mg/mL
PolymersTRITC-Con A
Core
dissolutionFITC-dextran
MF particles O  
FITC-Dextran #  
TRITC Con A ^  
PAH /w
Glucose
titration
TRITC
Glucose Wavelength Wavelength
4.2 Experimental Section
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were prepared in DI water for dextran and Con A, respectively, and the pH was adjusted 
to 8.5 by titrating with NaOH. Tetramethylrhodamine isothiocyanate (TRITC) was 
purchased from Molecular Probes to label succinyl-Con A using a standard amine- 
labeling protocol.136 Glucose, from Sigma, was dissolved in DI water at neutral pH, to 
prepare a lOOmg/mL stock solution. All solutions used in the experiments involving Con 
A contained 1 mM concentrations of calcium chloride (CaCy and magnesium chloride 
(MgCb) salts to preserve Con A and glucose binding.64
Instrumentation. A quartz crystal microbalance (QCM, USI-System, Japan) was 
used to study the self-assembly of Con A/dextran thin films. Absorbance spectra were 
collected using a UV-Vis absorbance spectrometer (Perkin Elmer Lambda 45). Zeta- 
potential measurements were taken using a ZetaPlus photon correlation spectroscopy and 
microelectrophoresis instrument (Brookhaven Instruments). A scanning fluorescence 
spectrometer (QM1, Photon Technology International) was used to collect fluorescence 
emission spectra from the sample using excitation at 488 nm. The microparticles and 
capsules containing FITC-dextran/TRITC-Con A were imaged using a confocal 
microscope (Leica Microsystems).
4.3 Methods
4.3.1 Assembly on QCM Resonator
To confirm the ability to form multilayer films from dextran and Con A, the LbL 
assembly of Con A/dextran was first monitored with QCM by constructing multilayer 
films on a quartz resonator. When a mass is adsorbed on the resonator there is a shift in
137resonant frequency, which is related to the adsorbed mass by the Sauerbrey equation.
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According to this relationship, the change in frequency (AF, Hz) is related to the total 
mass of the adsorbed thin film layer (Am, ng) as Am=-0.87AF.
QCM resonators were used as substrates for alternate assembly of FITC-dextran 
/Succinyl-Con A thin films. The resonator was a silver electrode, with a surface area of 
0.16 cm2 and natural resonance frequency of 9 MHz. During the assembly procedure, 
each resonator was dipped in the solution of polymer to be deposited for 15 min. The 
resonance frequency, was measured after rinsing the crystal with water and drying with 
nitrogen. Precursor films of (PAH/PSS)2/PDDA were deposited to obtain a smooth and 
uniformly charged substrate prior to the addition of the polysaccharide/protein 
multilayers. For FITC-dextran (MW 2MDa) and succinyl-Con A deposition, the 
resonator was immersed in bulk solution for 25 min to allow enough time for the 
adsorption. The change in resonance frequency was monitored for each adsorption step.
Following the completion of the layering process, the resonator was used to test 
the sensitivity of the Con A/dextran thin films to glucose by immersing the resonator in 
1.5mL of lOOmg/mL glucose solution. After dipping the resonator in the glucose 
solution, the frequency change was monitored every hour over a period of 7.5 hrs. After 
completing the assembly process on the resonator, absorbance measurements were 
performed on all the solutions used for deposition, including the glucose solution, to 
assess the desorption of the layered thin film components into the bulk solutions.
4.3.2 Assembly on Microspheres
The techniques used for successful assembly of Con A/dextran multilayers on the 
planar surfaces of QCM resonators were applied to form Con A/dextran multilayers on 
the surface of 5 pm MF particles. FITC-dextran (2MDa, 0.5mL) was added to 10 pL of
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the MF particle suspension. After allowing 20 min for complete adsorption saturation, 
the sample was rinsed using DI water and centrifuged at 4000 rpm for 8 min. This rinse 
process was repeated twice for each assembly step. Then, 0.5 mL of 0.5 mg/mL TRITC- 
Con A was added to the sample, and after a 20 min exposure, the sample was again 
rinsed twice. This assembly process was repeated to deposit multiple bilayers of TRITC- 
Con A/FITC-dextran, such that the outer surface was FITC-dextran.
To assess the charge of the adsorbed material and, therefore, determine the 
relative contribution of electrostatic attraction to the assembly process, multiple surface- 
potential measurements were taken after depositing and rinsing each layer. Fluorescence 
emission spectra were also collected from the suspension after depositing each layer, 
allowing tracking of the layering process and observation of FRET efficiency with each 
additional component of the nanofilms. Finally, the layered microparticles were imaged 
using a confocal microscope after each bilayer addition of FITC-Dextran/TRJTC-Con A. 
A 5pL drop of the suspension was pipetted onto a glass microscope slide, and sequential 
confocal images were taken with a 63X oil objective by exciting FITC at 488 nm and 
TRITC at 543 nm using Ar/ArKr and green HeNe lasers, respectively.
4.3.3 Glucose Effect on Con A/Dextran
Coated MF Particles
After completing the assembly of FITC-dextran and TRITC-Con A multilayers, 
fluorescence spectra of the particles and surrounding medium were collected. This was 
performed to determine the relative contribution of particles to fluorescence signals and 
to observe whether significant amounts of fluorophore-tagged macromolecules were 
present in the solution in free form. To assess the glucose-binding properties of the 
assembly, glucose was added to the continuously-stirred particle suspension in an attempt
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to displace FITC-dextran from TRITC-Con A. After each addition, fluorescence 
emission measurements were performed to observe the change in energy transfer. After 
the final step of adding glucose, the particles were centrifuged and the fluorescence was 
observed in order to assess the effect of the dissociation of FITC-dextran from TRITC- 
Con A on film stability. A comparison of the supernatant fluorescence spectra before and 
after addition of glucose was used to demonstrate the sensitivity of the Con A/dextran 
nanoassemblies to glucose. These experiments were completed in parallel to the studies 
with the QCM measurements, such that the two sets of data could confirm the assembly 
and dissociation of dextran/Con A multilayers both on planar surfaces and spherical 
microtemplates.
4.3.4 Encapsulation and Hollow
Capsule Formation
Following the successful demonstration of dextran/Con A multilayer glucose 
sensitivity and observation of the partial decomposition of these films, an ultrathin 
polymer shell was constructed around the Con A/dextran-coated particles to stabilize the 
localization of the polysaccharide and protein molecules. As the outer layer was FITC- 
dextran, and zeta-potential measurements confirmed that the surface charge was anionic, 
the coated microparticles were first suspended in a solution of the polycation PAH. After 
15 min of exposure, the sample was rinsed twice in DI water, and the surface potential 
was measured. This procedure was repeated to deposit a total of four bilayers of PAH 
and PSS plus one additional outer layer of PAH. Thus, the final film architecture on the 
surface of the particles at the conclusion of the assembly was {(FITC-Dextran/TRITC- 
Con A)3/FITC-dextran/ (PAH/PSS)4/PAH}. Following the completion of polymer layer 
deposition, MF core particles were dissolved by adding 0.5mL of HC1 at pH 1.1 to the
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particle suspension.138 Finally, the capsules were centrifuged and rinsed with DI water to 
remove residual MF monomer.
4.3.5 Glucose Effect on Capsules Containing 
Con A/Dextran Multilayers
After encapsulation of the dextran/Con A films within the polymeric shells and 
removal of the solid MF cores, the glucose response of the capsules was studied using the 
same procedures that were applied to the coated particles. The key comparisons made 
between the two cases (dextran/Con A films on solid particles versus hollow capsules 
with dextran/Con A multilayers inside a shell of polyelectrolyte multilayers) were the 
change in FRET following exposure to glucose, and the decomposition of the 
dextran/Con A layers, releasing molecules into the surrounding medium. To observe the 
glucose sensitivity of the microcapsules, 20 pL additions of lOOmg/mL glucose stock 
solution were given to 1 mL of a continuously-stirred capsule suspension (200mg/dL per 
step). To observe the change in energy transfer, fluorescence spectra were collected after 
each addition of glucose by exciting the sample at 488 nm and collecting the emission 
spectra from 500 nm to 650 nm. After the final step of glucose addition, the capsules 
were centrifuged and the supernatant fluorescence was measured to observe if displaced 
dextran was released from the capsules. Confocal microscopy was also used to observe 
the change in FRET within the capsule due to the addition of glucose, and to determine 
whether FITC-dextran was released into the interior of the capsule when displaced from 
Con A.
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4.4 Results and Discussion
4.4.1 QCM Results
Mass measurements performed after depositing each layer are shown in Figure
4.2. This graph presents, in the first phase, the change in adsorbed mass due to deposition 
of the following multilayer architecture: {(PAH/PSS)2/PDDA/(TRITC-Con A/FITC- 
Dextran)3/Glucose}. The precursor polymer layers exhibited the expected linear stepwise 
growth. The average stepwise increase in mass for Con A and dextran addition, which is 
not quite linear, corresponds to an average of -60 ng (-1011 molecules) and -40 ng (-109 
molecules), respectively. In spite of having a higher MW compared to that of Con A, the 
average mass of dextran deposited per step was found to be less. This was expected, 
because the multiple glucose residues of dextran allow association with glucose binding 
sites on multiple Con A molecules. Thus, the dextran may assemble into a configuration 
more parallel to the surface, effectively covering more surface area per molecule.
Addition o f glucose
Precursor layers
Layer Property
Figure 4.2. Mass deposited and released during adsorption of polyelectrolytes, FITC-dextran, and 
succinyl-Con A on the QCM resonator, and exposure of multilayer films to glucose.
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Due to the small number of glucose binding sites on Con A molecules and the 
repulsive electrostatic force present between dextran and Con A, it is expected that the 
adsorption of Con A onto dextran films would be weakly enforced. Thus, it was also 
hypothesized that dextran could pull some Con A from the resonator surface when the 
films with Con A outer layers were exposed to dextran solution. To test this theory, 
absorbance measurements of the solutions used for layering the QCM resonator were 
performed. These measurements, presented in Figure 4.3, show that the absorbance 
spectrum of FITC-dextran assembly solution, after exposure to films with an outer layer 
of Con A, possessed an absorbance peak at 280 nm. This confirms that some protein was 
removed from the surface into the solution during this immersion period. In contrast, the 
Con A solution, following exposure to films containing a FITC-dextran outer layer, did 
not contain an absorbance peak at 490 nm. Thus, the opposite effect (Con A removing 
dextran) was negligible. This is also logical, as the dextran molecules likely bind with 
multiple Con A molecules on the surface, and these multiple parallel associations per 
molecule make the adsorption much more stable.
In experiments to assess the glucose response of the films, the QCM resonators 
with dextran/Con A multilayers were exposed to lOOmg/mL glucose solution for 7.5 hrs, 
which resulted in an increase in resonance frequency corresponding to a decrease in 
adsorbed mass (Figure 4.2). This was expected behavior as glucose has been shown to 
displace dextran in competitive binding,85 and these experiments demonstrate saturation 
of the mass change after -2.5 hours. It is interesting that the response is so slow to 
equilibrate. This cannot currently be explained with confidence, but may be related to the 
diffusion barrier provided by the surface and the total mass of glucose present.
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Figure 4.3. Normalized absorbance spectra of FITC-dextran, succinyl-Con A, and glucose solutions 
used for assembling on QCM resonator, and testing their glucose sensitivity (scaled up with factors of 
12.5X, 25X, and 1000X, respectively).
Quantitatively, the total decrease in the film mass was 78.3 ng, which must 
correspond to the difference in glucose mass bound to the films and the dextran and/or 
Con A removed from the surface. In this case, glucose apparently displaced dextran from 
Con A, as absorbance measurements of the glucose solution after immersion of the QCM 
resonator (shown in Figure 4.3) possessed weak absorbance at 490 nm. In addition, an 
absorbance peak at 280 nm suggests the presence of Con A in solution as well. This was 
also expected, as glucose displacement of dextran from all glucose binding sites of a Con 
A molecule could free it from the film if other attractive forces are negligible. Thus, the 
QCM studies demonstrated that the affinity-binding nanoassemblies of dextran/Con A 
behaved as expected and further investigation was warranted.
4.4.2 Microparticle Coating Results
The surface potential of MF particles was measured to determine the contribution 
of electrostatic forces to dextran-Con A association for deposition of the multilayers with 
the architecture: {(FITC-Dextran/TRITC-Con A)3/FITC-Dextran/(PAH/PSS)4/PAH}. 
The average and standard deviation of the multiple zeta potential measurements for the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
75
particles after addition of each layer are given in Figure 4.4. The first layer of FITC- 
dextran (anionic) was bound to the MF (cationic) particles’ surfaces, primarily due to 
electrostatic forces of attraction. However, the continuous negative potential values 
measured for Con A/dextran multilayers (1FD to 4FD in Figure 4.4) correspond to the 
adsorption of materials with negative charge. Although these values do not confirm 
successful deposition of the materials, the QCM data (Figure 4.4) suggest film assembly, 
and the fluorescence spectra of the particles (Figure 4.5(a)) directly confirm alternate 
assembly of Con A/dextran in multilayers. Thus, taken together, these data confirm that 
layer-by-layer assembly of FITC-Dextran and TRITC-Con A can be performed under 
neutral conditions in spite of both molecules carrying a net negative charge, and that the 
association between Con A and dextran molecules is due to binding affinity. The 
attractive forces involved in this association are sufficient to overcome electrostatic 
repulsion.
70 n
50 -
FD: FITC-dextran 
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Figure 4.4. Mean and standard deviation values for zeta potential measurements of coated MF 
particles. Film architecture: {(FITC-Dextran/TRITC-Con A)3 /FITC-Dertran/(PAH/PSS)s}
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It can be observed from Figure 4.5(b) that the FITC:TRITC peak intensity ratio 
decreases with the addition of each layer up to two bilayers of FITC-dextran and TRITC- 
Con A, indicating that there is increase in energy transfer from FITC to TRITC. After 
two bilayers, the peak intensity ratio remained constant, suggesting that a constant level 
of energy transfer is achieved due to consistent association of dextran and Con A 
molecules with similar average distance between FITC and TRITC.
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Figure 4.5. (a) Normalized fluorescence spectra of particle suspension after depositing fluorescent 
materials FITC-dextran (FD) and TRITC-Con A (TC); (b) FITC:TRITC peak intensity ratios after 
adsorbing each layer on MF particles
To observe if free dextran and Con A molecules were present in the sample, the 
fluorescence of the coated particles was compared with the supernatant fluorescence 
following separation by centrifugation. It can be observed from Figure 4.6(a) that the 
supernatant fluorescence had a prominent FITC peak compared to TRITC, and the total
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emission intensity was an order of magnitude less than the suspension fluorescence. In 
comparing the fluorescence of the particles and the supernatant after adding glucose 
(Figure 4.6(b)), the relative FITC fluorescence of the supernatant increased significantly. 
Thus, it is apparent that when glucose was added to the sample, it was bound to Con A 
and displaced dextran into the bulk solution. By combining these observations with the 
QCM data presented earlier, the glucose interaction process may be described as follows: 
as dextran is released, the films partially decompose, and Con A-glucose complexes are 
also released. The absence of TRITC fluorescence in the supernatant after adding 
glucose indicates that the TRITC-Con A released into the supernatant is associated with 
glucose, not dextran, and therefore significant RET is not present.
Because ultrathin films based on electrostatic LbL self assembly are known to
1 TOswell with increasing salt concentration, additional experiments were performed to 
assess whether the observed changes in FRET and the release of FITC-dextran could 
have resulted from nonspecific effects of ionic strength or other properties of the 
environment. Fluorescence spectra of the particles (MF particles with FITC-dextran and 
TRITC-Con A multilayer films, without polymer coatings) and supernatant, following the 
addition of NaCl (up to 0.5 M) and dilution with water showed that there was no change 
in the FITC:TRITC peak intensity ratio. Therefore, the change in FRET observed for the 
nanoassembled Con A/dextran multilayer films likely arises specifically due to glucose 
and, thus, the displacement of dextran from Con A is believed to be a result of the 
competitive binding of glucose rather than a nonspecific change in the films. It is 
expected that these assemblies will have the same selectivity for glucose over other 
sugars as has been shown in other work,85 though this property is not investigated here.
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Figure 4.6. Fluorescence spectra of MF particle suspension coated with {(FrTC-dextran/TRITC-Con 
A)3 /FITC-dextran}, along with supernatant a) prior to addition of glucose, and b) after glucose 
titration.
4.4.3 Polymer-Coated Microcapsules
The charged polymers were deposited on top of the Con A-dextran multilayer 
films via electrostatic self assembly and the charge was varied from positive to negative 
in alternate fashion. The alternation of surface potential values (Figure 4.4, 1PAH to 
5PAH) corresponds to the adsorption of the positive (PAH) and negative (PSS) species, 
respectively. Confocal fluorescence images of the 5-pm capsules formed by MF 
dissolution are shown in Figure 4.7, from which it can be observed that the capsule walls 
remain intact after core dissolution. In addition, there does not appear to be significant 
amounts of free fluorescent molecules inside or outside the capsules indicating that the 
Con A/dextran assemblies remain mostly intact. The fluorescence intensity line scans of 
the capsules show the spatial distribution of fluorescence emitted from the image plane 
for both FITC and TRITC. These data clearly show the dimension of the capsules is 
approximately 5 pm and the fluorescence arising from the walls is much stronger than the 
background from the capsule interior and exterior.
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Figure 4.7. Confocal microscope images of capsules with {(FITC-dextran/TRITC-Con A>4 /FITC- 
dextran/(PAH/PSS)4 /PAH} as shell structure, and corresponding intensity line scans of capsules, 
showing FITC (left) and TRITC (right) intensities
It was hypothesized that the dextran in these capsules would be displaced from 
Con A by glucose. By this process, increasing the glucose concentration in the 
suspension of hollow capsules would result in an increase of free FITC-dextran 
concentration and, hence, increasing of the FITC fluorescence was expected from the 
suspension. Correspondingly, the average distance between dextran and Con A was 
expected to increase resulting in a decrease in the energy transfer between FITC and 
TRITC, due to which the relative fluorescence of TRITC would decrease.87
To test these expectations, fluorescence emission spectra of polymer-coated 
capsules were monitored with increasing glucose concentration. The FITC:TRITC peak 
intensity ratio plotted versus glucose concentration is shown in Figure 4.8. It can be 
observed that the FITC fluorescence did, in fact, increase relative to the TRITC 
fluorescence, up to approximately 1200mg/dL glucose. Over this range, the sensitivity 
curve shows approximately linear increase in FITC:TRITC fluorescence peak intensity 
ratio with glucose concentration. The slope of the sensitivity curve in the linear region 
was calculated to be 4x1 O'4 ratio units/(mg/dL), which corresponds to -7-10% of the total
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ratio change for each step of lOOmg/dL of glucose. Above the linear range, the signal 
appears to plateau, indicating the saturation of Con A binding sites with glucose. This 
sensitivity is near to that of the best case reported in the literature using intensity 
measurements of FRET, and was achieved without any attempt to optimize sensitivity or 
signal-to-noise ratio. Therefore, these results are encouraging and suggest further work 
may lead to improvements in the system properties related to measurement performance.
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Figure 4.8. Effect of glucose titration into suspension of capsules comprising {(FITC-dextran/TRITC- 
Con A)4 /FITC-dextran/(PAH/PSS)4 /PAH} as shell layers
In addition to testing response to glucose measured by changing FRET, the 
stability of the structures was investigated. After completing the addition of glucose, the 
capsules were centrifuged and the supernatant was collected to determine the loss of 
fluorescent molecules from the microcapsules. The emission intensity of the supernatant 
was two orders of magnitude lower than the emission from the capsules and, because the 
peak ratio was identical to that of the capsules, even this small signal can be attributed to 
inefficient separation of capsules from supernatant. This is in contrast to the findings 
when assessing FITC-dextran/TRITC-Con A assemblies on MF particles without the
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polymer shell, as noted above, where significant loss of FITC-dextran was seen in the 
supernatant. These results highlight the improved stability of the polysaccharide/protein 
films encapsulated by polymer nanofilms, and supports further development of this 
technology. However, further investigation will focus on quantitatively determining 
whether FITC-dextran or TRITC-Con A is released from the microcapsules.
The results of the response of the microcapsule suspension to glucose, taken 
together, indicate that the presence of glucose did result in separation of Con A and 
dextran, such that the energy transfer between FITC and TRITC was decreased. Also, this 
result corroborates with the theoretical model results in Chapter Three (Figure 3.5), 
which shows that there is an increase in the fluorescence from free-ligand with the 
increase in analyte concentration. Using the Forster distance for FITC and TRITC 
fluorophores as 5 5A,116 the estimated change in the average distance between FITC and 
TRITC molecules was found to be 3.5A with the addition of -0.1M glucose, which is a 
reasonable number given the size of a glucose molecule (-10 A). These small 
displacements could easily be achieved without significant rearrangement of the ultrathin 
films, and could be a result of the movement of glucose residues on dextran to 
accommodate for glucose molecules binding to the Con A sites.
Further confirmation of the stability of the microcapsules was provided by the 
confocal microscope images of the capsules after adding glucose. Still, these did not 
show any significant fluorescence inside or outside the capsules. There could be several 
reasons for not observing free molecules after the glucose addition. The dextran and Con 
A molecules may be moving apart such that there is a change in FRET, but they remain 
immobilized within the films. Thus, the films are sufficiently deformable that they can
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accommodate this change. This is a reasonable assumption given the previous calculation 
of 3.5A for average displacement which could not be resolved with microscopic 
measurements. Alternatively, the dextran and Con A molecules may be completely 
separated, but the free FITC-dextran molecules may be stuck in the polymer layers due to 
their large size. Regardless of the true physical arrangement of the molecules in the 
films, which will be the subject of further studies, the results here demonstrate the 
concept of FRET-based glucose sensing using dextran-Con A multilayers, and further 
work to investigate these novel nanostructured materials is warranted.
4.5 Conclusion
In conclusion, a novel glucose sensing system based on the LbL self assembly 
competitive binding and FRET techniques is demonstrated in this chapter. Glucose- 
sensitive Con A/dextran multilayer films were successfully assembled on planar 
substrates and microparticles due to the affinity between molecules. Hollow capsules 
containing Con A/dextran multilayers showed a glucose sensitive decrease in FRET with 
a detection range from 0 to 1800 mg/dL and a sensitivity of 4x1 O'4 ratio units/(mg/dL). It 
was estimated from the data that with the addition of -0.1M glucose solution to the 
capsule suspension the Con A and dextran molecules moved apart by an average distance 
of approximately 3.5 A, which corresponds to a 27 % increase in the FITC.TRITC 
intensity ratio. These findings show that the combined use of FRET, competitive binding, 
and LbL principles is a promising approach to build sensors, and this should be a more 
generally useful method for building many other biosensor elements beyond the model 
Con A-dextran system. Depending upon the structural dynamics of the ultrathin films in 
response to the analyte, similar approaches could potentially be used to realize drug
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carriers for controlled delivery. In spite of all the above-mentioned advantages of this 
sensor design, there are some inherent disadvantages of using Con A as one of the 
elements in the sensing assay, such as toxicity, aggregation, and specificity. Therefore, 
there is an urgent need to develop a new sensor design or find a replacement for Con A in 
the existing design. The next chapter demonstrates a sensor design by replacing Con A 
with another glucose binding protein, which is highly specific to glucose and is not toxic.
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CHAPTER 5
FLOURESCENT GLUCOSE SENSORS 
OPERATING IN VISIBLE REGION
To overcome the limitations of Con A, we have developed an alternative 
approach to the regular Con A-based competitive binding assay using an inactive form of 
the enzyme glucose oxidase (apo-GOx) as the glucose-binding protein, which is highly 
specific to P-D-glucose. Apo-GOx was previously used as a biosensor based on its 
ability to reconstitute into a holoenzyme with the addition of semi-artificial 
cofactors.140,141 Apo-GOx was also used for glucose sensing by itself,23 as it was shown 
that there was a decrease in the intrinsic fluorescence of apo-GOx/apo-GOD with the 
addition of glucose. This kind of sensing method cannot be corrected for inner filter 
effects as it is not ratiometric. Furthermore, any decrease in intensity could be partially 
due to the effect of assay dilution. Also, as UV light is used for excitation, complex 
instrumentation may be required, and also there could be interference from different 
proteins in biological samples.
This chapter demonstrates, for the first time, a FRET assay for glucose which 
utilizes the affinity of apo-GOx toward glucose. This system may potentially be used for 
in vivo glucose monitoring, if properly encapsulated. Furthermore, these sensors may be
84
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
85
used in drug delivery applications, wherein the glucose sensitive apo-GOx/dextran 
dissociation results in variable material properties that determine drug release.
5.1 Sensor Design
The working principle of the sensing system is illustrated in Figure 5.1. Briefly, 
apo-GOx is prepared from GOx by removing the FAD cofactor.23 When apo-GOx is 
tagged with TRITC and exposed to FITC-dextran, strong fluorescence peaks due to 
considerable RET between FITC and TRITC are observed. Because of the high affinity 
of the glucose towards apo-GOx, the addition of glucose will result in the displacement 
of dextran from apo-GOx, which is indicated by a decrease in the energy transfer 
efficiency (Figure 5.1) by a stronger FITC peak relative to TRITC. In this study, the 
glucose sensitivity of the TRITC-apo-GOx/FITC-dextran was demonstrated by 
measuring changes in RET between FITC and TRITC resulting from titration of glucose.
B  FAD
1 removal^
f GOx
a Apo-GOx
i FAD cofactor0 Absence of FAD
%Dextrano Glucose
Apo-GOx/dextran
complexes
TRITC
Addition
of dextran
removal
Addition 
of glucose
Apo-GOx/
Glucose
complexes
Figure 5.1. Schematic of a glucose assay based on competitive binding between dextran and glucose 
for binding sites on apo-GOx.
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This system retains the advantages of the competitive binding approach: selectivity to the 
analyte of interest, elimination of reaction byproducts, and no consumption of the analyte 
during the sensing process.
5.2 Experimental Section
Materials. FITC-dextran (FD, MW 2MDa, 500kDa), glucose oxidase (GOx, G- 
2133), sodium poly(styrene sulfonate) (PSS, MW -lM Da), poly(allylamine 
hydrochloride) (PAH, MW 70kDa), P-D-glucose, mannose, a-D-glucose, sucrose, 
sodium bicarbonate, dimethyl formamide, ammonium sulfate, peroxidase and sodium 
acetate buffer were obtained from Sigma. Tetramethylrhodamine isothiocyanate 
(TRITC, Molecular Probes) was used to label apo-GOx.136 Diazoresin (Diazo-10, 4- 
diazodiphenylamine/formaldehyde condensate hydrogen sulfate-zinc chloride salt, DAR) 
was purchased from PC Associates, NJ. All reagents were used as received. MnC0 3  
(5 pm) particles were prepared as previously described.142
Instrumentation. A UV-Vis absorbance spectrometer (Perkin Elmer Lambda 45) 
was used to collect absorbance spectra and perform catalytic activity tests. The slit size (4 
nm) and scanning speed (480 nm/min) were held constant throughout all the experiments. 
A scanning fluorescence spectrometer (QM1, Photon Technology International) was used 
to collect fluorescence emission spectra by exciting the sample at 480 nm. A 100-W 
longwave UV lamp (Blak-ray® Model B 100AP, Entela) was used to irradiate the 
microcapsules for photocrosslinking PSS and DAR layers in the capsule walls. Confocal 
images were taken with a Leica TCS SP2, equipped with a 63X objective and Ar/ArKr, 
HeNe lasers. Counts of microcapsules were obtained with a Beckman Coulter counter.
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5.3 Methods
5.3.1 Preparation of Apo-GOx
The basic procedure for apo-GOx preparation was followed as previously 
described.23 GOx (20mg) was dissolved in lmL of sodium acetate buffer and lOmL of 
prepared ammonium sulfate (25% saturated, pH 1.4) solution was added. The sample was 
then incubated in an ice bath with continuous stirring for 2 hrs. Excess (NH4)2 S0 4  salt 
was added to the solution to separate protein and FAD. The protein without FAD cofactor 
(apo-GOx) was precipitated by centrifuging (twice) at 4500 rpm and 4°C. The 
supernatant was then removed and sodium acetate buffer was added to redissolve and 
neutralize. Finally the apo-GOx was labeled with TRITC using a standard amine labeling 
procedure to obtain 1.67 moles of apo-GOx per mole of TRITC.
5.3.2 Assessment of FAD Cofactor Removal
Absorbance measurements were performed on the prepared apo-GOx solution to 
quantify the amount of FAD, which has a characteristic peak at 300 nm. In addition, apo- 
GOx activity measurements were performed to observe the decrease in activity compared 
to native GOx, using a standard colorimetric assay based on the oxidation of o- 
Dianisidine through a peroxidase coupled system on absorbance spectrometer. During 
continuous stirring with a magnetic bar, apo-GOx was added to the assay to achieve 0.17 
pM concentration and the absorbance at 500 nm was monitored as a function of time, 
resulting in a catalytic profile for the apo-GOx. This experiment was repeated for GOx 
and TRITC-apo-GOx.
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5.3.3 Solution Phase Experiments
Observations of RET between FITC-dextran (FD) and TAG were performed with 
a fluorescence spectrometer using 488 nm excitation with emission scans collected across 
the range of 500-625 nm. Initially, ~270pM FD was added to lmL DI water, and 
fluorescence spectra were then collected after each titration of TAG into the sample 
solution. To determine the nature of the energy transfer (non-radiative, radiative, or both), 
fluorescence measurements were also performed after dilution with DI water. Finally, to 
assess the relative affinity of apo-GOx for glucose and FD, RET changes were observed 
during stepwise addition of aliquots of 1 OOmg/mL P-D-glucose solution into the sample 
containing FD/TAG complexes. Sensitivity curves of the fluorescence peak ratio versus 
glucose concentration were constructed.
The effect of dextran molecular weight was studied by performing the same 
sensitivity experiments with equal molar concentrations (270pM) of 500kDa and 2MDa 
FITC-dextrans. The effect of FD/TAG complex concentration on displacement behavior 
was investigated by repeating the same procedure at different total concentrations of FD- 
500kDa/TAG complexes, and maintaining an approximately constant 1:1 ratio of glucose 
moieties on FD-500kDa:TAG. In order to demonstrate the specificity of the sensor for 
glucose, the RET glucose sensitivity measurements were repeated with the titration of 
mannose, a-D-glucose, and sucrose into a solution of (FD-500kDa)/TAG complexes, 
maintaining all other parameters constant.
In Chapter Four, layer-by-layer (LbL) self-assembly was used to entrap Con 
A/dextran multilayers into microcapsules. Unlike Con A, apo-GOx has only one binding 
site, which prevents the construction of the multilayers of apo-GOx and dextran. Hence,
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the procedure used for Con A/dextran assay is not applicable for the encapsulation of 
apo-GOx/dextran assay. Therefore, a new encapsulation technique is developed to 
encapsulate apo-GOx/dextran complexes into microcapsules using photo-sensitive 
materials, which is described in detail below.
5.3.4 Fabrication of Diazoresin-Based
Hollow Microcapsules
This approach employs the elegant LbL self-assembly143 approach for the 
fabrication of microcapsules comprising photocrosslinkable materials (DAR and PSS) in 
the shell structure, which are used for stable entrapment of RET assay elements. 
Solutions of PSS (anionic), PAH (cationic), and DAR (cationic) used for assembling 
{PSS/PAH} and {PSS/DAR} multilayers were prepared in DI water at 2mg/mL. To 
obtain monodispersed samples, MnC0 3  particles (5 pm) dispersed in DI water were 
sonicated for lOmin prior to LbL assembly. As the core particles are positively charged, 
they were coated with one bilayer of {PSS/PAH}, and then three bilayers of {PSS/DAR}, 
followed by one layer of {PSS/PAH/PSS} as the outer layer, as illustrated in Figure 
5.2(a-d). During each adsorption step, the particles were suspended in the polymer 
solution for 15min, followed by rinsing with DI water for three times to remove excess 
polyelectrolyte. The final architecture of the shell structure was 
{(PSS/PAH)(PSS/DAR)3(PSS/PAH/PSS)}.
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Figure 5.2. Fabrication of microcapsules and encapsulation of FD/TAG complexes.
It is noteworthy that the weak interaction between PSS/DAR layers could result in 
the disintegration of the capsule wall during the core dissolution process. To avoid this 
potential problem, initial and final bilayers of PSS/PAH were used to obtain a more 
stable shell structure.144 Hollow microcapsules were obtained by dissolving the MnCC>3 
cores in 0.1M hydrochloric acid (HC1) solution for 20min, followed by rinsing in DI 
water using centrifugation process four times to remove excess HC1 solution, as depicted 
in Figure 5.2(e).
5.3.5 Encapsulation of Sensing Chemistry 
in DAR-Based Microcapsules
Microcapsules prepared as described are permeable to macromolecules, such as 
enzymes, prior to UV irradiation but become impermeable after photocrosslinking.144 In 
order to encapsulate FD-500kDa/TAG and FD-2MDa/TAG complexes in the hollow 
shells, the capsule suspension was split into two different batches with approximately an 
equal number of capsules (~107). In the first case, the microcapsule suspension was 
mixed with the 0.95pM FD-500kDa solution for 5min, followed by the addition of the
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12.5(j.M TAG solution. The capsule suspension was incubated in the mixture of FD/TAG 
solution for 60 min, which allowed enough time for diffusion of the loading molecules 
into the capsule interior (Figure 5.2(f)). Confocal microscopy was used to visualize the 
loading process of the FD/TAG complexes into the microcapsules. A similar procedure 
was followed for complexes containing the larger dextran, with 0.3pM of FD-2MDa and 
12.5pM of TAG. In each case, the capsules were irradiated while still in the FD/TAG 
loading solution, using a UV lamp for 10 min to crosslink the DAR and PSS layers of the 
capsule walls. Ultraviolet exposure was observed to result in a decrease of the 
permeability of the multilayer wall, which stopped the outward diffusion of the 
encapsulated molecules from the microcapsule. The loaded capsules were then rinsed in 
DI water using centrifugation process three times to remove residual loading solution 
(Figure 5.2(g)).
5.3.6 Estimation of the Encapsulation
Efficiency
The procedure outlined below is the standard method used to calculate the loading 
efficiency of sensing assay elements in microcapsules. It is well understood that 
encapsulation of the sensing elements is based on diffusion from the loading solution and 
the loading rate is, therefore, directly proportional to the initial concentration of the 
loading solution. However, estimation of the final amount of loading solution 
encapsulated in the microcapsules is important in order to study the effects of ligand 
molecular weight on sensor response. The FD and TAG concentrations in the loading 
solution (Chad) were determined using UVrVis absorbance spectroscopy prior to the 
addition of hollow microcapsules. As described above, following the suspension of the 
microcapsules in the loading solution and exposing them to UV light, the capsules were
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rinsed thrice in DI water using centrifugation process and the supernatants were collected 
after each rinse. For each component, the concentrations in all the supernatants (e.g. 
Crinse=Crinsei+Crinse2 +Crinses) were determined by UV-Vis and subtracted from Cioa(i to 
estimate the amount of the encapsulated (Cencap) material. Encapsulation efficiency (E) 
was estimated as the ratio of the total number of FD or TAG moles loaded to number of 
capsules N  in the corresponding sample.
C = C - Cencap  lo a d  rinse
C (5.1)„  encap  v  '
is = --------
N
5.3.7 Stability of Encapsulation
For potential use as sensors, it is important for the encapsulated material to be 
retained in the microcapsule over time. An experiment for the assessment of the stability 
of the encapsulated material was performed on two sets of capsules loaded with FD- 
500kDa/TAG and FD-2MDa/TAG complexes, respectively. To estimate the percentage 
of loaded material lost from the capsules, leaching studies were performed by separating 
the supernatant solution from the microcapsules via centrifugation and measuring the 
fluorescence from the supernatant. After each measurement, the supernatant solution was 
placed back with the microcapsule suspension in DI water. In order to reduce 
photobleaching effect and preserve the biomolecule activity all samples were covered and 
stored at 4-8°C under dark conditions, until the completion of all the experiments. Three 
replicate measurements were collected for each sample at 0, 2, 4, 10, 20, 30, and 50 hrs. 
Standard solutions of 26 nM FD-500kDa, 8 nM FD-2MDa, and 333 nM TAG were also 
measured at each point in time to correct for instrumental drifts over time and also to 
estimate the supernatant concentration as a percentage of a standard. The FD peak was
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obtained by exciting the supernatant at 480 nm and collecting emission from 500 to 650 
nm, while the TAG peak was obtained by exciting at 543 nm and collecting from 555 to 
650 nm. FD and TAG peaks of the standard solutions were obtained in a similar manner. 
From loading efficiency and capsule counts, the FD and TAG concentrations present 
were calculated and the percentage of the leached FD and TAG were estimated.
5.3.8 Sensor Response in Microcapsules
A fluorescence spectrum of the microcapsules loaded with the FD/TAG 
complexes dispersed in DI water was collected as the starting point. Fluorescence spectra 
were then collected after each addition of lOOmg/mL glucose to the microcapsules. The 
change in FITC to TRITC peak intensity ratio was calculated from each spectrum and 
plotted with respect to the increments in glucose concentrations. To observe the effect of 
molecular weight on sensor response and also to determine the feasibility of tailoring the 
sensor response, glucose sensitivity experiments were repeated for two different ligand 
sizes and three different concentrations of capsules. In the first case, capsules loaded 
with (FD-500KDa)/TAG and (FD-2MDa)/TAG were assessed. Next, three different 
concentrations of (FD-500KDa)/TAG loaded capsules (~ 106, 2xl06, 3* 106 capsules/mL) 
were considered.
5.3.9 Reversibility
To test the reversibility of these sensors, loaded microcapsules were suspended in 
glucose solutions in random order with respect to concentration. To achieve this, 
FD/TAG-loaded microcapsules (4*105) were dispersed in DI water (0.5mL) and the 
glucose concentration of the suspension was increased by addition of glucose stock 
solution. The glucose levels were changed by rinsing the capsules to remove glucose
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after each measurement and then again adding glucose to reach a new concentration. In 
each case, after addition of glucose to the desired concentration and measurement of the 
fluorescence, the suspension was centrifuged, the supernatant (glucose) solution was 
removed and, finally, an equal volume of fresh DI water was added. The change in 
FITC:TRITC peak ratio was obtained at each step by collecting a fluorescence scan. This 
procedure was repeated to cover the glucose concentration over the range of 0-90 mM, in 
the order of 0, 4.15, 0.35, 9, 2.8, 0.02, 5.5, 19, 13.56, 60, 26.45, and 95 mM.
5.4 Results and Discussion
5.4.1 Assessment of FAD Co-factor 
Removal
The absorbance spectra of GOx and apo-GOx are shown in Figure 5.3(a). The 
absorbance peaks above 300nm in the spectrum corresponding to GOx are due to the 
presence of FAD cofactors. It can be observed that there are no such peaks above 300nm 
in apo-GOx absorbance spectrum, indicating the successful removal of the FAD 
cofactors. Activity measurements were performed at regular time intervals after FAD 
removal to ensure that apo-GOx did not regain activity with time and similar 
measurements were performed with TAG and GOx to determine the relative catalytic rate 
of the molecules. The results of these activity measurements are shown in Figure 5.3(b). 
The catalytic activity of apo-GOx and TAG was observed to be three and four orders of 
magnitude lower than the native GOx, respectively. The activity of apo-GOx 
approximately doubled over four weeks, but remained two orders of magnitude lower 
than the native GOx. The TAG activity was observed to be less than the apo-GOx activity 
which is likely the result of the labeling procedure employed to conjugate TRITC.
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Figure 5.3. (a) Absorbance of GOx and apo-GOx. (b) GOx, apo-GOx, and TRITC-apo-GOx activities 
with respect to time.
5.4.2 Energy Transfer Experiments
Energy transfer from FITC to TRITC was monitored by collecting fluorescence 
spectra after each titration of TAG into FITC-dextran sample solution. Energy transfer 
was observed to increase with each titration of TAG, as shown in Figure 5.4(a). The 
spectra were normalized to the FITC peak at 515 nm to accentuate the changes in the 
TRITC fluorescence. From the data in Figure 5.4(c), it can be observed that the 
FITC:TRITC peak intensity ratio decreases with each addition of TAG. This does not 
directly indicate that energy transfer is non-radiative, as the same effect could be 
observed with radiative energy transfer. To determine that this change in peak intensity 
ratios was affected by radiative energy transfer, the assay was diluted with aliquots of DI 
water after the last addition of TAG. If the energy transfer is radiative, then the peak ratio 
should change with the dilution of the sample. The change in FITC:TRITC peak intensity 
ratios for the spectra after diluting the sample are given in Figure 5.4(c). The constant 
peak intensity ratio seen in Figure 5.4(c) after each addition of DI water confirms that the 
energy transfer between FITC-dextran and TAG is non-radiative.
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Figure 5.4. Normalized fluorescence spectra with the addition of (a) TRITC-apo-GOx (TAG) to FD- 
500kDa; (b) p-D-glucose added to the sample containing FD/TAG complexes, (c) Change in the 
F1TC:TRITC intensity peak ratio with the addition of glucose.
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The glucose sensitivity of the TAG/FITC-dextran samples was measured three 
separate times. The corresponding fluorescence spectra is shown in Figure 5.4(b) and the 
average FITC:TRITC peak ratio is plotted versus glucose concentration in Figure 5.4(c). 
The data clearly show a decrease in the energy transfer with increasing glucose 
concentration up to approximately 140 mM glucose. A 30% decrease in energy transfer 
was observed for a concentration of 90 mM glucose. These measurements verify that the 
apo-GOx and dextran molecules dissociated in the presence of glucose.
For easier comparison of different experimental results, sensitivity curves were 
obtained in all the RET experiments by plotting the percentage change in FITC:TRITC 
peak ratio versus glucose concentration (Figure 5.5), and the slope of the linear region 
was calculated as a measure of sensitivity response. In the case where FD-500kDa was 
used as the competitive ligand, a total change of 17% in energy transfer was observed due 
to 40 mM glucose, with a sensitivity of 0.5%/mM in the region of interest (0-40 mM). 
The same procedure was repeated with FD-2MDa, from which it was observed that there 
was a 7.5% change in RET with the addition of 40 mM glucose. The increase in dextran 
molecular weight was associated with ~2.5 times decrease in sensitivity and ~3 times 
increase in the dissociation constant, as shown in the inset of Figure 5.5.
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Figure 5.5. FITC: TRITC peak intensity ratio with the addition of glucose to FD/TAG complexes. 
Error bars show one standard deviation of three replicate measurements.
A key point to note for these data is that the calculated dissociation constants 
closely match reported values for glucose oxidase.145 Thus, the processes required for 
cofactor removal and labeling of apo-GOx do not destroy the glucose binding behavior of 
the enzyme. This suggests that the binding of glucose and dextran is occurring in the 
active site as opposed to other regions of the enzyme that may be adhesive for sugars. 
Furthermore, this finding is critical for sensors intended for physiological monitoring, as 
the higher kd values (millimolar range) more closely match the relevant range for glucose 
than the micromolar dissociation constants possessed by glucose binding proteins.
It is also noteworthy that the observed variation in the sensor response with 
different molecular weights of dextran could be due to an overall increase in the FD/TAG 
complex concentration in the sample. To achieve equal RET efficiency with different 
molecular weights of FD, the ratio of the number of glucose residues (proportional to FD- 
MW) on FD to the number of binding sites on TAG must be identical. As the number of 
TAG molecules that can bind to FD is directly proportional to glucose residues on FD,
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the TAG concentration at which the energy transfer saturated during TAG titration 
increases proportionally with dextran molecular weight. This results in a total increase in 
the FD/TAG complexes present in the assay, which translates directly to a change in 
sensor response. This explains why the glucose sensitivity experiments (Figure 5.4(c)) 
show that 80 mM glucose is required to reach the saturation point for the larger dextran, 
whereas the saturation was reached with 40 mM glucose for the smaller molecule. 
Additional experiments conducted with lower FD molecular weights (77kDa and 
250kDa) indicated that the sensitivity was increasing and the saturation concentration 
was lower with decreasing FD molecular weight (results not shown). These findings 
indicate that the sensitivity and range of the system can be “tuned” to some extent by 
controlling FD molecular weight.
5.4.3 Effect o f  Concentration on
Sensor Response
To further explore the tunability of the system, sensitivity experiments were 
repeated at four different concentrations of FD-500kDa/TAG complexes. For these tests, 
the total FD/TAG complex concentration was varied over a wide range, but the ratio of 
FD/TAG mass was held constant in all experiments. An initial fluorescence spectrum 
was collected in each case for FD/TAG complex concentrations of 38pM/106 nm, 
125pM/298 nm, 275pM/694 nm, and 1100pM/2620 nm, respectively. Fluorescence 
spectra were collected after each addition of glucose to the FD/TAG complexes and, as 
expected, there was a change in the FITC:TRITC peak ratio with the addition of glucose, 
which is plotted as percentage change in normalized peak ratio in Figure 5.6. In all cases, 
glucose solution was added until there was no further change in the FITC to TRITC peak 
ratio value indicating a saturated response, except for the highest concentration, where
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the response did not reach saturation even with the addition of 300 mM glucose. The 
sensitivity and dissociation constant (kj) for these four systems are plotted versus 
complex concentration over the range of 0-30 mM glucose concentration in Figure 5.7.
It is evident that the concentration of complexes that are present dramatically 
affects both the sensitivity and the range of the response. With approximately a thirty 
times increase in the FD/TAG complex concentration, the sensitivity was reduced by four 
times and the dissociation constant was increased by approximately five times the value 
for the lowest concentration. The required glucose concentration to reach the saturation 
point was increased approximately 10 times, from 30 mM to 300 mM, when the FD/TAG 
complex concentration was increased approximately 30 times (FD concentration from 38 
to llOOpM).
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Figure 5.6. Percentage change in FITC:TRITC peak ratio with the addition of glucose into different 
FD/TAG complex concentrations. Lines are regression curves used only to clearly indicate the trend 
for each set of measurements. Error bars show one standard deviation of three replicate 
measurements.
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Figure 5.7. Relationship of sensitivity (%/mM) and dissociation constant (kj) to concentration of 
assay components (constant mole ratio).
These results agree with the previous studies on the effect of receptor:ligand ratio 
on sensor response using a single dimensionless equation (discussed in Chapter Three 
(Figure 3.5)), which shows that there is an increase in the fluorescence from free-ligand 
with the increase in analyte concentration.146 Also, with the increase in the total 
concentration of the assay elements while keeping the ligand/receptor ratio constant, 
there is drop in sensitivity and an increase in the detection range (Figure 3.6), which 
agrees with the results obtained in this particular experiment.
By comparing the results obtained in the current and previous sections, it can be 
concluded that the sensor response follows the same trend with the increase in dextran 
molecular weight and FD/TAG complex concentration, because the final condition in 
both cases is identical, i.e., there is an increase in FD/TAG complex concentration. Thus, 
the sensor properties can be tailored by varying the dextran molecular weight or FD/TAG 
complex concentration.
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5.4.4 Specificity
It is known that glucose oxidase exhibits a high degree of specificity for P-D- 
glucose. It has been reported that a-D-glucose, D-mannose and D-ffuctose are also 
oxidized by the enzyme, but at least at a 20-fold reduced rate.147 This suggests that the 
binding specificity for the molecules is likely to be different. However, in the case of the 
apo-enzyme, the specificity had to be experimentally determined as no previous reports 
were found. To observe the effect of different sugars on the response of the FD/TAG 
glucose assay, the sensitivity experiments were repeated with p-D-glucose, mannose, a- 
D-glucose, and sucrose. For these experiments, the starting concentrations for the assay 
complexes were 270pM:170 nm FD:TAG. To observe the specific nature of the sensor, 
the different sugar solutions were titrated into the sample in a stepwise manner until the 
RET reached saturation. The corresponding percentage change in FITC:TRITC peak 
intensity ratios versus sugar concentration are plotted in Figure 5.8. It can be observed 
from the response curves that the maximum sensitivity was achieved with p-D-glucose, 
and there was -5 -10  times lower sensitivity for mannose, sucrose, and a-D-glucose.
The total percentage changes in peak ratio with the addition of different sugars 
also follows the same trend as the sensitivity, i.e., with the addition of 50 mM P-D- 
glucose, mannose, a-D-glucose, and sucrose solutions there is 16.9%, 6.0%, 5.9%, and 
2.5% change in RET, respectively. The dissociation constants for P-D-glucose, mannose, 
a-D-glucose, and sucrose were observed to be 14 mM, 24 mM, 46 mM, and 3 mM, 
respectively. It can be observed that in the case of sucrose, the linear region is reduced by 
more than 10X compared to glucose. This large difference in sensor response is attributed 
to the significant variation of the sucrose structure (disaccharide) from, that of P-D-
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glucose (monosaccharide), which results in very weak hydrogen bond interactions 
between sucrose and apo-GOx.147 The above results prove that apo-GOx retains its 
binding specificity for p-D-glucose, and the presence of low levels of other sugars will 
not significantly interfere with accurate measurement of glucose concentration.
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Figure 5.8. Percentage change in the normalized FITC:TRITC peak ratio values with the addition of 
different sugars. Error bars denote one standard deviation of three replicate measurements.
5.4.5 Encapsulation of FD/TAG 
Complexes in Microcapsules
Microcapsules with {(PSS/PAH)(PSS/DAR)3 (PSS/PAH/PSS)} shell architecture 
were prepared as previously described and used for encapsulating FD/TAG complexes. 
Both FD-500kDa/TAG and FD-2MDa/TAG complexes were encapsulated in parallel 
experiments. Confocal images of representative polyelectrolyte microcapsules loaded 
with the glucose assay (there was no obvious difference between capsules loaded with 
FD-500KDa and FD-2MDa) are shown in Figure 5.9. It can be observed from the images
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of capsules in loading solution (Figure 5.9(a-b)) and corresponding line scan in Figure 
5.9(g), that there is equal concentration of FD/TAG in the interior and exterior of the 
capsules. This was expected because the semi-permeable capsule walls allow diffusion of 
macromolecules. However, the exposure of the microcapsules to UV light results in the 
crosslinking of the adjacent DAR and PSS layers in the capsule wall, decreasing the 
permeability of the capsule walls to FD/TAG complexes. As the final step, the capsules 
were rinsed to remove excess FD/TAG complexes, yielding microcapsules loaded with 
the sensing assay (Figure 5.9(c-f)). It can be observed from Figure 5.9(c-d) that the FITC 
and TRITC fluorescence is concentrated in the capsule interior and walls, indicating the 
immobilization of FD/TAG complexes inside and on the capsule walls. When UV light 
was not used to irradiate capsules before rinsing in DI water, the resulting capsules 
showed weak fluorescence from the capsule walls with no fluorescence from the solution 
in the interior of the capsules. High encapsulation in the walls could be due to a 
combination of electrostatics (residual charged residues of polyelectrolytes in walls), van 
der Waals forces, different solubility/partitioning, and physical entrapment of the sensing 
elements (upon crosslinking). Due to the relative magnitude of the forces, it is likely that 
electrostatic forces of attraction between negatively charged FD/TAG complexes and 
positive polymer layers in the capsule walls dominate all the other types of interactions. 
It is noteworthy that association with capsule walls is seen without the wall crosslinking, 
so the contribution of the latter effect is expected to be minimal.
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Figure 5.9 Confocal images of the microcapsules (a) & (b) in FD-500KDa/TAG complex loading 
solution; (c) & (d) after UV exposure and rinsing in DI water; (e) phase transmission image of the 
loaded microcapsules; (f) overlay of FITC, TRITC fluorescence and transmission mode image. 
Fluorescence line scan of the capsules (g) during loading process (from a and b) and (h) after 
encapsulation process (from c and d).
From Figure 5.9(e-f), which clearly show the capsule walls before and after 
encapsulation and from the line scans (Figure 5.9(g-h)) of the loaded and rinsed capsules, 
it can be observed that the encapsulated FD/TAG complexes are distributed uniformly in 
the hollow interior and on the capsule walls. The mismatch of the shapes of the line scans 
in Figure 5.9(g-h) is due to the loading protocol used. It can be observed from the 
intensity scales, that the average intensity value inside the capsule is almost the same. 
There are no peaks at capsule walls for FD-line scans because the dextran can readily 
diffuse into capsules without any entrapment in the walls. However, during the 
encapsulation of TAG after loading of FD, it was observed that a much stronger green 
fluorescence signal was associated with the capsule walls, as dextran could be attracted to 
TAG, which was entrapped in the walls due to its structure and charge. Therefore, after
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rinsing, a fraction of the FD and TAG was entrapped in the capsule walls, which resulted 
in the strong peaks in the FD-line scans in Figure 5.9(g). It is noteworthy that the broad 
peaks of TAG in Figure 5.9(g) are due to the presence of TAG, still present when the 
image was collected. However, after the excess TAG was removed high intensity from 
the walls results in apparently sharper edges.
The encapsulation efficiency of FD/TAG complexes was estimated by measuring 
the absorbance of the rinse solutions and obtaining the capsule count using the Coulter
17counter. The results, presented in Table 5.1 prove that each capsule contains ~10" and 
10'15 moles of FD and TAG, respectively, in the capsules loaded with FD-500kDa/TAG 
and FD-2MDa/TAG complexes (the mass of the loaded FD and TAG was in the same 
order of magnitude for the two sets of capsules considered). It can be observed from 
Table 5.1 that the FD/TAG mole ratio is slightly higher in the case of the smaller dextran 
due to encapsulation of more FD-500kDa moles relative to FD-2MDa. Using the 
molecular weights of dextran and glucose molecules, it was estimated that there are 
1.27xl0'13 and 2.16x10 13 total glucose residues in the capsules loaded with FD- 
500kDa/TAG and FD-2MDa/TAG complexes, respectively. The greater number of 
glucose residues provide more binding sites for apo-GOx molecules, which is supported 
by the calculations in Table 5.1. It can be observed that there is a greater number of TAG 
molecules in the capsules loaded with FD-2MDa/TAG (1.07x10"15) as compared to FD- 
500kDa/TAG (7.85* 10"16), because of a larger number of glucose residues in the former 
case. Even though there is a 1.7 times increase in the number of glucose residues in FD- 
2MDa/TAG loaded microcapsules over FD-500kDa/TAG loaded capsules, there is only 
1.3 times increase in the corresponding TAG concentration. While this suggests that the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
107
apo-GOx/dextran association does not scale linearly with the dextran length, further 
investigation on what factors affect encapsulation efficiency will be required to establish 
a clear mathematical relationship. However, these results do prove that the amount of 
sensing assay in the microcapsules does vary with molecular weight, and the sensor 
response characteristics depend upon the encapsulated assay concentration, ligand size, 
and FD/TAG ratio.
Table 5.1. Encapsulation efficiency parameters for FITC-dextran of two different molecular weights.
Calculated parameters FITC-Dextran MW (Da)
500k 2M
# o f FD-moles and mass (pg)/capsule
# of TAG moles and mass (pg)/capsule 
FD/TAG mole ratio in a capsule
# of glucose residues/FD molecule
# of glucose moles/capsule
# of glucose residues/ TAG molecule
5 .1xl0‘l7/25.4 
7.9x10'16/125.2 
6.5x1 O'2 
2500
1.3x10"
1.6x10
2.2x10''743.3 
1.1 x 10",5/171.3 
2 .0x l0 '2 
10000 
2.1xl0-13 
2 .0xl02
5.4.6 Leaching of Encapsulated Molecules
from Microcapsules
Loss of FITC-dextran (FD) and TRITC-apo-glucose oxidase (TAG) molecules 
from microcapsules was quantified using fluorescence spectroscopy studies, where 
release of the encapsulated molecules from the microcapsules was observed as an 
increase in the fluorescence intensity of the supernatant. The results obtained from this 
experiment are given in Figure 5.10, where the percentage leached indicates the 
percentage of initially encapsulated FD and TAG molecules lost from the capsules to the 
supernatant solutions. These experiments were performed on capsules loaded with FD- 
500kDa/TAG and FD-2MDa/TAG complexes. It is clear from the data that the leaching 
is higher for the capsules loaded with FD-500kDa/TAG, but still less than 4%. This
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result is intuitive because the diffusivity scales as the inverse of the square root of 
molecular weight, and both free and complexed forms of FD-500kDa will have larger 
diffusivity than the corresponding free and complexed forms of FD-2MDa. It is also 
noteworthy that dextran molecules, which possess a linear structure with branches, are 
expected to diffuse more readily through the capsule walls compared to apo-GOx 
molecules (globular structure) because of the lower hydrodynamic volume. This trend 
can be observed in Figure 5.10, which shows that the amount of FD leached is always 
greater than corresponding TAG concentration. Since the TAG is bound to FD, relatively 
few TAG (2M-TAG) molecules can diffuse out of the capsule in the case where TAG is 
bound to FD-2MDa.
4
3
2
1 '500K-TAG
2M-TAG
0
0 10 20 30 40 50
Time (hrs)
Figure 5.10. Percentage of the initially encapsulated FD and TAG in the microcapsules lost to the 
supernatant; (500K-FD and 500K-TAG) and (2M-FD and 2M-TAG) indicate the FD and TAG moles 
in the supernatant corresponding to the capsules loaded with (FD-500kDa/TAG) and (FD- 
2MDa/TAG) complexes, respectively.
It is very likely that the 4% loss in the loaded materials is due in part to molecules 
weakly trapped in or on the capsule walls, because there is no significant barrier present 
to resist diffusion of the assay molecules. It is noteworthy that in all cases there is only a 
small amount of leaching i.e., about 1 -  4% of the initially encapsulated molecules that
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occurs during the first lOhrs of leaching studies, after which there was no change in the 
fluorescence intensities from the supernatant solutions. Thus, the photo-crosslinking 
technique appears to be an appropriate approach for stable encapsulation of the elements 
for the competitive binding assay.
5.4.7 Sensor Response to Glucose
Addition in Microcapsules
Glucose sensitivity experiments were performed on the microcapsules loaded 
with FD-500kDa/TAG and FD-2MDa/TAG complexes. The fluorescence spectrum was 
collected after each addition of P-D-glucose to microcapsules loaded with FD/TAG 
complexes and the corresponding percentage change in the FITC:TRITC peak ratio was 
calculated for each case, as shown in Figure 5.11. It can be seen that there is a linear 
increase in the peak ratio with the addition of glucose up to 30 mM for the capsules 
loaded with FD-500kDa/TAG complexes, with a sensitivity of 2.75%/mM. The signal 
saturation after 30 mM indicates that all the available binding sites on apo-GOx were 
occupied by glucose molecules.
By closely examining the curves in Figure 5.11, it becomes obvious that there is a 
small difference between the glucose responses of the two sets of capsules. The 
sensitivity over the linear region (0-30 mM) for capsules loaded with FD-2MDa/TAG 
complexes was 2.5%/mM. A possible reason for this is the difference in encapsulation 
efficiency, which will be discussed below in more detail. By using the encapsulation 
efficiency and back calculating the number of FD and TAG molecules in both samples, it 
was found that the ratio (no. of glucose moieties/TAG) is approximately equal in the two 
sets of capsules loaded with FD-500kDa/TAG and FD-2MDa/TAG complexes (Table
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5.2). Thus, the minimal variation in the sensor response of the two sets of microcapsules 
is attributed to the insignificant difference in the concentration of sensing assay elements.
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Figure 5.11. Percentage change in the normalized FITC:TRITC peak ratio with the addition of 
glucose to the microcapsules loaded with FD-500kDa/TAG and FD-2MDa/TAG complexes. Error 
bars show one standard deviation of three replicate measurements.
Table 5.2. Details of the sample used for testing sensor response in microcapsules.
Calculated parameters FITC-Dextran MW (Da)
500k 2M
# of FD moles (picomoles) 20.5 6.7
# of TAG moles (picomoles) 315.5 329.5
# of glucose residues/FD 2500.0 10000.0
# glucose moles (picomoles) 51219.5 66659.5
# of glucose residues/TAG 162.3 202.0
It was previously found that there is a considerable variation in the sensitivity and 
dissociation constant with different molecular weights of dextran for solution-phase 
experiments, which is due to the high FD/TAG complex concentrations and not merely
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due to the increase in molecular weight. In the case of microcapsules, however, the 
encapsulation efficiency is limited by the molecular weight of the loading materials and 
capsule size. Therefore, the loading procedure resulted in the encapsulation of almost an 
equal mass of FD and TAG per capsule in the capsules loaded with FD-500kDa and FD- 
2MDa (Table 5.1). As opposed to solution phase experiments, there is no significant 
variation in the sensing assay concentration with the encapsulation of FD-500kDa/TAG 
and FD-2MDa/TAG into microcapsules (Table 5.2). Thus, there is no significant 
difference in the sensor response of the two sets of capsules. This explanation agrees with 
the solution phase experimental results (Figure 5.4 and Figure 5.6), which show that there 
is a significant change in the sensor response mainly with the variation in FD/TAG 
complex concentration. Thus, it can be concluded that the sensor response is mainly 
dependent on the number of ligand and receptor molecules that are available, and not the 
size of the ligand molecule. The small difference in sensor response of the two sets of 
microcapsules could result from the difference in the encapsulation efficiency or the 
behavior of dextran molecules with different molecular weights due to the conformation 
of dextran chains in the capsule interior.
5.4.8 Effect of Capsule Concentration on
Sensor Response
It was demonstrated in solution phase experiments that the sensor response can be 
tailored by varying the assay concentrations. In order to test the feasibility of tailoring the 
sensor response with the sensing assay encapsulated in microcapsules, the glucose 
sensitivity experiments were performed with FD-500kDa/TAG loaded capsules at three 
different concentrations: lxlO6, 2*106, and 3x 106 capsules/mL. Fluorescence scans were 
collected at each addition of glucose solution to the capsules, and the corresponding
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changes in the FITC:TRITC peak ratios for all three samples are plotted in Figure 5.12. 
It is immediately evident that with a 3X increase in capsule concentration, there is a 
decrease in the total change in the percentage of RET from 73% to 58%, and also a 
higher glucose concentration is required to reach the FITC:TRITC peak ratio saturation 
point. It can be seen from Table 5.3 that a 3X increase in capsule concentration results in 
a 3. IX decrease in sensitivity and a 4X increase in dissociation constant. This trend 
corroborates the solution-phase experimental results. These results prove that the 
sensitivity can be tailored by changing the competitive binding assay concentration, 
regardless of the environment of the assay.
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Figure 5.12. Effect of capsule concentration on the change in FITC:TRITC peak ratio with the 
addition of glucose solution. Error bars show one standard deviation of three replicate 
measurements.
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Table 5.3. Change in sensitivity and dissociation constant with varying capsule concentration.
Capsules/
mL
FD
(moles)
TAG
(moles)
Sensitivity 
(% A 
ratio/mM)
Total change 
in peak 
ratio/lOOmM 
glucose (%)
Linear
range
(mM) (mM)
l.OxlO6 2.1x10" 3.2xl0'10 6.11 73 0-10 5
2.0xl06 4.1x10'" 6.3x10" 2.67 66 0-30 12
3.2xl06 6.7x10'" 1.0x1 O'9 1.95 58 0-40 19
It can be observed from the microcapsule and solution phase glucose sensitivity 
experiments that there is approximately a two-fold increase in the sensitivity for the case 
of the microcapsules. This observation is the result of a low concentration of mobile 
sensing assay elements, due in part to the entrapment of -70% of the total encapsulated 
molecules in the capsule walls. The apo-GOx and dextran molecules that are entrapped in 
the walls may not dissociate in the presence of glucose molecules. Thus, the total number 
of mobile molecules will be far less than in solution phase samples. This low 
concentration (-30%) of freely moving FD/TAG complexes is ultimately reducing the 
active sensing assay concentration which results in the increased sensitivity, as predicted 
by theory, and was experimentally verified by studying the effect of competitive binding 
assay concentration on response (Figure 5.7).
The response time of this system was not measured separately, because the sensor 
response was observed to reach steady-state in approximately 1-2 minutes which is the 
approximate time required for the collection of one fluorescence scan. There was no 
observable change in the response time with the variation in assay elements concentration 
and ligand molecular weight. The response kinetics will be the subject of future studies, 
but clearly the response occurs in a reasonable time and will not be a limiting factor for 
implementation of this system for glucose sensing.
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5.4.9 Reversibility of the Glucose Sensors
The reversibility of the fabricated sensors was tested by exposing FD- 
500kDa/TAG loaded microcapsules to random glucose concentrations. Fluorescence 
spectra were collected after each addition and removal of glucose solution from the 
microcapsules and the corresponding changes in FITC:TRITC peak ratios are plotted in 
Figure 5.13. It is clear that there is a linear response in the 0-10 mM range and a 
decreased yet measurable response up to 20 mM, which covers much of the region of 
interest for glucose monitoring in diabetics. Sensitivity with random glucose 
concentrations was calculated to be 2.5%/mM with a total sensitivity of more than 50%, 
which is comparable to the sensitivity obtained with capsules exposed to a stepwise 
increase in glucose concentrations. These results show that the microcapsule based 
sensors are completely reversible without any significant loss in sensitivity. Further 
assessment of the forward and reverse response kinetics is currently being studied with a 
flow-through system.
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Figure 5.13. Percentage change in the normalized FITC:TRITC peak ratio with the addition of 
random glucose concentrations to the microcapsules loaded with FD-500kDa/TAG complexes. Error 
bars show one standard deviation of three replicate measurements.
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In the above demonstrated system, the use of prefabricated microcapsules for 
carrying the sensing assay is advantageous, because it allows (a) for the free movement 
of sensing elements during competitive binding process, which is critical for proper 
functioning of the sensor that rely upon the equilibrium association and dissociation of 
free molecules, and (b) in maintaining the constant concentrations of the ligand and 
receptor with continuously varying analyte concentration. The generic sensor design 
described here opens the door for a wide variety of analytes to be sensed using the 
versatile sensing technique, which involves selection of analyte-specific enzyme and a 
competing ligand, and can be considered a platform technology for development of 
biosensors based on competitive-binding and fluorescence RET based techniques. 
Potential targets include neurochemicals, such as glutamate and choline, lipids, and 
estrogen.148 The general approach to construction of specific “smart” responsive systems 
may be useful in other applications, such as drug delivery, wherein the apo-GOx/dextran 
dissociation determines release of an encapsulated compound in response to glucose.149
The sensitivity of apo-GOx/dextran system was observed to be 103 times greater 
than Con A/dextran system that was demonstrated in Chapter four. Even though, the 
encapsulation techniques in both the cases are entirely different, we did not try to develop 
a Con A/dextran sensing system using the DAR based encapsulation technique, because 
of the demonstrated advantages of apo-GOx and its excellent sensor response 
characteristics. Even if a Con A/dextran system were to be demonstrated with 
comparable sensitivity to apo-GOx based system using different encapsulation techniques 
or FRET pairs, it would not be of any greater significance because of the disadvantages 
of Con A.
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With specific reference to the glucose-sensing microcapsules described here, the 
sensors employing apo-GOx elements can potentially be used for in vivo glucose sensing 
without the concern of the toxicity associated with Con A. It is also noteworthy that the 
sensors can be easily extended into the NIR region by replacing the FITC-TRITC RET 
pair with an appropriate NIR donor-acceptor combination. It is also appropriate to note 
that these sensors could be interrogated using fluorescence lifetime measurements,21’90’91 
which will be better suited to in vivo monitoring because they are less affected by the 
fluorophore concentration and optical properties of the medium.
5.5 Conclusion
A novel glucose sensing system based on competitive binding, resonance energy 
transfer, and polymer microcapsule technology has been demonstrated. Microcapsules 
containing FD/TAG complexes showed a decrease in RET due to the addition of glucose, 
with the sensitivity ranging from 2 -  6% /mM over the range of 0 to 40 mM. It was found 
that the key variable in tuning the response of the system (sensitivity and dissociation 
constant) to glucose is the concentration of FD/TAG complexes. The assay comprising 
an apo-GOx recognition element showed 5 to 10 times more sensitivity to P-D-glucose as 
compared to other sugars. Based on the sensitivity, specificity, dissociation constant 
values, and reversible response, this sensor system appears to be suitable for glucose 
monitoring in diabetic patients. The apo-enzyme based competitive binding assay 
described in this chapter can be used as a platform technology for developing different 
biosensors to detect several neurochemicals, such as, glutamate, choline and ascorbic acid 
using the respective enzymes (glutamate oxidase, choline oxidase, and ascorbate oxidase) 
as receptor molecules. Also, other analytes such as, cholesterol and lactate may also be
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detected using this technology. These glucose-responsive FD/TAG complexes can also 
potentially be used in the future for controlled drug delivery studies, e.g.: insulin can be 
released due to apo-GOx/dextran dissociation in response to glucose.
In spite of the advantages of this sensor design, it may not be an ideal system for 
subcutaneous implantation, because of the use of dyes which fluoresce in the visible 
region. The main disadvantage of the prototype microcapsule-based glucose sensors is 
the use of FITC and TRITC as the energy transfer pair. While more photostable analogs 
of these dyes are available, these visible excitation/emission systems operate at short 
wavelengths where tissue is highly scattering. Even if fluorescence lifetime 
measurements are used for in vivo interrogation, it is desirable to replace the visible range 
fluorescent dyes with near infrared (NIR) fluorophores to increase penetration depth and 
decrease scattering losses. The next chapter demonstrates a similar sensor design using 
dyes that fluoresce in the orange/red region.
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CHAPTER 6
FLOURESCENT GLUCOSE SENSORS 
OPERATING IN ORANGE/RED REGION
This chapter is the extension of the sensor design demonstrated in Chapter Five in 
to longer wavelength (orange/red) region. This chapter describes the investigation of 
glucose sensitivity of TRITC-dextran/cyanine(Cy5)-apo-GOx complexes encapsulated in 
polyelectrolyte microcapsules using fluorescence spectroscopic and imaging techniques, 
and compares their performance characteristics with those obtained for the FITC:TRITC 
energy transfer pair to determine the sensor response characteristics after replacing the 
green/orange dyes with the orange/red fluorescence RET pair.
6.1 Sensor Design
The transduction mechanism used in this sensor is similar to the one illustrated in 
Figure 5.1. The basic procedure for apo-GOx preparation was followed as previously 
described.23 The apo-GOx prepared by this method was observed to maintain its reduced 
catalytic activity and preserve its binding capacity for at least four weeks. The close 
proximity of Cy5-apo-GOx (CAG) and TRITC-dextran (TD) in the absence of glucose 
results in strong fluorescence peaks due to energy transfer from TRITC to Cy5. As apo- 
GOx has higher affinity for glucose over dextran, the addition of glucose results in the
118
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displacement of dextran from apo-GOx, accompanied by a decrease in the energy 
transfer efficiency, which will be indicated by a stronger TRITC peak relative to Cy5. It 
is noteworthy that this apo-enzyme sensing approach retains the advantages of 
competitive binding assays (no analyte consumption) and RET-based sensors 
(ratiometric, high sensitivity) while adding the high specificity of enzymatic sensors and 
reduced scattering due to the employment of longer wavelength fluorophores.
6.2 Experimental Section 
Materials. Amino-dextran (MW 500kDa), GOx (G-2133), sodium poly(styrene 
sulfonate) (PSS, MW -lM Da), poly(allylamine hydrochloride) (PAH, MW 70kDa), 
P-D-glucose, mannose, a-D-glucose, sucrose, sodium bicarbonate, dimethyl formamide, 
ammonium sulfate, and sodium acetate buffer were obtained from Sigma. 
Tetramethylrhodamine isothiocyanate (TRITC) and Cyanine bis-NHS ester (Cy5) were
obtained from Molecular Probes and conjugated to amino-dextran and apo-GOx,
116respectively, using standard amine labeling procedures. Diazoresin (Diazo-10, 4- 
diazodiphenylamine/formaldehyde condensate hydrogen sulfate-zinc chloride salt, DAR) 
was purchased from PC Associates, NJ. All reagents were used as received. MnC0 3  
(5 pm) particles were prepared as previously described as templates for the polymer 
microcapsules.142
Instrumentation. A UV-Vis spectrometer (Perkin Elmer Lambda 45) was used to 
collect absorbance spectra. The slit size (4 nm) and scanning speed (480 nm/min) were 
held constant throughout all the experiments. A scanning fluorescence spectrometer 
(QM1, Photon Technology International) was used to collect fluorescence emission 
spectra by exciting the sample at 543 nm. A 100-W longwave UV lamp (Blak-ray
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Model B 100AP, Entela) was used to irradiate the microcapsules for photocrosslinking 
the PSS and DAR layers in the capsule walls. Confocal images were taken with a Leica 
TCS SP2 microscope equipped with a 63X oil immersion objective and green and red 
He-Ne excitation lasers. Counts and sizes of microcapsules were obtained with a 
Beckman Coulter counter (Z2) using a 100pm aperture. A YSI biochemical analyzer was 
used to measure the glucose concentrations.
6.3 Methods
6.3.1 Solution Phase Experiments
All glucose sensitivity experiments were performed in PBS (0.01M phosphate 
buffer, 0.0027 potassium chloride, and 0.137M sodium chloride) solution maintained at 
pH 7.4. The apo-GOx and amino-dextran used in all experiments were conjugated to Cy5 
and TRITC, with a labeling ratio of 1.14 and 1.12, respectively. In all experiments, the 
changes in energy transfer from TRITC-dextran (TD) to Cy5-apo-GOx (CAG) were 
monitored at every step using a fluorescence spectrometer to collect emission across the 
range of 560-725 nm. Initially, 17 picomoles of TD (donor) were added to 0.4 mL of 
PBS, which was followed by the stepwise addition of 80 picomoles of total CAG into the 
sample solution. To observe the dissociation of dextran and apo-GOx complexes with the 
addition of glucose, RET changes were observed with the titration of 100 mg/mL p-D- 
glucose solution aliquots into the sample containing TD/CAG complexes.
It is known that glucose oxidase (GOx) exhibits at least a 20X higher specificity 
for P-D-glucose over other sugars (e.g. a-D-glucose, D-mannose, D-fructose).147 
Previously in Chapter five (Figure 5.8), the specificity of the glucose sensor based on 
(FITC-dextran, FD)/(TRITC-apo-GOx, TAG) was found to be five to ten times more
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specific to P-D-glucose compared to other sugars. The specificity of the new sensor was 
investigated in this report because the amine conjugation efficiency of Cy5 is much 
greater than TRITC, which could result in a different degree of labeling near glucose 
binding sites and this could ultimately change the binding properties. The specific nature 
of the sensor for glucose was demonstrated by performing similar RET measurements 
with the titration of P-D-glucose, a-D-glucose and mannose into the solution of TD/CAG 
complexes, maintaining all other parameters constant. Sensitivity curves were obtained 
by plotting the percentage change in TRITC:Cy5 peak ratio versus analyte concentration. 
The slope of the linear region was calculated as a measure of response sensitivity.
6.3.2 Formation of Hollow 
Microcapsules
Solutions of PSS (anionic), PAH (cationic), and DAR (cationic) used for 
assembling {PSS/PAH} and {PSS/DAR} multilayers were prepared in DI water at 
2mg/mL. As described in detail in Figure 5.2, the positively-charged manganese 
carbonate (MnCC^) particles were coated with the ionic polymers to obtain a final 
architecture of {(PSS/PAH)(PSS/DAR)3(PSS/PAH/PSS)}. Hollow microcapsules were 
then obtained by dissolving the MnCC>3 cores using 0.1M hydrochloric acid (HC1) 
solution.
6.3.3 Encapsulation of Sensing 
Elements
The microcapsules prepared as described above contain porous walls, which are 
permeable to sensing elements (TD and CAG) prior to UV irradiation, but become 
impermeable after photocrosslinking.144 The microcapsule suspension was incubated in 
the mixture of lpM TD and 6pM CAG for 60min, which allowed sufficient time for
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diffusion of loading molecules into the capsule interior. In order to encapsulate the 
TD/CAG molecules in microcapsules, DAR and PSS layers in the capsule walls were 
crosslinked by exposing the microcapsules in loading solution to UV light. As the final 
step, the capsules were rinsed in DI water three times using centrifugation process to 
remove excess TD/CAG complexes, yielding microcapsules loaded with the sensing 
assay elements, with a final form as illustrated in Figure 6.1.
Capsule wall
fM  ( * j  Polyelectrolytes 
^  Cy5-apo-GOx 
•  TRITC-dextran
Figure 6.1. Schematic of the microcapsules loaded with dextran/apo-GOx complexes.
6.3.4 Sensor Response to Random 
Glucose Concentrations in 
Microcapsules
Glucose sensitivity experiments were performed on the microcapsules loaded 
with TD/CAG complexes to demonstrate a reversible sensor response. The sensing assay- 
loaded microcapsules were exposed to random glucose concentrations, after collecting an 
initial fluorescence spectrum with TD/CAG loaded microcapsules in PBS buffer. The 
random glucose concentrations were achieved by repeating two steps several times: (1) 
increase the glucose concentration with the addition of stock solution to microcapsules in 
buffer, then collect the fluorescence spectrum, and (2) reduce the glucose levels in the 
suspension by centrifuging and removing the supernatant (glucose) solution, measuring 
the actual glucose concentration of this solution with the biochemical analyzer, then
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adding an equal volume of fresh PBS buffer without glucose. Fluorescence spectra were 
collected after each addition and removal of glucose solution from the microcapsules and 
the corresponding changes in TRITC:Cy5 peak ratios are calculated for changing glucose 
concentration. This procedure was repeated to cover the glucose concentration in the 
range of 0-2800mg/dL, in the order of 0, 164, 56, 108, 632, 433, 813, 1980 and 
2800mg/dL.
6.4 Results and Discussion
6.4.1 Solution Phase Glucose Response 
Tests
Titration of TRITC-dextran up to 43 nM into 200 nM of CAG in PBS solution led 
to strong fluorescence emission peaks corresponding to TRITC and Cy5 at 543 nm 
excitation; implying significant energy transfer from TRITC to Cy5. To observe the 
displacement of dextran from apo-GOx with the addition of glucose, spectra were 
measured after the titration of lOOmg/mL P-D-glucose solution aliquots into the sample 
containing TD/CAG complexes. As hypothesized, the glucose in the solution displaced 
dextran from apo-GOx resulting in decreased energy transfer from TRITC to Cy5, as 
indicated by the increase in TRITC peak relative to Cy5 (Figure 6.2(a)). The percentage 
change in TRITC:Cy5 peak ratio (relative to the baseline ratio, at zero glucose) as a 
function of glucose concentration is shown in Figure 6.2(b), from which it can be 
observed that there is a total change of 15% in energy transfer due to 360 mg/dL glucose. 
The data clearly show that the response is linear in the range of 0-540 mg/dL, with a 
sensitivity of 0.06%/(mg/dL). These measurements confirm that apo-GOx and dextran 
molecules were dissociated in the presence of glucose, though the overall change in
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signal is only about one fourth of that observed when FITC and TRITC were used as the 
donor and acceptor, respectively.
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Figure 6.2. (a) Normalized fluorescence spectra with the addition of p-D-glucose to TD/CAG 
complexes in PBS buffer, (b) Percentage change in TRITC: Cy5 peak ratio with the addition of P-D- 
glucose, P-D-glucose, and mannose solutions. Error bars show one standard deviation of three 
replicate measurements.
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6.4.2 Sensor Specificity
To demonstrate the specificity of the TD/CAG based glucose sensor, the RET 
measurements were performed with the titration of P-D-glucose, mannose, and a-D- 
glucose, into solutions of 50 nM:200 nM TD:CAG complexes. The corresponding 
percentage change in TRITC:Cy5 peak intensity ratio versus analyte concentration is 
plotted in Figure 6.2(b), from which it can be observed that the maximum sensitivity was 
achieved with P-D-glucose, and there was -5 -10  times lower sensitivity for mannose and 
a-D-glucose. This agrees with the previous results (Figure 5.8), and proves that the apo- 
GOx retains its binding specificity for P-D-glucose in spite of exposing the sensing 
elements to several chemical processes, such as protein precipitation, conjugation, etc.
6.4.3 Encapsulation o f  Sensing  
C hem istry in M icrocapsnles
Microcapsules with {(PSS/PAH)(PSS/DAR)3 (PSS/PAH/PSS)} shell architecture 
were prepared as described and used for encapsulating TD/CAG complexes. Confocal 
images of polyelectrolyte microcapsules loaded with the glucose assay are shown in 
Figure 6.3, from which it can be observed that the TRITC and Cy5 fluorescence is 
concentrated in the capsule interior and walls, indicating the immobilization of TD/CAG 
complexes inside and on the capsule walls. High encapsulation in the walls could be due 
to a combination of electrostatics (residual charges of polyelectrolytes), van der Waals 
forces, different solubility/partitioning, and physical entrapment of the sensing elements 
(upon crosslinking). It is noteworthy that association with capsule walls occurs prior to 
wall crosslinking, so the contribution of the latter effect is expected to be minimal.
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Figure 6.3. Confocal fluorescence images of typical microcapsules loaded with TRITC-dcxtran and 
Cy5-apo-GOx; (a) TRITC and (b) Cy5 fluorescence; (c) Overlay of the TRITC and Cy5 fluorescence.
6.4.4 Demonstration of Reversible 
Sensor Response
To test the reversibility of these sensors, loaded microcapsules were exposed to 
random glucose concentrations. The fluorescence spectra were collected after each 
addition and removal of glucose solution from the microcapsules, and the corresponding 
changes in TRITC:Cy5 peak ratios are plotted in Figure 6.4. It is clear that there is a 
linear response in the 0-720mg/dL range with a sensitivity of 0.05%/(mg/dL), which is 
comparable to the sensitivity obtained in solution-phase experiments. The dissociation 
constant in the case of TD/CAG was observed to be 202mg/dL, which is comparable to 
that obtained with FD/TAG complexes.
Figure 6.4. Percentage in TRITC: CyS peak ratio with the addition of random p-D-glucose 
concentrations to the TD/CAG loaded microcapsules. Error bars show one standard deviation of 
three measurements.
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After comparing the results obtained with the current sensor design (TD/CAG) 
and previously reported FD/TAG based sensor, it was observed that there is a drop in 
sensitivity by a factor of three to four due to the replacement of FITC:TRITC dyes with 
TRITC:Cy5. This decrease in sensitivity may be attributed to several factors. First, the 
labeling ratio for dextran varied between the commercially-available FITC-dextran (24.5) 
and custom-labeled TRITC-dextran (1.12). Considering equal molar concentrations of 
FD/TAG and TD/CAG complexes, this variation in dextran labeling ratio could logically 
result in a lower average RET efficiency for bound dextran in the latter case. 
Consequently, with the addition of glucose, the total percentage change in energy transfer 
would reduce, translating into lower sensitivity. This reasoning is supported by the theory 
discussed in Chapter Three, which explains the significance of labeling ratio and RET 
efficiency. It was shown in the model that the decrease in RET efficiency, which is 
dependent on the labeling ratio of ligand and receptor molecules, will result in a 
significant drop in the sensitivity and detection range (Figure 3.8). Second, the TRITC- 
dextran used in this study was prepared using amino-dextran (cationic), whereas the 
FITC-dextran (from Sigma) was anionic. Because apo-GOx is anionic at pH 7.4, it is 
possible that a fraction of the cationic dextran used in this study could complex with apo- 
mGOx on the basis of electrostatic forces in addition to affinity forces. If the ionic 
complexes do not dissociate with the addition of glucose, this will contribute a strong 
static baseline signal for all of the measurements, resulting in decreased sensitivity. 
Finally, there is a significant variation in the conjugation reaction of apo-GOx with Cy5 
compared to TRITC. For this study, the Cy5 bis-NHS ester can simultaneously bind to 
two amine groups on apo-GOx, whereas the isothiocyanate group of TRITC can only
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react with a single amine. Binding multiple amine groups on the protein could partially 
disrupt the conformation of the apo-GOx and alter binding properties, resulting in a 
decreased glucose affinity. However, given the agreement between the dissociation 
constants obtained from the two studies, this last possibility is less likely to be a 
significant factor. Determination of the major contributing factors and sensitivity 
optimization will be part of future work.
The system demonstrated here carries the advantages of using (a) prefabricated 
microcapsules for carrying the sensing assay, because it allows for the free movement of 
the sensing elements during the competitive binding process, and in maintaining the 
concentrations of the ligand and receptor constant in the presence of continuously varying 
analyte concentration, and (b) orange/red dyes which will enable the use of longer 
excitation wavelengths where by tissue scattering is reduced making the sensor more 
appropriate for in vivo applications. It is noteworthy that even though there is a 3X drop 
in sensitivity with the use of longer wavelengths, this is not a large concern when the 
expected improvement in signal intensities measured through the skin is taken into 
consideration. It is also appropriate to note that these sensors could be interrogated using 
fluorescence lifetime measurements,90 which will be better suited to in vivo monitoring 
because they are less affected by the fluorophore concentration and optical properties of 
the medium. Ongoing studies include complete sensor response characterization, 
including long-term stability analysis, and careful investigation of the reasons for 
sensitivity loss when longer-wavelength dyes are employed. The successful 
demonstration of apo-GOx/dextran based assay by replacing FITC/TRITC (as
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demonstrated in Chapter five) with TRITC/Cy5 indicate that this assay can be modified 
according to the required application.
6.5 Conclusion
A novel glucose sensing system based on competitive binding, resonance energy 
transfer, and polymer microcapsule technology operating in the long wavelength region 
has been demonstrated. This glucose assay, comprised of apo-GOx/dextran complexes, 
showed -5-10 times more sensitivity to P-D-glucose compared to other sugars. 
Microcapsules containing TRITC-dextran/Cy5-apo-GOx complexes showed a decrease 
in RET due to the addition of glucose, with a sensitivity of 0.06%/(mg/dL) over the range 
of 0-720mg/dL. Based on the sensitivity, specificity, and reversible response in the region 
of interest (0-360mg/dL), this sensing system can be used for glucose monitoring in 
diabetic patients. It is postulated that a 3X loss in sensitivity with the use of longer 
wavelength dyes will be compensated for by an increase in the intensity levels and a 
decrease in the signal to noise ratio. Therefore, future studies will aim at discovering the 
reasons for the sensitivity loss with longer wavelength dyes and focus more on the 
improvement of sensor response characteristics. These glucose-responsive systems can 
also potentially be used in future for “smart” drug delivery studies, e.g.: insulin may be 
released in response to apo-GOx/dextran dissociation.
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CHAPTER 7
FLUORESCENT NEAR INFRARED 
GLUCOSE SENSORS
In previous chapters, FRET based glucose sensors operating in visible and long- 
wavelength regions were demonstrated. In order to further extend this work to clinical 
studies, a glucose sensor operating in the near infrared (NIR) region is more appropriate 
because of the reduced light scattering in the dermis. However, the broad excitation 
spectrum of the available NIR dyes makes it impossible to find an efficient FRET pair for 
the NIR region. Therefore, this chapter employs the apo-GOx/dextran based competitive 
binding assay discussed in previous chapters, but now used in conjunction with a 
different transduction (quenching) mechanism. This chapter describes the investigation of 
an NIR glucose sensor comprised of competitive binding assay encapsulated in 
polyelectrolyte microcapsules, and compares their performance characteristics with those 
obtained for the FITC/TRITC, TRITC/Cy5 energy transfer pair to determine the sensor 
response characteristics with NIR dyes.
7.1 Sensor Design
A schematic of a glucose sensor based on the quenching mechanism is shown in 
Figure 7.1. The dyes used in this sensing mechanism are Alexa Fluor (AF) 647, QSY21,
130
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and AF750. AF647 emits in the range of 650-720nm, which overlaps with the QSY21 
absorbance spectrum. Therefore, when AF647 and QSY21 are in close proximity, QSY21 
significantly quenches the fluorescence of AF647. As QSY21 is not fluorescent, there is 
only one fluorescent peak, preventing ratiometric analysis of the data. Therefore, AF750 
is used as a reference dye, as it can be partially excited at 640nm (which is also the 
excitation wavelength for AF647). Also, AF750 is not influenced by the quenching and 
the presence of glucose. When apo-GOx tagged to AF647 is exposed to QSY21 -dextran 
(QSY-dex), they will be in close proximity due to the binding affinity between apo-GOx 
and dextran. This results in the weak fluorescent peak at 675nm due to the quenching of 
AF647 by QSY21. Because of the high affinity of glucose towards apo-GOx, the addition 
of glucose will result in the displacement of dextran from apo-GOx, decreasing the 
quenching effect on AF647, which is indicated by a stronger AF647 peak (Figure 7.1). In 
this study, the glucose sensitivity of the AF647-apo-GOx (AF-AG)/QSY-dex complexes 
entrapped in microcapsules along with AF750 was demonstrated by measuring the 
changes in fluorescence intensities of AF647 relative to the reference dye (AF750).
Quenching
m
Addition 
of glucose
Apo-GOx (AG)
A Alexa Fluor 
' (AF)-647
QSY21-Dextran
(QSY-dex)
Glucose
•  AF750
A F 750
A F 647
P o st-G lu co se
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Figure 7.1. Schematic of the RET quenching system for glucose monitoring based on the competitive 
binding between dextran and glucose for binding sites on apo-GOx.
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7.2 Experimental Section 
Materials. Glycidyl 3-(trimethoxysilyl)propyl ether (glycidyl-silane), GOx (G- 
2133), sodium poly(styrene sulfonate) (PSS, MW ~lMDa), poly(allylamine 
hydrochloride) (PAH, MW 70kDa), p-D-glucose, sodium bicarbonate, dimethyl 
formamide, ammonium sulfate, sodium acetate buffer were obtained from Sigma. Alexa 
Fluor (AF) 647, AF 750, and QSY21 from Molecular Probes, were used to label apo- 
GOx, PAH, and amino-dextran (500kDa, Molecular Probes), respectively, using a 
standard amine labeling procedure.136 All reagents were used as received. MnC0 3  (5 pm) 
particles were prepared as previously described.150
Instrumentation. A UV-Vis spectrometer (Perkin Elmer Lambda 45) was used to 
collect absorbance spectra. The slit size (4 nm) and scanning speed (480 nm/min) were 
held constant throughout all the experiments. A scanning fluorescence spectrometer 
(QM1, Photon Technology International) along with a new photomultiplier tube (R928) 
was used to increase the sensitivity in the longer wavelengths (650-800nm), and to collect 
fluorescence emission spectra by exciting the sample at 640 nm. Confocal images were 
taken with a Leica TCS SP2 microscope equipped with a 63X oil immersion objective 
and green and red He-Ne excitation lasers. Counts and sizes of microcapsules were 
obtained with a Beckman Coulter counter (Z2) using a 100pm aperture.
7.3 Methods
7.3.1 Solution Phase Experiments
Assay optimization. The glucose assay concentration was optimized by 
performing a simple titration experiment to obtain maximum change in signal for a given 
analyte concentration. The concentrations of the sensing assay elements were optimized
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based on the concentration dependent quenching of AF647 by QSY21. In order to 
observe the quenching pattern, 700nM QSY21-dextran (QSY-dex) was titrated into 
40nM AF647-AG (AF-AG) in a stepwise manner. A fluorescence spectrum of AF-AG 
was collected after each addition of QSY-dex. It was hypothesized that there will be a 
significant drop in fluorescence due to non-radiative quenching compared to radiative. In 
the case of radiative quenching, higher quencher concentrations are required to observe a 
small drop in fluorescence intensity. Thus, the least amount of QSY-dex required to 
significantly (non-radiatively) quench AF-AG fluorescence is determined.
Glucose sensitivity. The apo-GOx and amino-dextran used in all experiments 
were conjugated to AF647 and QSY21, with a labeling ratio of 3.2 and 2.4, respectively. 
The quenching process between AF-AG and QSY-dex was monitored using the 
fluorescence spectrometer by exciting the sample at 640 nm and collecting the emission 
across the range of 650-750 nm. Initially, -16.5 picomoles of AF647-AG were added to 
0.4mL of DI water. The initial fluorescence spectrum was collected after titrating 143nM 
QSY-dex into the sample solution containing 41nM AF-AG. Finally, to assess the 
relative affinity of apo-GOx for glucose and QSY-dex, changes in the quenching 
efficiency were observed during the stepwise addition of aliquots of lOOmg/mL /3-D- 
glucose solution into the sample containing QSY-dex/AF-AG complexes. The effect of 
QSY-dex concentration on the displacement behavior was investigated by repeating the 
same procedure at different concentrations of QSY-dex. The reference dye (AF750) was 
not incorporated in this assay as the experiments were performed in solution phase and 
the dye was showing some anomalous effects on glucose response characteristics, such as 
delayed response (~20min). As there is no reference peak in this assay, fluorescence
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changes in AF647 peak were corrected for dilution effects by diluting QSY-dex/AF-AG 
complexes with aliquots of DI water and subtracting the change due to water from that 
due to glucose. For all the experiments, sensitivity curves were constructed by plotting 
AF647 fluorescence peak intensity (corrected for dilution) versus glucose concentration.
After the successful demonstration of a near infrared glucose sensor using apo- 
GOx/dextran system in solution phase, the next step is to incorporate these assay 
elements into a microcontainer. In order to encapsulate the sensing elements, a new 
approach was used for entrapping the assay elements using glycidyl-silane. This process 
is superior to the DAR based encapsulation technique discussed in Chapter five when one 
considers the disadvantages of DAR such as, toxicity, and the inconvenient assembly 
conditions, as the assembly process must be performed in the absence of UV light.
7.3.2 Fabrication of Silane-Based
Organo-Inorgano
Microcapsuies
The sensing assay along with the reference dye is encapsulated into microcapsuies 
using a facile method based on glycidyl-silane hydrolysis and condensation. The 
permeability of the capsule walls is controlled by incorporating silane in the shell 
structure, wherein silane builds a crosslinking network by undergoing hydrolysis and 
condensation reactions, which is described in detail below.
Silane theory
The formation of interpenetrating network by glycidyl-silane is a two step process 
as shown in Figure 7.2. In step 1, glycidyl groups on silane are conjugated to amine 
groups on PAH upon mixing. During this conjugation step, the ring opening reaction of 
epoxy groups on glycidyl-silane will result in the formation of hydroxyl groups.
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reaction
Step 1: PAH NH2 + CH2- C H  S i la n e ------------->  P A H .............NHCH2CH........ Silane
Step 2: (a) RSi(OCH)3 + 2H20  H >'d r o l y s i s  > RSi(OH)3 + 3CH3OH
R R R
Figure 7.2. Chemical crosslinking of PAH and silane (step 1); Hydrolysis and condensation of silane 
in the presence of water (step 2).
Step two involves formation of the interpenetrating network through the 
formation of -Si-O- bonds. In the presence of water, silane undergoes hydrolysis which 
releases methanol, and condensation which releases water. It is hypothesized that the 
formation of the interpenetrating network is much slower than the conjugation reaction 
between glycidyl and amine groups. The condensation step may take several days to 
reach saturation, which offers a great opportunity for materials to penetrate into the 
microcapsuies and become encapsulated.
Manganese carbonate (MnCCh) particles, with 5 pm in diameter are used as 
sacrificial core material. Multilayers of PSS (cationic material) and PAH conjugated to 
glycidyl-silane (PAH-silane, anionic material) were deposited based on the LbL self- 
assembly process. The final film architecture (Figure 7.3(b)) on the surface of the 
template particles at the completion of the assembly was {(PSS/(PAH-silane))4/PSS). 
The change in surface potential with the deposition of each layer was measured using a 
zeta-potential analyzer. Following the completion of the polymer layer deposition, 
MnCC>3 core particles were dissolved (Figure 7.3(c)) yielding silane-based hollow 
microcapsuies.
Condensation O -S i-O -S i-O -S i-O(b) nRSi(OH)3
+ nH20O O O
O -S i-O -S i-O -S i-O
R R R
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Figure 7.3. Fabrication of organic/inorganic hybrid microcapsuies (a -  c); encapsulation of AF647- 
AG/QSY-dextran into hollow microcapsuies (d -  f); and (g) incorporation of reference dye (AF-750).
7.3.3 Encapsulation of Sensing Chemistry
in Oreano/Inorgano Hybrid
Microcapsuies
Microcapsuies with (PSS/(PAH-silane))4/PSS) shell architecture were prepared as 
described and used for encapsulating glucose assay by dispersing microcapsuies in a AF- 
AG:QSY-dex (230pM:990pM) complexes solution (Figure 7.3(d)). The concentration of 
the loading molecules inside the microcapsuies was found to reach equilibrium with the 
exterior loading solution within minutes, because of the semi-permeable nature of the 
capsule walls. However, during the two-day period of the incubation of the microcapsuies 
in the loading solution, there is enough time for the hydrolysis and condensation of silane 
to take place and thus, facilitate the formation of the interpenetrating network (Figure 
7.3(e)). This network within the shell structure will result in a decrease in the 
permeability of the capsule wall, thus suppressing the leaching of the material that was 
loaded into the capsule interior. As the final step, the capsules were rinsed in DI water to 
remove excess loading molecules yielding microcapsuies loaded with AF647-AG and 
QSY21-dextran (Figure 7.3(f)). Finally, the reference dye is incorporated into the
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microcapsule walls by coating the outer layer (PSS) of microcapsuies with PAH-AF750 
(Figure 7.3(g)) by utilizing the electrostatic forces of attraction. The detailed description 
of the effect of silane on the formation of microcapsuies and encapsulation of 
biomolecules is discussed elsewhere.151 Confocal microscopy was used to assess the 
loading of assay elements into microcapsuies. Encapsulation efficiency was estimated as 
described in Chapter five (section 5.3.6). The NIR assay elements were not encapsulated 
into microcapsuies using the DAR technique because the silane based method showed 
good loading efficiency and is not associated with toxicity problems and inconvenient 
assembling conditions.
Stability. This experiment is described in more detail in Chapter five (section 
5.3.7). An experiment for the assessment of the stability of the encapsulated material was 
performed on the capsules loaded with QSY-dex/AF-AG complexes. As opposed to the 
procedure in Chapter five, leaching of the loaded assay elements was estimated at only 
one point, i.e., after five weeks from the day of encapsulation. A standard solution of 50 
nM AF-AG was used to estimate the supernatant concentration as a percentage of a 
standard.
7.3.4 Sensor Response in
Microcapsuies
A fluorescence spectrum of the microcapsuies loaded with the AF-AG/QSY-dex 
complexes and AF750 reference dye dispersed in DI water was collected as the starting 
point. Fluorescence spectra were then collected after each addition of lOOmg/mL glucose 
solution to the microcapsuies. The change in AF647 to AF750 peak intensity ratio was 
calculated from each spectrum and plotted with respect to the increments in glucose 
concentrations. To determine the feasibility of tailoring the sensor response, glucose
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sensitivity experiments were repeated with three different concentrations of capsules, 
(4.3x i o 5, 8.6xl05, 1,72x 106 capsules/mL).
7.3.5 Reversibility
To test the reversibility of these sensors, microcapsuies loaded with sensing assay 
were suspended in glucose solutions in random order with respect to concentration. To 
achieve this, AF-AG/QSY-dex loaded microcapsuies (2.88x 106 capsules/mL) were 
dispersed in DI water and the glucose concentration of the suspension was increased by 
addition of glucose stock solution. The glucose levels were changed by rinsing the 
capsules in DI water to remove the glucose after each measurement followed by adding 
glucose to a new concentration. In each case, after addition of glucose to the desired 
concentration and measuring the fluorescence, the suspension was centrifuged three 
times, the supernatant (glucose) solution was removed and, finally, an equal volume of 
fresh DI water was added. The change in AF647/AF740 peak ratio was obtained at each 
step by collecting a fluorescence scan. This procedure was repeated to cover the glucose 
concentration in the range of 0-60 mM, in the order of 0, 5.3, 0, 13.5, 20, 3.31, 26.6, 32.5, 
5.5,44.6, 6.3,61.6, 10 mM.
7.4 Results and Discussion
7.4.1 Solution Phase Experiments
Assay optimization. Fluorescence spectra collected during the titration of QSY- 
dex into AF-AG is shown in Figure 7.4. Because of the affinity between AF-AG and 
QSY-dex, AF647 and QSY dyes will be in close proximity which will result in the 
quenching of AF647 fluorescence by QSY21, which is indicated by a decrease in the 
AF647 peak. It can be observed from Figure 7.4 that there is a significant decrease in the
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fluorescence corresponding to AF647-AG after adding 200nM QSY-dex, due to the close 
proximity of the AF647 and QSY dyes. Also, further additions of QSY-dex have a small 
quenching effect on the AF647 fluorescence, which could be most likely due to the 
radiative quenching because there is a smaller decrease in AF647 fluorescence with the 
addition of quencher concentrations, greater than 150nM.
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Figure 7.4. Quenching of AF647-AG due to increasing concentrations of QSY21-dextran.
Therefore, from the quenching pattern, it can be observed that maximum 
quenching (70%) due to non-radiative energy transfer can be obtained with the addition 
of 145nM QSY-dex into 35nM AF-AG. Similar experiments were performed at two 
different concentration of AF-AG (17.5nM and 70nM) to observe the effect of 
concentration on the quenching process. As expected, quenching in the case of higher 
AF-AG concentration required higher QSY-dex concentrations to reach saturation.
Glucose response tests. Taking the optimum assay concentrations obtained from 
the above experiment into consideration, 142 nM QSY-dex was titrated into 42 nM of 
AF-AG in DI water which led to a decrease in the AF647 fluorescence emission peak,
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implying significant quenching of AF647 by the quencher, QSY21. To observe the 
glucose sensitivity of dextran/apo-GOx complexes, fluorescence spectra were measured 
after the titration of lOOmg/mL P-D-glucose solution aliquots into the sample containing 
QSY-dex/AF-AG complexes. As hypothesized, the glucose in the solution displaced 
dextran from apo-GOx resulting in the decrease in quenching, as indicated by the 
increase in AF647 peak (Figure 7.5(a)).
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Figure 7.5. Normalized (a) Fluorescence spectra and (b) Percentage change in AF647:AF750 peak 
ratio with the addition of glucose into AF-AG/QSY-dex complexes with different dextran 
concentrations. Lines are regression curves used only to clearly indicate the trend for each set of 
measurements. Error bars show one standard deviation of three replicate measurements.
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The percentage change in AF647.AF750 peak ratio (corrected for dilution) as a 
function of glucose concentration is shown in Figure 7.5(b) from which it can be 
observed that there is 25% increase in the AF 647 peak due to 30mM glucose with a 
sensitivity of 0.7%/mM. The data clearly show that the response is linear in the range of 
0-30 mM. The most significant characteristic of this assay is that, in spite of the extension 
of this assay into NIR region, the sensitivity is comparable to the FD/TAG based glucose 
assay (Chapter five).
Effect of quencher concentration on sensor response. To observe the effect of 
quenching molecule concentration, similar glucose sensitivity experiments were 
performed with different concentrations of QSY-dex, while maintaining constant 42nM 
AF-AG concentration. The corresponding sensor response characteristics are shown in 
Figure 7.5(b). It can be observed from these results that the detection range and the 
sensitivity of this sensor can be significantly varied by changing the apo-GOx:dextran 
molar ratio. The reason for this observation is because of the two main consequences of 
an increase in QSY-dex concentration, (a) an increase in the number of dextran molecules 
associated with AF-AG, and (b) the total decrease in AF 647 signal due to quenching 
effect. Therefore, an increase in the total glucose concentration is required to dissociate 
all the QSY-dex/AF-AG complexes, which can be observed in Figure 7.5(b). Also, as the 
initial decrease in AF647 intensity is high for the case of high dextran concentrations, the 
signal reversal is also high with the addition of glucose, as more number of AF-AG 
molecules are being freed. It was calculated that with a 5X increase in QSY-dex 
concentration, there is a 4X times increase in dissociation constant and a 6.6X increase in 
the total percentage change in the signal.
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Thus, the sensitivity in over a wide range of glucose (0-200mM) can be
significantly varied by controlling the quencher concentration. However, the sensitivity in
the region of interest (0-30mM) is almost same in all the experiments. Thus, the main
parameter that can be varied by controlling quencher concentration is the dissociation
constant (kj) of the sensing assay. All these results corroborate with the modeling results
explained in Chapter Three, which show that with the increase in ligand concentration
there is an increase in the linear region and the total change in signal.
7.4.2 Encapsulation of AF-AG/QSY-dex 
Complexes in Microcapsuies
As previously described, oppositely charged polymers were deposited on MnC0 3  
particles via electrostatic self assembly. The reversal of the surface-potential with the 
addition of each layer, as shown in Figure 7.6(a), demonstrates the successful fabrication 
of the shell on the template particles. Microcapsuies with (PSS/PAH-sil)4PSS)} shell 
architecture were prepared by core dissolution and used for encapsulating AF-AG/QSY- 
dex complexes and reference dye (AF750).
Material deposited
(a)
Figure 7.6. (a) Surface potential values obtained after coating each layer on MnC03 particles. Error 
bars show one standard deviation of three replicate measurements; (b) Confocal fluorescence images 
of microcapsuies loaded with AF647-apo-GOx, QSY21-dextran and AF750-PAH with AF647 
fluorescence.
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Confocal images of representative polyelectrolyte microcapsuies loaded with the 
glucose assay are shown in Figure 7.6(b). The encapsulation efficiency of AF-AG/QSY- 
dex complexes was estimated by measuring the supernatant concentrations and obtaining 
the capsule count using the Coulter counter and was found to be lxlO‘I6and 1.34x1 O'16 
AF-AG and QSY-dex moles/capsule, respectively.
From the leaching studies it was estimated that the number of moles of AF-AG in
-j
supernatant is 10 times lower than the AF-AG moles encapsulated in the microcapsuies. 
Thus, it was estimated that only 0.12% of the initially loaded assay molecules have 
leached out over a five week period. Compared to the leaching studies on microcapsuies 
loaded using DAR based encapsulation procedure, this data is highly promising as the 
leaching is reduced by 40 times. However, in order to study the leaching of loaded 
molecules over a period of time, leaching studies must be performed at regular time 
intervals over a five week period. These studies can help in accounting for the loss in 
sensitivity over long period of time.
7.4.3 Sensor Response to Glucose
Addition in Microcapsuies
To demonstrate the sensor response characteristics of microcapsuies loaded with 
sensing assay and to test the feasibility of tailoring the sensor response with the 
microcapsule concentration, glucose sensitivity experiments were performed on three 
different concentrations of microcapsuies (4.3xl05, 8.6xl05, 1.72xl06, 3.87xl06 
capsules/mL) loaded with AF-AG/QSY-dex complexes and reference dye (PAH-AF750). 
Fluorescence spectra were collected after each addition of P-D-glucose to the 
microcapsuies loaded with AF-AG/QSY-dex complexes. The fluorescence spectra are 
normalized to a reference peak (776nm) to account for dilution and instrumentation
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drifts, as shown in Figure 7.7. The corresponding percentage change in the AF647:AF750 
peak ratio was calculated for each case, as shown in Figure 7.8.
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Figure 7.7. Fluorescence spectra of the microcapsuies loaded with sensing assay and reference dye 
(AF750) with the addition of glucose solution. All the spectra are normalized to the reference peak at 
776nm.
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Figure 7.8. Effect of capsule concentration on the change in AF647:AF750 peak ratio with the 
addition of glucose solution. Error bars show one standard deviation of three replicate 
measurements.
For the case of the 8.6* 105 caps/mL sample, it can be seen that there is a linear 
increase in the peak ratio with the addition of glucose up to 30mM for the capsules 
loaded with AF-AG/QSY-dex complexes, with a sensitivity of 2.67%/mM. It is 
noteworthy that even after extension the apo-GOx/dextran based competitive binding
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assay from the visible (500-600nm) to the NIR region (650-800nm), there is no 
significant drop in the achievable sensitivity in the region of interest (0-30mM). It is 
immediately evident that with a 4X increase in capsule concentration, there is a decrease 
in the total change in the percentage of RET from 69% to 58%. Furthermore, it is clear 
that a higher glucose concentration is required to reach the AF647:AF750 peak ratio 
saturation point. It can be seen from Table 7.1 that a 3X increase in capsule concentration 
results in a ~ 3X decrease in sensitivity in the region of interest (0-30mM) and ~ 4X 
increase in dissociation constant. This trend corroborates with the previously 
demonstrated theoretical modeling results in Chapter Three. These results prove that the 
sensitivity can be tailored by changing the competitive binding assay concentration.
Table 7.1. Change in sensitivity and dissociation constant with varying capsule concentration.
Sensitivity Linear
Capsules/ QSY-dex AF-AG (% A range kd
mL (moles) (moles) ratio/mM) (mM) (mM)
4 .3 x l0 5 1.8x10'“ 2.3xlO‘10 5.15 0-10 4.1
8.6*105 3.7x10'“ 4 .6 x 1 0 “ 3.09 0 - 3 0 10
1.72xl06 7.3x10'“ 9 .2 x 1 0 “ 1.97 0 - 4 0 20
3 .44xl06 1.84xlO'10 1.46xlO'10 0.8 0 - 8 0 60
7.4.4 Demonstration of Reversible 
Sensor Response
The reversibility of these sensors was tested by exposing the microcapsuies 
(2.88x106 capsules/mL) to random glucose concentrations. Fluorescence spectra were 
collected after each addition and removal of glucose solution from the microcapsuies and 
the corresponding changes in AF647:AF750 peak ratios are plotted in Figure 7.9. It is 
clear that there is a linear response in the 0 - 8 0  mM range, with a sensitivity of 
0.83%/mM, which is comparable to the sensitivity obtained with capsules (same
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concentration) exposed to a stepwise increase in glucose concentrations (Figure 7.8). 
These results show that the microcapsule based sensors are completely reversible, 
without any significant loss in sensitivity.
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Figure 7.9. Percentage change in AF647:AF750 peak ratio with the addition of random P-D-glucose 
concentrations to the AF-AG/QSY-dex loaded microcapsuies. Error bars show one standard 
deviation of three replicate measurements.
It can be observed from microcapsule and solution phase glucose sensitivity 
experiments that there is approximately a two-fold increase in the sensitivity for the case 
of the microcapsuies. As explained in Chapter five, this observation is the result of a low 
concentration of mobile sensing assay elements, due in part to the entrapment of -72% of 
the total encapsulated molecules in the capsule walls. The apo-GOx and dextran 
molecules that are entrapped in the walls may not dissociate in the presence of glucose 
molecules. Thus, the total number of mobile molecules will be far less than in the 
solution phase samples. This low concentration (-27%) of freely moving QSY-dex/AF- 
AG complexes is ultimately reducing the active sensing assay concentration, which 
results in the increased sensitivity as predicted by theoretical modeling of the effect of 
competitive binding assay concentration on response (Chapter Three (Figure 3.6)).
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7.4.5 Photobleaching Effect
The long term functional stability of the above described glucose sensors greatly 
depends on the stability of the encapsulated or immobilized fluorophores. It has been 
previously demonstrated that there is only 0.12% leaching of the encapsulated assay 
molecules. Thus, leaching of the loaded elements is not a concern. However, the 
photostability of the sensors is a major concern, since the transduction scheme (energy 
transfer) involved in this work depends on measuring the intensity of the fluorophores. 
To assess the photobleaching behavior of the sensors in the presence and in the absence 
of glucose, two experiments were performed in which the sample was continuously 
excited at 640nm with 20mM glucose and OmM glucose concentrations. The results of 
these experiments are given in Figure 7.10. It can be observed from the figure that the 
photobleaching rates of AF647 (-2.96%/min) and AF750 (-2.8%/min) are almost 
identical in the absence of glucose. However, with the addition of glucose AF647 (- 
1.12%/min) is bleaching rapidly compared to AF750 (-0.55%/min). This variation in the 
bleaching rates could be the effect of a decrease in energy transfer, which results in the 
observed decrease in the bleaching of AF750 dye. It can be observed from Figure 7.10b 
that there is 10% decrease in peak ratio in the presence of glucose, whereas in the 
absence of glucose there is no change in peak ratio. For example in Figure 7.9, there is 
20% increase in signal with the addition of glucose. But if these sensors are exposed to 
light for 15 min, then there will be 10% decrease in the signal, resulting in the decrease in 
sensitivity. These results indicate that continuous exposure of the sensors to light in the 
presence of glucose may result in the loss of sensitivity. Therefore, in the future, during 
real time monitoring of the sensors this variation in bleaching rates has to be considered.
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Figure 7.10. Photobleaching of the AF647-AG/QSY-dex and AF7S0 loaded microcapsuies by 
continuously exciting at 640nm (a) with and without glucose, and (b) Change in the peak ratio with 
respect to time, with and without glucose.
7.5 Conclusion
A novel glucose sensing system based on competitive binding, quenching 
mechanism, and polymer microcapsule technology operating in near infrared region has 
been demonstrated. Sensing assay elements were entrapped in microcapsuies using a 
silane based encapsulation procedure which could be less toxic,152 also there is no need 
for exposure of capsules to extreme conditions. Microcapsuies containing QSY- 
dextran/AF-AG complexes showed glucose sensitivity of -2-5%/mM over the range of 0- 
30mM. Thus, this assay is superior to all the other assays demonstrated in the previous 
chapters, because it has the advantages of, (a) non-toxic nature, which was the main 
problem with Con A based assays, (b) the silane based encapsulation procedure 
employed in this system is simple, and is free of toxic materials, (c) comparable and 
better sensitivity to FD/TAG and TD/CAG based assays, respectively, and (d) significant 
increase in the signal levels due to the use of NIR dyes. Based on the sensitivity, 
specificity, and reversible response in the region of interest (0-3 OmM), this sensing 
system can be used for glucose monitoring in diabetic patients.
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Also, the successful demonstration of the extension of the apo-GOx/dextran based 
competitive binding assay into the NIR region indicates the potential to modify this assay 
according to the requirements of an application. By choosing appropriate apo-enzyme 
and competing ligand molecules, various biosensors can also be developed for detecting 
different analytes. Thus, the sensor design demonstrated in this chapter can be considered 
as a platform technology for designing biosensors based on competitive binding and 
energy transfer techniques.
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SUMMARY AND FUTURE WORK
8.1 Summary
This dissertation demonstrated a generic design for developing fluorescent 
biosensors based on the encapsulation of a competitive binding assay into a micro­
container. A model biosensor for glucose monitoring was developed using this approach. 
Initially, a glucose sensor operating in the visible light region was demonstrated, which 
was then followed with the detailed discussion of the approaches pursued for extending 
the sensor operating region from the visible to the near infrared (NIR) region. Also, the 
disadvantages of each sensor prototype and the possible ways to overcome these 
limitations are summarized at the end of each chapter.
The first part of this project was focused on demonstrating a glucose sensor based 
on the encapsulation of previously reported FRET based FITC-dextran (FD)/TRITC-Con 
A (TC) assay in microcapsuies. Even though the hollow microcapsuies comprised of 
FD/TC multilayers showed reasonable glucose sensitivity (Table 8.1), there are some 
inherent disadvantages in using Con A as one of the elements in this assay, such as 
toxicity, aggregation, and specificity. Also, the total obtainable signal in this assay is 
limited by the amount that can be coated on the microparticle surface.
150
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Table 8.1. Sensor response characteristics of different variations of competitive binding assays.
Receptor labeled- 
Ligand molecule
Acceptor labeled- 
Receptor molecules
Reference dye 
labeled 
polycation
Sensitivty 
(% A 
ratio/mM)
Dissociation 
Constant 
(kd, mM)
FITC-Dextran TRITC-Con A - 0.3 50
FITC-Dextran TRITC-Apo-Gox - 2 , 6 . 2 20,5
TRITC-Dextran Cy5-Apo-Gox - 0.83 12
QSY21-Dextran AF647-Apo-Gox AF750-PAH 0.8-5 .2 4 -60
In order to overcome the concerns regarding Con A, a glucose sensing system was 
proposed which replaces Con A in the above described sensing system with a deactivated 
enzyme glucose oxidase (apo-GOx). The use of deactivated enzyme makes this approach 
more generic as different analytes can be detected by choosing the corresponding enzyme 
(which can be deactivated) as the receptor molecule in competitive binding assay. Also, 
as the enzymes are highly specific towards their substrate molecule there will not be any 
concerns over toxicity. In addition, toxicity is not a concern when Con A is removed 
from the assay elements and the aggregation issue can be solved since enzymes bind to 
one substrate molecule at a time.
Another significant achievement is the encapsulation of a competitive binding 
assay comprised of dextran/apo-GOx complexes into microcapsuies by incorporating 
photosensitive materials (diazoresin (DAR) and poly (styrene sulfonate) (PSS)) in the 
capsule wall structure. This encapsulation process resulted in the efficient loading of 
assay elements compared to FD/TC encapsulation. The employment of prefabricated 
microcapsuies for entrapping the competitive binding sensing assay is advantageous, 
because it allows for the free movement of sensing elements during the competitive 
binding process while maintaining the concentrations of the ligand and receptor constant
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in the presence of varying analyte concentration. Therefore, this approach is highly 
appropriate for developing smart tattoo systems.
Microcapsuies containing FD/TRITC-apo-GOx (TAG) complexes showed a 
glucose sensitivity ranging from 2 -  6% /mM (Table 8.1). Also, FD/TAG based glucose 
assay is 10 times more sensitive compared to FD/TC assay and is also highly specific (5 -  
10X more sensitive) towards glucose over other sugars. It was also found that the 
response of this system (sensitivity and dissociation constant) to glucose can be tuned by 
varying the concentration of FD/TAG complexes. In spite of these advantages, this sensor 
design may not be an ideal system for subcutaneous implantation because of the use of 
dyes which fluoresce in visible region, where tissue is highly light scattering.
In order to extend FD/TAG based glucose sensor into the longer wavelength 
region, FITC/TRITC pair was replaced with TRITC/Cy5 FRET pair. Microcapsuies 
containing TRITC-dextran (TD)/Cy5-apo-GOx (CAG) complexes showed a sensitivity of 
0.83%/mM, which is 3 -  4X lower than the sensitivity obtained with the FD/TAG assay. 
This drop in sensitivity could be due to the lower FRET efficiency between TRITC and 
Cy5, different labeling ratios, etc. Also, using the TRITC/Cy5 dyes extended the 
operating region by only lOOnm, which may not result in a significant decrease in tissue 
scattering. In order to carry out implantation studies, it is highly desirable to extend the 
operating wavelength region more into the NIR region.
Another concern in the above mentioned apo-GOx/dextran systems is the use of 
DAR, which is toxic, and the inconvenient assembly conditions, as the assembly process 
must be performed in the absence of UV light. Also, the biomacromolecules which are 
loaded into microcapsuies are exposed to UV light, which may result in the loss of
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activity or binding affinity to certain molecules. Therefore, another approach has to be 
developed in order to improve the stability of the biomolecules in the microcapsuies.
In order to extend the operating region into the NIR, various dyes operating in the 
NIR region were selected. Due to the difficulties in finding an efficient NIR FRET pair, 
quenching is used as the transduction mechanism in the dextran/apo-GOx competitive 
binding assay. The sensing assay elements, quencher (QSY21)-dextran/fluorescent 
(AF647)-apo-GOx and reference dye (AF750), were entrapped in microcapsuies using a 
simple silane based encapsulation procedure. Unlike the DAR based encapsulation 
procedure, this silane based technique is very simple in terms of maintaining proper 
assembling conditions, and it also may not have the toxicity concern. Microcapsuies 
containing labeled dextran/apo-GOx complexes showed glucose sensitivity of ~2- 
5%/mM (Table 8.1). Also, a significant achievement in this assay is that, in spite of the 
extension of the operating region from visible to NIR, its sensitivity to glucose is 
comparable to the assay operating in the visible region. Thus, this assay is superior to all 
the other assays demonstrated in this dissertation, because it has the advantages of, (a) 
non-toxic nature, which was the main problem with Con A based assays, (b) the silane 
based encapsulation procedure employed in this system is simple, and is free of toxic 
materials, (c) The sensitivity of this system is comparable to and better than FD/TAG and 
TD/CAG based assays and (d) a significant increase in the signal levels (signal to noise 
ratio) due to the decrease in light scattering resulting from the use of NIR dyes. Thus, the 
NIR glucose sensor is highly promising for conducting in vivo studies in a rat model.
The generic sensor design described here opens the door for a wide variety of 
analytes to be sensed using this versatile sensing technique which involves the selection
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of an analyte-specific enzyme and a competing ligand. Therefore, this design can be 
considered as a platform technology for the development of biosensors based on 
competitive binding and RET techniques. Potential targets include neurochemicals, such 
as glutamate, choline, lipids, and estrogen. In conclusion, fluorescence affinity sensors 
were shown to be promising for monitoring glucose concentrations in diabetic patients.
8.2 Future Work
Optimization. The sensor response can be further optimized by varying the 
labeling ratio of apo-GOx and dextran molecules with donor and acceptor dyes. Also, 
apo-GOx molecule contains three reactive molecular groups, amine, thiol groups and 
carboxylic acid, that are candidates for conjugation of the FRET donor Alexa Fluor 647. 
This fact can be exploited to determine which molecular group needs to be labeled to 
achieve the desired sensitivity and different concentrations of assay molecules can be 
encapsulated into microcapsuies using different concentrations of loading solutions. The 
stability of the encapsulated sensing elements in microcapsuies should be measured over 
a long period of time.
Stability. The stability of the assay molecules encapsulated in microcapsuies 
using silane based procedure must be tested by performing the leaching experiments as 
described in Chapter five (section 5.3.7). Also, sensor response must be monitored at 
regular intervals over a long time period to observe the magnitude of drift in the response.
Further experiments must be performed on the flow through system to more 
accurately test the reversibility and response time of the sensors. While using the flow 
through system, variations in the photobleaching rates of different dyes have to be 
considered, as the sample is continuously excited which may have significant bleaching
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effect on the dyes. It would be appropriate to conduct fluorescence lifetime studies on 
these sensors because they are not concentration dependent and could also be the best 
approach for future in vivo experiments. Finally, the response of the sensors should be 
evaluated in vivo, first in the rat model, then in larger models with skin similar to that of 
humans (e.g., porcine models).
This work could be further used in detecting different metabolites other than 
glucose. For example, a lactate sensor can be designed by using apo-lactate oxidase and 
poly(lactic acid) as the receptor and ligand molecules, respectively. Also, this sensing 
mechanism can be further extended to develop drug-delivery systems; for example, 
insulin may be released in response to apo-GOx/dextran dissociation.
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